Name,Agency product number,Active substance,International non-proprietary name (INN) or common name,Therapeutic area (MeSH),Anatomical therapeutic chemical (ATC) code,Generic,Marketing-authorisation holder,Revision,Date of issue of marketing authorisation valid throughout the European Union,Contact address,Additional monitoring,Orphan,Conditional approval,Biosimilar,Marketing-autorisation applicant,Date of opinion,Exceptional circumstances,Date of refusal of marketing authorisation,Countries
Bortezomib Sun,EMEA/H/C/004076,bortezomib,bortezomib,Multiple Myeloma,L01XX32,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",SUN Pharmaceutical Industries (Europe) B.V.,4,22/07/2016,"Polarisavenue 87
2132JH Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
Verzenios,EMEA/H/C/004302,abemaciclib,abemaciclib,Breast Neoplasms,L01XE50,,Eli Lilly Nederland B.V.,1,26/09/2018,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Orgalutran,EMEA/H/C/000274,ganirelix,ganirelix,"Reproductive Techniques, Assisted
Ovulation Induction",H01CC01,,Merck Sharp and Dohme B.V,17,16/05/2000,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Aldurazyme,EMEA/H/C/000477,laronidase,laronidase,Mucopolysaccharidosis I,A16AB05,,Genzyme Europe B.V.,17,09/06/2003,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Imatinib Accord,EMEA/H/C/002681,imatinib,imatinib,"Precursor Cell Lymphoblastic Leukemia-Lymphoma
Dermatofibrosarcoma
Myelodysplastic-Myeloproliferative Diseases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hypereosinophilic Syndrome",L01XE01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,13,30/06/2013,"Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Levetiracetam Actavis Group,EMEA/H/C/002305,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,11,04/12/2011,"Reykjavíkurvegur 76-78
220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Kalydeco,EMEA/H/C/002494,ivacaftor,ivacaftor,Cystic Fibrosis,R07AX02,,Vertex Pharmaceuticals (Europe) Ltd,15,22/07/2012,"2 Kingdom Street
London W2 6BD
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Levetiracetam Actavis,EMEA/H/C/002355,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,13,03/10/2011,"Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Karvea,EMEA/H/C/000142,irbesartan,irbesartan,Hypertension,C09CA04,,Sanofi-aventis groupe,35,26/08/1997,"54 rue La Boétie
75008 Paris
France",,,,,,,,,France
Vimizim,EMEA/H/C/002779,recombinant human n-acetylgalactosamine-6-sulfatase (rhgalns),elosulfase alfa,Mucopolysaccharidosis IV,A16AB12,,BioMarin International Limited,10,27/04/2014,"Shanbally, Ringaskiddy
County Cork, P43 R298
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Levetiracetam Teva,EMEA/H/C/002316,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,13,25/08/2011,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Zebinix,EMEA/H/C/000988,eslicarbazepine acetate,eslicarbazepine acetate,Epilepsy,N03AF04,,"BIAL - Portela & Ca, S.A.",24,20/04/2009,"BIAL - Portela & Ca, S.A.
A Avenida da Siderurgia Nacional
PT-4745-457 S. Mamede do Coronado
Portugal",,,,,,,,,Portugal
Xalkori,EMEA/H/C/002489,crizotinib,crizotinib,"Carcinoma, Non-Small-Cell Lung",L01XE16,,Pfizer Europe MA EEIG,24,22/10/2012,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Halaven,EMEA/H/C/002084,Eribulin,eribulin,"Breast Neoplasms
Liposarcoma",L01XX41,,Eisai GmbH,17,16/03/2011,,,,,,,,,,
Exforge HCT,EMEA/H/C/001068,"Amlodipine besylate
valsartan
hydrochlorothiazide",amlodipine besylate / valsartan / hydrochlorothiazide,Hypertension,C09DX01,,Novartis Europharm Limited,14,15/10/2009,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Dafiro HCT,EMEA/H/C/001160,"Amlodipine besylate
valsartan
hydrochlorothiazide",amlodipine besylate / valsartan / hydrochlorothiazide,Hypertension,C09DX01,,Novartis Europharm Limited,14,03/11/2009,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Exforge,EMEA/H/C/000716,"amlodipine (as besylate)
valsartan",amlodipine / valsartan,Hypertension,C09DB01,,Novartis Europharm Limited,22,16/01/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Kanuma,EMEA/H/C/004004,sebelipase alfa,sebelipase alfa,"Lipid Metabolism, Inborn Errors",A16,,Alexion Europe SAS,2,27/08/2015,"1-15 avenue Edouard Belin
92500 Rueil Malmaison
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Dafiro,EMEA/H/C/000776,"amlodipine
valsartan",amlodipine / valsartan,Hypertension,C09DB01,,Novartis Europharm Limited,24,15/01/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Coagadex,EMEA/H/C/003855,Human coagulation factor X,human coagulation factor X,Factor X Deficiency,B02BD13,,Bio Products Laboratory Limited,1,15/03/2016,"Dagger Lane
Elstree
Hertfordshire WD6 3BX
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Rolufta Ellipta (previously Rolufta),EMEA/H/C/004654,umeclidinium bromide,umeclidinium,"Pulmonary Disease, Chronic Obstructive",R03BB07,,GlaxoSmithKline Trading Services Limited,3,19/03/2017,"Currabinny
Carrigaline
County Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Ionsys,EMEA/H/C/002715,fentanyl hydrochloride,fentanyl,"Pain, Postoperative",N02AB03,,Incline Therapeutics Europe Ltd,2,18/11/2015,"21 St Thomas Street
Bristol
BS1 6JS
United Kingdom",,,,,,,,,United Kingdom
Venclyxto,EMEA/H/C/004106,Venetoclax,venetoclax,"Leukemia, Lymphocytic, Chronic, B-Cell",L01XX52,,AbbVie Deutschland GmbH Co. KG,6,04/12/2016,"Knollstrasse
67061 Ludwigshafen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Germany
Laventair Ellipta (previously Laventair),EMEA/H/C/003754,"umeclidinium bromide
vilanterol",umeclidinium bromide / vilanterol,"Pulmonary Disease, Chronic Obstructive",R03AL03,,Glaxo Group Ltd,7,07/05/2014,"Glaxo Wellcome House
Berkeley Avenue
Greenford
Middlesex UB6 0NN
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Liprolog,EMEA/H/C/000393,insulin lispro,insulin lispro,Diabetes Mellitus,A10AC04,,Eli Lilly Nederland B.V.,24,31/07/2001,"Eli Lilly Nederland BV
Grootslag 1-5,
NL-3991 RA Houten
The Netherlands",,,,,,,,,The Netherlands
Zytiga,EMEA/H/C/002321,abiraterone acetate,abiraterone,Prostatic Neoplasms,L02BX03,,Janssen-Cilag International N.V.,20,04/09/2011,"Turnhoutseweg 30
BE-2340 Beerse
Belgium",,,,,,,,,Belgium
Rivastigmine 1 A Pharma,EMEA/H/C/001181,rivastigmine,rivastigmine,"Alzheimer Disease
Dementia
Parkinson Disease",N06DA03,,1 A Pharma GmbH,9,10/12/2009,"Keltenring 1 + 3
D-82041 Oberhaching
Germany",,,,,,,,,Germany
ViraferonPeg,EMEA/H/C/000329,peginterferon alfa-2b,peginterferon alfa-2b,"Hepatitis C, Chronic",L03AB10,,Merck Sharp Dohme Ltd ,36,28/05/2000,"Merck Sharp Dohme Ltd
Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Humalog,EMEA/H/C/000088,insulin lispro,insulin lispro,Diabetes Mellitus,A10AC04,,Eli Lilly Nederland B.V.,29,29/04/1996,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands",,,,,,,,,The Netherlands
Lucentis,EMEA/H/C/000715,ranibizumab,ranibizumab,"Wet Macular Degeneration
Macular Edema
Myopia, Degenerative
Diabetes Complications",S01LA04,,Novartis Europharm Limited,30,21/01/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Kyntheum,EMEA/H/C/003959,brodalumab,brodalumab,Psoriasis,L04AC12,,LEO Pharma A/S,2,16/07/2017,"Industriparken 55
DK-2750 Ballerup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Atazanavir Mylan,EMEA/H/C/004048,atazanavir sulfate,atazanavir,HIV Infections,J05AE08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,4,21/08/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Cuprior,EMEA/H/C/004005,Trientine tetrahydrochloride,trientine,Hepatolenticular Degeneration,A16AX,,GMP-Orphan SA,1,04/09/2017,"Pepiniere Paris Sante Cochin
27-29 rue du Faubourg Saint-Jacques
75014 Paris
France",,,,,,,,,France
Lemtrada,EMEA/H/C/003718,alemtuzumab,alemtuzumab,Multiple Sclerosis,L04AA34,,Sanofi Belgium,6,11/09/2013,"Leonardo Da Vincilaan 19
B-1831 Diegem
Belgium",,,,,,,,,Belgium
Dexdor,EMEA/H/C/002268,dexmedetomidine hydrochloride,dexmedetomidine,Conscious Sedation,N05CM18,,Orion Corporation,9,15/09/2011,"Orionintie 1
FI-02200 Espoo
Finland",,,,,,,,,Finland
Uptravi,EMEA/H/C/003774,Selexipag,selexipag,"Hypertension, Pulmonary",B01AC27,,Janssen Cilag International NV,7,11/05/2016,"Turnhoutseweg 30
B 2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Sustiva,EMEA/H/C/000249,efavirenz,efavirenz,HIV Infections,J05AG03,,Bristol-Myers Squibb Pharma EEIG,43,27/05/1999,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Kuvan,EMEA/H/C/000943,Sapropterin dihydrochloride,sapropterin,Phenylketonurias,A16AX07,,BioMarin International Limited,16,01/12/2008,"Shanbally
Ringaskiddy Cork Co.
Cork
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Bridion,EMEA/H/C/000885,sugammadex,sugammadex,Neuromuscular Blockade,V03AB35,,Merck Sharp & Dohme B.V.,14,24/07/2008,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Intrarosa,EMEA/H/C/004138,Prasterone,prasterone,Menopause,G03,,Endoceutics Limited,1,07/01/2018,"Salisbury House
London Wall
London EC2M 5PS
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Remsima,EMEA/H/C/002576,infliximab,infliximab,"Arthritis, Psoriatic
Spondylitis, Ankylosing
Colitis, Ulcerative
Psoriasis
Crohn Disease
Arthritis, Rheumatoid",L04AB02,,Celltrion Healthcare Hungary Kft.,13,09/09/2013,"1062 Budapest
Váci út 1-3. WestEnd Office Building B torony
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Inhixa,EMEA/H/C/004264,enoxaparin sodium,enoxaparin sodium,Venous Thromboembolism,B01AB05,,Techdow Europe AB,8,14/09/2016,"Kåbovägen 32
752 36 Uppsala
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Sweden
Repaglinide Accord,EMEA/H/C/002318,repaglinide,repaglinide,"Diabetes Mellitus, Type 2",A10BX02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,4,21/12/2011,"Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Atripla,EMEA/H/C/000797,"efavirenz
emtricitabine
tenofovir disoproxil fumarate",efavirenz / emtricitabine / tenofovir disoproxil,HIV Infections,J05AR06,,Bristol-Myers Squibb and Gilead Sciences Limited,29,12/12/2007,"Unit 13, Stillorgan Industrial Park
Blackrock
Co. Dublin
Ireland",,,,,,,,,Ireland
Zomarist,EMEA/H/C/001049,"vildagliptin
metformin hydrochloride",vildagliptin / metformin,"Diabetes Mellitus, Type 2",A10BD08,,Novartis Europharm Limited ,17,30/11/2008,"Elm Park, Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Ecansya (previously Capecitabine Krka),EMEA/H/C/002605,capecitabine,capecitabine,"Colonic Neoplasms
Breast Neoplasms
Colorectal Neoplasms
Stomach Neoplasms",L01BC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",9,19/04/2012,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Zoledronic acid Actavis,EMEA/H/C/002488,zoledronic acid monohydrate,zoledronic acid,"Fractures, Bone",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf  ,11,19/04/2012,"Actavis Group PTC ehf
Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Sirturo,EMEA/H/C/002614,bedaquiline fumarate,bedaquiline,"Tuberculosis, Multidrug-Resistant",J04A,,Janssen-Cilag International N.V.,14,04/03/2014,"Turnhoutseweg 30
B-2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Belgium
Desloratadine Actavis,EMEA/H/C/002435,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Urticaria
Rhinitis, Allergic, Seasonal",R06AX27,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,11,12/01/2012,"Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Infanrix Hexa,EMEA/H/C/000296,"Diphtheria toxoid
tetanus toxoid
Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin)
hepatitis B surface antigen
poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain))
Haemophilus influenzae type-b polysaccharide","diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed)","Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Poliomyelitis
Diphtheria",J07CA09,,GlaxoSmithKline Biologicals S.A.,39,22/10/2000,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Duloxetine Mylan,EMEA/H/C/003981,duloxetine,duloxetine,"Neuralgia
Diabetic Neuropathies
Anxiety Disorders
Depressive Disorder, Major",N06AX21,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,7,18/06/2015,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Exjade,EMEA/H/C/000670,deferasirox,deferasirox,"beta-Thalassemia
Iron Overload",V03AC03,,Novartis Europharm Limited,41,27/08/2006,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Vidaza,EMEA/H/C/000978,azacitidine,azacitidine,Myelodysplastic Syndromes,L01BC07,,Celgene Europe B.V. ,17,16/12/2008,"Celgene Europe B.V.
Winthontlaan 6 N
3526KV Utrecht
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Daptomycin Hospira,EMEA/H/C/004310,daptomycin,daptomycin,"Soft Tissue Infections
Skin Diseases, Bacterial",J01XX09,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hospira UK Limited,3,21/03/2017,"Horizon Honey Lane
Maidenhead
Hurley SL6 6RJ
United Kingdom",,,,,,,,,United Kingdom
Onpattro,EMEA/H/C/004699,patisiran sodium,patisiran,"Amyloidosis, Familial",N07,,Alnylam Netherlands B.V.,0,26/08/2018,"Strawinskylaan 3051 1077 ZX
Amsterdam
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Capecitabine Accord,EMEA/H/C/002386,capecitabine,capecitabine,"Colonic Neoplasms
Breast Neoplasms
Colorectal Neoplasms
Stomach Neoplasms",L01BC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,8,19/04/2012,"Accord Healthcare Limited
Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Rotarix,EMEA/H/C/000639,"human rotavirus, live attenuated","rotavirus vaccine, live, attenuated","Immunization
Rotavirus Infections",J07BH01,,GlaxoSmithKline Biologicals S.A.,28,20/02/2006,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Irbesartan Zentiva (previously Irbesartan Winthrop),EMEA/H/C/000785,irbesartan,irbesartan,Hypertension,C09CA04,,Zentiva k.s.,20,18/01/2007,"U kabelovny 130
Dolni Mecholupy
102 37 Prague 10
Czech Republic",,,,,,,,,Czech Republic
Baraclude,EMEA/H/C/000623,Entecavir,entecavir,"Hepatitis B, Chronic",J05AF10,,Bristol-Myers Squibb Pharma EEIG,23,25/06/2006,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Herzuma,EMEA/H/C/002575,trastuzumab,trastuzumab,"Stomach Neoplasms
Breast Neoplasms",L01XC03,,Celltrion Healthcare Hungary Kft.,3,08/02/2018,"Vaci ut 1-3
WestEnd Office Building B torony
1062 Budapest
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Vyxeos,EMEA/H/C/004282,daunorubicin hydrochloride / cytarabine,daunorubicin / cytarabine,"Leukemia, Myeloid, Acute",L01XY01,,Jazz Pharmaceuticals Ireland Limited,0,22/08/2018,"Fifth Floor Waterloo Exchange
Waterloo Road
D04 E5W7
Dublin 4
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Opdivo,EMEA/H/C/003985,nivolumab,nivolumab,"Melanoma
Hodgkin Disease
Carcinoma, Renal Cell
Carcinoma, Non-Small-Cell Lung",L01XC,,Bristol-Myers Squibb Pharma EEIG,21,18/06/2015,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Truberzi,EMEA/H/C/004098,eluxadoline,eluxadoline,"Irritable Bowel Syndrome
Diarrhea",A07,,Allergan Pharmaceuticals International Limited,4,18/09/2016,"Clonshaugh Industrial Estate
Coolock
Dublin 17
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Kisplyx,EMEA/H/C/004224,lenvatinib mesilate,lenvatinib,"Carcinoma, Renal Cell",L01XE29,,Eisai Europe Ltd,6,24/08/2016,"European Knowledge Centre
Mosquito Way
Hertfordshire
Hatfield AL10 9SN
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Cosentyx,EMEA/H/C/003729,Secukinumab,secukinumab,"Arthritis, Psoriatic
Psoriasis
Spondylitis, Ankylosing",L04AC10,,Novartis Europharm Limited,11,14/01/2015,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Lynparza,EMEA/H/C/003726,Olaparib,olaparib,Ovarian Neoplasms,L01,,AstraZeneca AB,5,15/12/2014,"SE-151 85 Södertälje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Abilify Maintena,EMEA/H/C/002755,aripiprazole,aripiprazole,Schizophrenia,N05AX12,,Otsuka Pharmaceutical Netherlands B.V.,13,14/11/2013,"Herikerbergweg 292
1101 CT Amsterdam
Netherlands",,,,,,,,,The Netherlands
Prevenar 13,EMEA/H/C/001104,"pneumococcal polysaccharide serotype 1 / pneumococcal polysaccharide serotype 14 / pneumococcal polysaccharide serotype 18C / pneumococcal polysaccharide serotype 19A
pneumococcal polysaccharide serotype 19F / pneumococcal polysaccharide serotype 23F / pneumococcal polysaccharide serotype 3 / pneumococcal polysaccharide serotype 4
pneumococcal polysaccharide serotype 5
pneumococcal polysaccharide serotype 6A
pneumococcal polysaccharide serotype 6B / pneumococcal polysaccharide serotype 7F / pneumococcal polysaccharide serotype 9V protein","pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)","Pneumococcal Infections
Immunization",J07AL02,,Pfizer Europe MA EEIG,31,08/12/2009,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
IntronA,EMEA/H/C/000281,interferon alfa-2b,interferon alfa-2b,"Carcinoid Tumor
Leukemia, Hairy Cell
Lymphoma, Follicular
Hepatitis B, Chronic
Hepatitis C, Chronic
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Melanoma
Multiple Myeloma",L03AB05,,Merck Sharp & Dohme B.V.,30,08/03/2000,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Ecalta,EMEA/H/C/000788,anidulafungin,anidulafungin,Candidiasis,J02AX06,,Pfizer Europe MA EEIG,17,19/09/2007,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Soliris,EMEA/H/C/000791,Eculizumab,eculizumab,"Hemoglobinuria, Paroxysmal",L04AA25,,Alexion Europe SAS,24,19/06/2007,"1-15 Avenue Edouard Belin
92500 Rueil-Malmaison
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Nexium Control,EMEA/H/C/002618,esomeprazole,esomeprazole,Gastroesophageal Reflux,A02BC05,,Pfizer Healthcare Ireland,11,25/08/2013,"9 Riverwalk
National Digital Park
Citywest Business Campus
Dublin 24
D24 NT20",,,,,,,,,Ireland
Memantine Mylan,EMEA/H/C/002660,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,4,21/04/2013,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Dukoral,EMEA/H/C/000476,"recombinant cholera toxin B subunit
vibrio cholerae 01","cholera vaccine (inactivated, oral)","Cholera
Immunization",J07AE01,,Valneva Sweden AB,12,27/04/2004,"S-105 21 Stockholm
Sweden",,,,,,,,,Sweden
Tremfya,EMEA/H/C/004271,guselkumab,guselkumab,Psoriasis,L04AC,,Janssen-Cilag International N.V.,1,09/11/2017,"Turnhoutseweg 30
B-2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Simponi,EMEA/H/C/000992,Golimumab,golimumab,"Arthritis, Psoriatic
Spondylitis, Ankylosing
Colitis, Ulcerative
Arthritis, Rheumatoid",L04AB06,,Janssen Biologics B.V.,31,30/09/2009,"Einsteinweg 101
NL-2333 CB Leiden
The Netherlands",,,,,,,,,The Netherlands
Ryzodeg,EMEA/H/C/002499,"insulin aspart
insulin degludec",insulin degludec / insulin aspart,Diabetes Mellitus,A10AD06,,Novo Nordisk A/S,10,20/01/2013,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Nucala,EMEA/H/C/003860,Mepolizumab,mepolizumab,Asthma,R03DX09,,GlaxoSmithKline Trading Services,9,01/12/2015,"Currabinny
Carrigaline
County Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Lenvima,EMEA/H/C/003727,lenvatinib mesylate,lenvatinib,Thyroid Neoplasms,L01XE,,Eisai Europe Ltd,5,27/05/2015,"European Knowledge Centre
Mosquito Way
Hertfordshire
Hatfield AL10 9SN
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva,EMEA/H/C/004250,"efavirenz
emtricitabine
tenofovir disoproxil, phosphate",efavirenz / emtricitabine / tenofovir disoproxil,HIV Infections,J05AR06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Zentiva k.s.,2,16/07/2017,"U kabelovny 130
Dolni Mecholupy
102 37 Prague 10
Czech Republic","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Czech Republic
Jinarc,EMEA/H/C/002788,Tolvaptan,tolvaptan,"Polycystic Kidney, Autosomal Dominant",C03XA01,,Otsuka Pharmaceutical Europe Ltd,9,26/05/2015,"Gallions Wexham
Springs Framewood Road
Wexham
Slough SL3 6PJ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Trevicta (previously Paliperidone Janssen),EMEA/H/C/004066,paliperidone palmitate,paliperidone,Schizophrenia,N05AX13,,Janssen-Cilag International NV,8,04/12/2014,"Turnhoutseweg 30
2340 Beerse
Belgium",,,,,,,,,Belgium
Kyprolis,EMEA/H/C/003790,carfilzomib,carfilzomib,Multiple Myeloma,L01XX45,,Amgen Europe B.V.,13,18/11/2015,"Minervum 7061
Breda 4817ZK
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Afinitor,EMEA/H/C/001038,everolimus,everolimus,"Carcinoma, Renal Cell
Breast Neoplasms
Pancreatic Neoplasms",L01XE10,,Novartis Europharm Limited,21,02/08/2009,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Blincyto,EMEA/H/C/003731,blinatumomab,blinatumomab,Precursor Cell Lymphoblastic Leukemia-Lymphoma,L01XC,,Amgen Europe B.V.,8,22/11/2015,"Minervum 7061
4817 ZK Breda
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
BeneFIX,EMEA/H/C/000139,Nonacog alfa,nonacog alfa,Hemophilia B,B02BD04,,Pfizer Europe MA EEIG,37,26/08/1997,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Xeplion,EMEA/H/C/002105,paliperidone palmitate,paliperidone,Schizophrenia,N05AX13,,Janssen-Cilag International N.V.,13,03/03/2011,"Turnhoutseweg 30
BE-2340 Beerse
Belgium",,,,,,,,,Belgium
Orkambi,EMEA/H/C/003954,"Lumacaftor
ivacaftor",lumacaftor / ivacaftor,Cystic Fibrosis,R07AX30,,Vertex Pharmaceuticals (Europe) Ltd,13,18/11/2015,"2 Kingdom Street
London W2 6BD
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Invega,EMEA/H/C/000746,paliperidone,paliperidone,"Schizophrenia
Psychotic Disorders",N05AX13,,Janssen-Cilag International NV,16,24/06/2007,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Ivabradine Zentiva,EMEA/H/C/004117,ivabradine hydrochloride,ivabradine,"Angina Pectoris
Heart Failure",C01EB17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Zentiva, k.s.",1,10/11/2016,"U kabelovny 130
Dolni Mecholupy
102 37 Prague 10
Czech Republic",,,,,,,,,Czech Republic
Eylea,EMEA/H/C/002392,aflibercept,aflibercept,"Wet Macular Degeneration
Macular Edema
Diabetes Complications",S01LA05,,Bayer AG,15,21/11/2012,"51368 Leverkusen
Germany",,,,,,,,,Germany
Fasenra,EMEA/H/C/004433,benralizumab,benralizumab,Asthma,R03DX10,,AstraZeneca AB,2,07/01/2018,"SE-151-85 Sodertalje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Telzir,EMEA/H/C/000534,fosamprenavir calcium,fosamprenavir,HIV Infections,J05AE07,,ViiV Healthcare BV,39,11/07/2004,"Huis ter Heideweg 62
3705 LZ Zeist
The Netherlands",,,,,,,,,The Netherlands
Flebogamma DIF (previously Flebogammadif),EMEA/H/C/000781,Human normal immunoglobulin,human normal immunoglobulin,"Mucocutaneous Lymph Node Syndrome
Guillain-Barre Syndrome
Bone Marrow Transplantation
Purpura, Thrombocytopenic, Idiopathic
Immunologic Deficiency Syndromes",J06BA02,,Instituto Grifols S.A.,15,22/07/2007,"Can Guasch 2
E-08150 Parets del Vallès
Barcelona
Spain",,,,,,,,,Spain
Dupixent,EMEA/H/C/004390,dupilumab,dupilumab,"Dermatitis, Atopic",D11AH05,,sanofi-aventis groupe,2,26/09/2017,"54 rue La Boetie
75008 Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Praxbind,EMEA/H/C/003986,idarucizumab,idarucizumab,Hemorrhage,V03AB,,Boehringer Ingelheim International GmbH,5,19/11/2015,"Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Kaletra,EMEA/H/C/000368,"lopinavir
ritonavir",lopinavir / ritonavir,HIV Infections,J05AR10,,AbbVie Deutschland GmbH Co. KG,49,19/03/2001,"Knollstrasse
67061 Ludwigshafen
Germany",,,,,,,,,Germany
Cresemba,EMEA/H/C/002734,isavuconazole,isavuconazole,Aspergillosis,J02AC,,Basilea Medical Ltd,3,14/10/2015,"(c/o Cox Costello Horne Limited)
Langwood House
63-81 High Street
Rickmansworth
Hertfordshire WD3 1EQ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Abilify,EMEA/H/C/000471,aripiprazole,aripiprazole,"Schizophrenia
Bipolar Disorder",N05AX12,,Otsuka Pharmaceutical Netherlands B.V.,42,03/06/2004,"Herikerbergweg 292
1101 CT Amsterdam
Netherlands",,,,,,,,,The Netherlands
Steglatro,EMEA/H/C/004315,ertugliflozin l-pyroglutamic acid,ertugliflozin,"Diabetes Mellitus, Type 2",A10BK04,,Merck Sharp & Dohme B.V.,2,20/03/2018,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Lumigan,EMEA/H/C/000391,bimatoprost,bimatoprost,"Glaucoma, Open-Angle
Ocular Hypertension",S01EE03,,Allergan Pharmaceuticals Ireland,29,07/03/2002,"Castlebar Road
Westport, Co Mayo
Ireland",,,,,,,,,Ireland
Incruse Ellipta (previously Incruse),EMEA/H/C/002809,umeclidinium bromide,umeclidinium bromide,"Pulmonary Disease, Chronic Obstructive",R03BB07,,Glaxo Group Ltd,9,27/04/2014,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Xigduo,EMEA/H/C/002672,"metformin hydrochloride
dapagliflozin propanediol monohydrate",dapagliflozin / metformin,"Diabetes Mellitus, Type 2",A10BD15,,AstraZeneca AB,10,15/01/2014,"SE-151-85 Sodertalje
Sweden",,,,,,,,,Sweden
Sovaldi,EMEA/H/C/002798,Sofosbuvir,sofosbuvir,"Hepatitis C, Chronic",J05AX15,,Gilead Sciences Ireland UC,15,15/01/2014,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Anoro Ellipta (previously Anoro),EMEA/H/C/002751,"umeclidinium bromide
vilanterol trifenatate",umeclidinium bromide / vilanterol,"Pulmonary Disease, Chronic Obstructive",R03AL03,,Glaxo Group Ltd,8,07/05/2014,"Berkeley Avenue
Greenford
Middlesex UB6 0NN
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Prasugrel Mylan,EMEA/H/C/004644,prasugrel besilate,prasugrel,"Myocardial Infarction
Acute Coronary Syndrome
Angina, Unstable",B01AC22,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,2,15/05/2018,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Spherox,EMEA/H/C/002736,spheroids of human autologous matrix-associated chondrocytes,spheroids of human autologous matrix-associated chondrocytes,Cartilage Diseases,M09AX02,,CO.DON AG,2,09/07/2017,"Warthestr. 21
14513 Teltow
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Zavesca,EMEA/H/C/000435,miglustat,miglustat,"Gaucher Disease
Niemann-Pick Diseases",A16AX06,,Janssen Cilag International NV,28,19/11/2002,"Turnhoutseweg 30
B 2340 Beerse
Belgium",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Aclasta,EMEA/H/C/000595,zoledronic acid,zoledronic acid,"Osteoporosis
Osteitis Deformans
Osteoporosis, Postmenopausal",M05BA08,,Novartis Europharm Limited ,24,14/04/2005,"Elm Park, Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Respreeza,EMEA/H/C/002739,alpha1-proteinase inhibitor (human),alpha1-proteinase inhibitor (human),"Genetic Diseases, Inborn
Lung Diseases",B02AB02,,CSL Behring GmbH,4,19/08/2015,"Emil-von-Behring-Straße 76
35041 Marburg
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
NexoBrid,EMEA/H/C/002246,concentrate of proteolytic enzymes enriched in bromelain,concentrate of proteolytic enzymes enriched in bromelain,Debridement,D03BA03,,MediWound Germany GmbH,8,17/12/2012,"Eisenstrasse 5
65428 Rüsselsheim
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Lenalidomide Accord,EMEA/H/C/004857,lenalidomide,lenalidomide,Multiple Myeloma,L04AX04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Limited,0,19/09/2018,"Sage House
319 Pinner Road
North Harrow
Middlesex HA1 4HF
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Kigabeq,EMEA/H/C/004534,vigabatrin,vigabatrin,"Spasms, Infantile
Epilepsies, Partial",N03AG04,,ORPHELIA Pharma SAS,0,19/09/2018,"85 Boulevard Saint-Michel
75005 Paris
France",,,,,,,,,France
Airexar Spiromax,EMEA/H/C/004267,"salmeterol
fluticasone propionate",salmeterol xinafoate / fluticasone propionate,"Pulmonary Disease, Chronic Obstructive
Asthma",R03AK06,,Teva B.V.,2,17/08/2016,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Targretin,EMEA/H/C/000326,bexarotene,bexarotene,"Lymphoma, T-Cell, Cutaneous",L01XX25,,Eisai GmbH,18,28/03/2001,"Lyoner StraBe 36
60528 Frankfurt am Main
Deutschland",,,,,,,,,Germany
Vimpat,EMEA/H/C/000863,lacosamide,lacosamide,Epilepsy,N03AX18,,UCB Pharma SA,29,28/08/2008,"Allée de la Recherche 60
BE-1070 Brussels
Belgium",,,,,,,,,Belgium
Descovy,EMEA/H/C/004094,"emtricitabine
tenofovir alafenamide",emtricitabine / tenofovir alafenamide,HIV Infections,J05AR17,,Gilead Sciences Ireland UC,12,20/04/2016,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Braftovi,EMEA/H/C/004580,Encorafenib,encorafenib,Melanoma,L01XE,,Pierre Fabre Medicament,0,19/09/2018,"45 Place Abel Gance
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Mektovi,EMEA/H/C/004579,binimetinib,binimetinib,Melanoma,L01XE,,Pierre Fabre Medicament,0,19/09/2018,"45 Place Abel Gance
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Exviera,EMEA/H/C/003837,dasabuvir sodium,dasabuvir,"Hepatitis C, Chronic",J05AP09,,AbbVie Ltd,13,14/01/2015,"Vanwall Business Park
Vanwall Road
Maidenhead
Berkshire SL6 4UB
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Parsabiv,EMEA/H/C/003995,etelcalcetide hydrochloride,etelcalcetide,"Hyperparathyroidism, Secondary",H05BX04,,Amgen Europe B.V.,5,10/11/2016,"Minervum 7061
4817 ZK Breda
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Stribild,EMEA/H/C/002574,"elvitegravir
cobicistat
emtricitabine
tenofovir disoproxil fumarate",elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil,HIV Infections,05AR09,,Gilead Sciences Ireland UC,19,23/05/2013,"Carrigtohill
County Cork, T45 DP77
Ireland",,,,,,,,,Ireland
Tolura,EMEA/H/C/001196,telmisartan,telmisartan,Hypertension,C09CA07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto ",8,03/06/2010,"Krka, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Clopidogrel Apotex (previously Clopidogrel Mylan Pharma),EMEA/H/C/001189,clopidogrel besilate,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Apotex Europe B.V.,15,15/10/2009,"Archimedesweg 2
2333 CN Leiden
The Netherlands",,,,,,,,,The Netherlands
RoActemra,EMEA/H/C/000955,tocilizumab,tocilizumab,"Arthritis, Rheumatoid
Arthritis, Juvenile Rheumatoid",L04AC07,,Roche Registration GmbH,24,15/01/2009,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Dynastat,EMEA/H/C/000381,parecoxib sodium,parecoxib,"Pain, Postoperative",M01AH04,,Pfizer Europe MA EEIG,27,21/03/2002,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Tecfidera,EMEA/H/C/002601,dimethyl fumarate,dimethyl fumarate,Multiple Sclerosis,N07XX09,,Biogen Idec Ltd,12,29/01/2014,"Innovation House
70 Norden Road
Maidenhead
Berkshire SL6 4AY
United Kingdom",,,,,,,,,United Kingdom
Xofigo,EMEA/H/C/002653,radium Ra223 dichloride,radium Ra223 dichloride,Prostatic Neoplasms,V10XX03,,Bayer AG,10,12/11/2013,"Kaiser-Wilhelm-Allee 1
51373 Leverkusen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Nimenrix,EMEA/H/C/002226,"Neisseria meningitidis serogroup A polysaccharide conjugated to tetanus toxoid
Neisseria meningitidis serogroup C polysaccharide conjugated to tetanus toxoid / Neisseria meningitidis serogroup W-135 polysaccharide conjugated to tetanus toxoid
Neisseria meningitidis serogroup Y polysaccharide conjugated to tetanus toxoid","meningococcal group A, C, W 135 and Y conjugate vaccine","Meningitis, Meningococcal",J07AH08,,Pfizer Europe MA EEIG,23,19/04/2012,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Stelara,EMEA/H/C/000958,Ustekinumab,ustekinumab,"Psoriasis
Arthritis, Psoriatic
Crohn Disease",L04AC05,,Janssen-Cilag International NV,25,15/01/2009,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Keytruda,EMEA/H/C/003820,Pembrolizumab,pembrolizumab,"Melanoma
Hodgkin Disease
Carcinoma, Non-Small-Cell Lung",L01,,Merck Sharp & Dohme B.V.,15,16/07/2015,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Raplixa,EMEA/H/C/002807,"human fibrinogen
human thrombin",human fibrinogen / human thrombin,"Hemostasis, Surgical",B02BC30,,Mallinckrodt Pharmaceuticals Ireland Limited,6,18/03/2015,"College Business Technology Park
Cruiserath
Blanchardstown
Dublin 15
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Iclusig,EMEA/H/C/002695,ponatinib,ponatinib,"Leukemia, Myeloid
Leukemia, Lymphoid",L01XE24,,Incyte Biosciences Distribution B.V.,19,30/06/2013,"Paasheuvelweg 25
1105 BP Amsterdam
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited),EMEA/H/C/004488,pemetrexed ditromethamine,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pfizer Europe MA EEIG,4,23/04/2017,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Imatinib Teva B.V.,EMEA/H/C/004748,imatinib mesilate,imatinib,"Dermatofibrosarcoma
Gastrointestinal Stromal Tumors
Leukemia, Myelogenous, Chronic, BCR-ABL Positive",L01XE01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,0,14/11/2017,"Swensweg
2031 GA
Haarlem
Netherlands",,,,,,,,,The Netherlands
Ilumetri,EMEA/H/C/004514,tildrakizumab,tildrakizumab,Psoriasis,L04AC,,Almirall S.A,0,16/09/2018,"Ronda General Mitre
151 08022 Barcelona
Spain","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Spain
Sevelamer carbonate Zentiva,EMEA/H/C/003971,sevelamer carbonate,sevelamer carbonate,"Hyperphosphatemia
Renal Dialysis",V03AE02,,Genzyme Europe BV,11,14/01/2015,"Gooimeer 10
1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Opsumit,EMEA/H/C/002697,Macitentan,macitentan,"Hypertension, Pulmonary",C02KX04,,Actelion Registration Ltd,11,19/12/2013,"Chiswick Tower 13th Floor
389 Chiswick High Road
London W4 4AL
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Mycophenolate mofetil Teva,EMEA/H/C/000882,mycophenolate mofetil,mycophenolate mofetil,Graft Rejection,L04AA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,20,20/02/2008,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Praluent,EMEA/H/C/003882,Alirocumab,alirocumab,Dyslipidemias,C10AX14,,sanofi-aventis groupe,10,22/09/2015,"54 rue La Boetie
75008 Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Dexxience,,betrixaban maleate,betrixaban,Venous Thromboembolism,B01AF,,,,,,,,,,Portola Pharma UK Limited,25/07/2018,,,
Cinacalcet Mylan,EMEA/H/C/004014,cinacalcet hydrochloride,cinacalcet,"Hyperparathyroidism, Secondary
Hypercalcemia",H05BX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,2,18/11/2015,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Rasilez HCT,EMEA/H/C/000964,"aliskiren
hydrochlorothiazide",aliskiren / hydrochlorothiazide,Hypertension,C09XA52,,Noden Pharma DAC,15,15/01/2009,"D'Olier Chambers
16A D'Olier Street
Dublin 2
Ireland",,,,,,,,,Ireland
Odefsey,EMEA/H/C/004156,"emtricitabine
rilpivirine hydrochloride
tenofovir alafenamide",emtricitabine / rilpivirine / tenofovir alafenamide,HIV Infections,J05AR19,,Gilead Sciences Ireland UC,13,20/06/2016,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Bydureon,EMEA/H/C/002020,exenatide,exenatide,"Diabetes Mellitus, Type 2",A10BJ01,,AstraZeneca AB,14,16/06/2011,"151 85 Södertälje
Sweden",,,,,,,,,Sweden
Inovelon,EMEA/H/C/000660,Rufinamide,rufinamide,Epilepsy,N03AF03,,Eisai GmbH,17,15/01/2007,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,
Aptivus,EMEA/H/C/000631,tipranavir,tipranavir,HIV Infections,J05AE09,,Boehringer Ingelheim International GmbH,36,24/10/2005,"Binger Strasse 173
D-55218 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Stivarga,EMEA/H/C/002573,regorafenib,regorafenib,Colorectal Neoplasms,L01XE21,,Bayer Pharma AG,14,25/08/2013,"13342 Berlin
Germany",,,,,,,,,Germany
Potactasol,EMEA/H/C/002282,topotecan,topotecan,"Uterine Cervical Neoplasms
Small Cell Lung Carcinoma",L01XX17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,7,05/01/2011,"Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Myfenax,EMEA/H/C/000884,mycophenolate mofetil,mycophenolate mofetil,Graft Rejection,L04AA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,20,20/02/2008,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Xerava,EMEA/H/C/004237,eravacycline,eravacycline,"Infection
Bacterial Infections",J01AA,,Tetraphase Pharmaceuticals Ireland Limited,0,19/09/2018,"10 Earlsfort Terrace
Dublin 2 D02 T380
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Pramipexole Teva,EMEA/H/C/000940,pramipexole dihydrochloride monohydrate,pramipexole,Parkinson Disease,N04BC05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,19,17/12/2008,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Zonegran,EMEA/H/C/000577,zonisamide,zonisamide,"Epilepsies, Partial",N03AX15,,Eisai GmbH,29,09/03/2005,,,,,,,,,,
Xeljanz,EMEA/H/C/004214,tofacitinib citrate,tofacitinib,"Arthritis, Rheumatoid",L04AA29,,Pfizer Limited,5,21/03/2017,"821 Ramsgate Road Sandwich
Kent CT13 9NJ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Strensiq,EMEA/H/C/003794,asfotase alfa,asfotase alfa,Hypophosphatasia,A16AB,,Alexion Europe SAS,8,27/08/2015,"1-15 avenue Edouard Belin
92500 Rueil Malmaison
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,France
Lixiana,EMEA/H/C/002629,edoxaban tosylate,edoxaban,"Stroke
Venous Thromboembolism",B01,,Daiichi Sankyo Europe GmbH,8,18/06/2015,"Zielstattstrasse 48
81379 München
Gerrmany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Kanjinti,EMEA/H/C/004361,trastuzumab,trastuzumab,"Stomach Neoplasms
Breast Neoplasms",L01XC03,,"Amgen Europe B.V., Breda",2,15/05/2018,"Minervum 7061 4817ZK
Breda
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Alkindi,EMEA/H/C/004416,hydrocortisone,hydrocortisone,Adrenal Insufficiency,H02AB09,,Diurnal Europe B.V.,3,08/02/2018,,,,,,,,,,
Zoledronic Acid Hospira,EMEA/H/C/002365,zoledronic acid monohydrate,zoledronic acid,Hypercalcemia,M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pfizer Europe MA EEIG,13,18/11/2012,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Topotecan Hospira,EMEA/H/C/001192,topotecan,topotecan,"Uterine Cervical Neoplasms
Small Cell Lung Carcinoma",L01XX17,,Pfizer Europe MA EEIG,11,09/06/2010,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Kovaltry,EMEA/H/C/003825,octocog alfa,octocog alfa,Hemophilia A,B02BD02,,Bayer Pharma AG,5,17/02/2016,"Muellerstrasse 178
13353 Berlin
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Perjeta,EMEA/H/C/002547,pertuzumab,pertuzumab,Breast Neoplasms,L01XC13,,Roche Registration GmbH ,16,03/03/2013,"Roche Registration GmbH
Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
NeuroBloc,EMEA/H/C/000301,botulinum toxin type B,botulinum toxin type B,Torticollis,M03AX01,,Sloan Pharma S.a.r.l,30,21/01/2001,"33 Rue du Puits Romain
8070 Bertrange
Luxembourg",,,,,,,,,Luxembourg
Cinqaero,EMEA/H/C/003912,Reslizumab,reslizumab,Asthma,R03DX08,,Teva B.V.,4,15/08/2016,"Swensweg 5
2031GA Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Deferiprone Lipomed,EMEA/H/C/004710,Deferiprone,deferiprone,"Iron Overload
beta-Thalassemia",V03AC02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Lipomed GmbH,0,19/09/2018,"Hegenheimer Strasse 2
79576 Weil am Rhein
Germany",,,,,,,,,Germany
Renvela,EMEA/H/C/000993,sevelamer carbonate,sevelamer carbonate,"Hyperphosphatemia
Renal Dialysis",V03AE02,,Genzyme Europe B.V.,16,09/06/2009,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Neulasta,EMEA/H/C/000420,pegfilgrastim,pegfilgrastim,"Neutropenia
Cancer",L03AA13,,Amgen Europe B.V.,32,21/08/2002,"Minervum 7061
NL-4817 ZK Breda
The Netherlands",,,,,,,,,The Netherlands
Binocrit,EMEA/H/C/000725,epoetin alfa,epoetin alfa,"Anemia
Kidney Failure, Chronic",B03XA01,,Sandoz GmbH,18,27/08/2007,"Biochemiestrasse 10
AT-6250 Kundl
Austria",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Abseamed,EMEA/H/C/000727,epoetin alfa,epoetin alfa,"Anemia
Kidney Failure, Chronic
Cancer",B03XA01,,Medice Arzneimittel Pütter GmbH Co. KG,19,27/08/2007,"Kuhloweg 37-39
D-58638 Iserlohn
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Invokana,EMEA/H/C/002649,canagliflozin,canagliflozin,"Diabetes Mellitus, Type 2",A10BK02,,Janssen-Cilag International N.V.,12,14/11/2013,"Turnhoutseweg 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Darzalex,EMEA/H/C/004077,Daratumumab,daratumumab,Multiple Myeloma,L01XC24,,Janssen-Cilag International N.V.,6,19/05/2016,"Turnhoutseweg 30
2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Epoetin Alfa Hexal,EMEA/H/C/000726,epoetin alfa,epoetin alfa,"Anemia
Kidney Failure, Chronic
Cancer",B03XA01,,Hexal AG,19,27/08/2007,"Industriestrasse 25
D-83607 Holzkirchen
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Yervoy,EMEA/H/C/002213,Ipilimumab,ipilimumab,Melanoma,L01XC11,,Bristol-Myers Squibb Pharma EEIG,24,12/07/2011,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Roteas,EMEA/H/C/004339,edoxaban tosylate,edoxaban,"Stroke
Venous Thromboembolism",B01AF03,,Daiichi Sankyo Europe GmbH,2,19/04/2017,"Zielstattstrasse 48
81379 Munich
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Arixtra,EMEA/H/C/000403,fondaparinux sodium,fondaparinux sodium,"Venous Thrombosis
Pulmonary Embolism
Myocardial Infarction
Angina, Unstable",B01AX05,,Aspen Pharma Trading Limited,28,20/03/2002,"3016 Lake Drive
City West Business Campus
Dublin
Dublin 24
Ireland",,,,,,,,,Ireland
Prialt,EMEA/H/C/000551,ziconotide,ziconotide,"Injections, Spinal
Pain",N02BG08,,RIEMSER Pharma GmbH,21,20/02/2005,"An derWiek 7
17493 Greifswald-Insel Riems
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Hulio,EMEA/H/C/004429,adalimumab,adalimumab,"Hidradenitis Suppurativa
Psoriasis
Crohn Disease
Uveitis
Arthritis, Rheumatoid
Colitis, Ulcerative
Spondylitis, Ankylosing
Arthritis, Psoriatic",L04AB04,,Mylan S.A.S.,0,16/09/2018,"117 Allee des Parcs
69800 Saint-Priest
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Viekirax,EMEA/H/C/003839,"Ombitasvir
paritaprevir
ritonavir",ombitasvir / paritaprevir / ritonavir,"Hepatitis C, Chronic",J05AP53,,AbbVie Deutschland GmbH Co. KG,15,14/01/2015,"Knollstrasse
67061 Ludwigshafen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Cimzia,EMEA/H/C/001037,Certolizumab pegol,certolizumab pegol,"Arthritis, Rheumatoid",L04AB05,,UCB Pharma SA ,22,30/09/2009,"UCB Pharma SA
Allée de la Recherche 60
B-1070 Bruxelles
Belgium",,,,,,,,,Belgium
Veyvondi,EMEA/H/C/004454,vonicog alfa,vonicog alfa,von Willebrand Diseases,B02BD10,,Baxalta Innovations GmbH,0,30/08/2018,"Industriestrasse 67
A-1221 Vienna
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Austria
Fluenz Tetra,EMEA/H/C/002617,"reassortant influenza virus (live attenuated) of the following four strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Bolivia/559/2013, MEDI 255962)A/Hong Kong/4801/2014 (H3N2) - like strain(A/New Caledonia/71/2014, MEDI 263122)B/Brisbane/60/2008 - like strain(B/Brisbane/60/2008, MEDI 228030)B/Phuket/3073/2013 - like strain(B/Phuket/3073/2013, MEDI 254977)","influenza vaccine (live attenuated, nasal)","Influenza, Human",J07BB03,,AstraZeneca AB,14,03/12/2013,"SE-151 85 Södertälje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Hemlibra,EMEA/H/C/004406,Emicizumab,emicizumab,Hemophilia A,B02BX,,Roche Registration Limited,2,22/02/2018,"6 Falcon Way, Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Kadcyla,EMEA/H/C/002389,trastuzumab emtansine,trastuzumab emtansine,Breast Neoplasms,L01XC14,,Roche Registration GmbH,10,14/11/2013,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Fortacin,EMEA/H/C/002693,"lidocaine
prilocaine",lidocaine / prilocaine,"Sexual Dysfunction, Physiological",N01BB20,,Plethora Solutions Limited,7,14/11/2013,"Recordati Ireland Ltd.
Raheens East
Ringaskiddy, Co. Cork,
Ireland",,,,,,,,,Ireland
Kymriah,EMEA/H/C/004090,tisagenlecleucel,tisagenlecleucel,"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Lymphoma, Large B-Cell, Diffuse",L01,,Novartis Europharm Limited,0,22/08/2018,"Frimley Business Park
Camberley GU16 7SR
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Ninlaro,EMEA/H/C/003844,ixazomib citrate,ixazomib,Multiple Myeloma,L01XX50,,Takeda Pharma A/S,4,20/11/2016,"Dybendal Alle 10
2630 Taastrup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Denmark
Trazimera,EMEA/H/C/004463,trastuzumab,trastuzumab,"Stomach Neoplasms
Breast Neoplasms",L01XC03,,Pfizer Europe MA EEIG,1,26/07/2018,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Belgium
Inductos,EMEA/H/C/000408,dibotermin alfa,dibotermin alfa,"Tibial Fractures
Fracture Fixation, Internal
Spinal Fusion",M05BC01,,Medtronic BioPharma B.V.,22,08/09/2002,"Earl Bakkenstraat 10
6422 PJ Heerlen
The Netherlands",,,,,,,,,The Netherlands
Cholib,EMEA/H/C/002559,"fenofibrate
simvastatin",fenofibrate / simvastatin,Dyslipidemias,C10BA04,,Mylan IRE Healthcare Ltd,8,25/08/2013,"Unit 35/36 Grange Parade,
Baldoyle Industrial Estate,
Dublin 13
Ireland",,,,,,,,,Ireland
Rapilysin,EMEA/H/C/000105,reteplase,reteplase,Myocardial Infarction,B01AD08,,Actavis Group PTC ehf,25,28/08/1996,"Reykjavikurvegi 76-78
220 Hafnarfjordur
Iceland",,,,,,,,,Iceland
Revinty Ellipta,EMEA/H/C/002745,"fluticasone furoate
vilanterol trifenatate",fluticasone furoate / vilanterol,Asthma,R03AK10,,Glaxo Group Ltd,15,01/05/2014,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Truvada,EMEA/H/C/000594,"emtricitabine
tenofovir disoproxil fumarate",emtricitabine / tenofovir disoproxil,HIV Infections,J05AR03,,Gilead Sciences Ireland UC,38,20/02/2005,"Carrigtohill
County Cork, T45 DP77
Ireland",,,,,,,,,Ireland
Triumeq,EMEA/H/C/002754,"abacavir sulfate
dolutegravir sodium
lamivudine",abacavir sulfate / dolutegravir sodium / lamivudine,HIV Infections,J05AR13,,ViiV Healthcare UK Limited,10,31/08/2014,"980 Great West Road
Brentford TW8 9GS
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Xelevia,EMEA/H/C/000762,sitagliptin,sitagliptin,"Diabetes Mellitus, Type 2",A10BH01,,Merck Sharp & Dohme B.V.,26,20/03/2007,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Hirobriz Breezhaler,EMEA/H/C/001211,indacaterol maleate,indacaterol,"Pulmonary Disease, Chronic Obstructive",R03AC18,,Novartis Europharm Limited,14,30/11/2009,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
NeoRecormon,EMEA/H/C/000116,epoetin beta,epoetin beta,"Kidney Failure, Chronic
Anemia
Cancer
Blood Transfusion, Autologous",B03XA01,,Roche Registration GmbH,27,15/07/1997,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Angiox,EMEA/H/C/000562,Bivalirudin,bivalirudin,Acute Coronary Syndrome,B01AE06,,The Medicines Company UK Ltd,22,19/09/2004,"115 L Milton Park
Abingdon
Oxfordshire
OX14 4SA
United Kingdom",,,,,,,,,United Kingdom
Alecensa,EMEA/H/C/004164,alectinib hydrochloride,alectinib,"Carcinoma, Non-Small-Cell Lung",L01XE,,Roche Registration GmbH,7,15/02/2017,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Bavencio,EMEA/H/C/004338,avelumab,avelumab,Neuroendocrine Tumors,L01XC31,,Merck Europe B.V.,3,17/09/2017,"Gustav Mahlerplein 102
1082 MA Amsterdam
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,The Netherlands
Conbriza,EMEA/H/C/000913,bazedoxifene,bazedoxifene,"Osteoporosis, Postmenopausal",G03XC02,,Pfizer Europe MA EEIG,11,16/04/2009,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Lifmior,EMEA/H/C/004167,etanercept,etanercept,"Arthritis, Psoriatic
Spondylitis, Ankylosing
Psoriasis",L04AB01,,Pfizer Europe MA EEIG,5,12/02/2017,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Cometriq,EMEA/H/C/002640,cabozantinib,cabozantinib,Thyroid Neoplasms,L01XE,,Ipsen Pharma,12,20/03/2014,"65, quai Georges Gorse
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,France
Rapamune,EMEA/H/C/000273,Sirolimus,sirolimus,"Graft Rejection
Kidney Transplantation",L04AA10,,Pfizer Limited,37,12/03/2001,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Nerlynx,EMEA/H/C/004030,neratinib,neratinib,Breast Neoplasms,L01X,,Puma Biotechnology Limited,0,30/08/2018,"11th Floor
Whitefriars Lewins Mead
Bristol BS1 2NT
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Tafinlar,EMEA/H/C/002604,dabrafenib mesylate,dabrafenib,Melanoma,L01XE23,,Novartis Europharm Limited,18,25/08/2013,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Vectibix,EMEA/H/C/000741,panitumumab,panitumumab,Colorectal Neoplasms,L01XC08,,Amgen Europe B.V.,30,02/12/2007,"Minervum 7061
NL-4817 ZK Breda
The Netherlands",,,,,,,,,The Netherlands
Axumin,EMEA/H/C/004197,Fluciclovine (18F),fluciclovine (18F),"Prostatic Neoplasms
Radionuclide Imaging",V09IX12,,Blue Earth Diagnostics Ltd,4,21/05/2017,"215 Euston Road
London NW1 2BE
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Simbrinza,EMEA/H/C/003698,"brinzolamide
brimonidine tartrate",brinzolamide / brimonidine tartrate,"Ocular Hypertension
Glaucoma, Open-Angle",S01EC54,,Novartis Europharm Limited,5,17/07/2014,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Yescarta,EMEA/H/C/004480,axicabtagene ciloleucel,axicabtagene ciloleucel,"Lymphoma, Follicular
Lymphoma, Large B-Cell, Diffuse",L01X,,Kite Pharma EU B.V.,0,22/08/2018,"Science Park 408
1098 XH Amsterdam
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Ontruzant,EMEA/H/C/004323,trastuzumab,trastuzumab,"Stomach Neoplasms
Breast Neoplasms",L01XC03,,Samsung Bioepis UK Limited (SBUK),1,14/11/2017,"5th Floor Profile West
950 Great West Road
Brentford TW8 9ES
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,United Kingdom
Cablivi,EMEA/H/C/004426,Caplacizumab,caplacizumab,"Purpura, Thrombotic Thrombocytopenic",B01A,,Ablynx NV,0,30/08/2018,"Technologiepark 21
9052 Zwijnaarde
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Tagrisso,EMEA/H/C/004124,osimertinib mesylate,osimertinib,"Carcinoma, Non-Small-Cell Lung",L01XE,,AstraZeneca AB,8,01/02/2016,"SE-151 85 Södertälje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Tyverb,EMEA/H/C/000795,lapatinib,lapatinib,Breast Neoplasms,L01XE07,,Novartis Europharm Limited,28,09/06/2008,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Tovanor Breezhaler,EMEA/H/C/002690,Glycopyrronium bromide,glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03BB06,,Novartis Europharm Limited,12,27/09/2012,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Steglujan,EMEA/H/C/004313,"ertugliflozin l-pyroglutamic acid
sitagliptin phosphate monohydrate",ertugliflozin / sitagliptin,"Diabetes Mellitus, Type 2",A10BD24,,Merck Sharp & Dohme B.V.,3,22/03/2018,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Tarceva,EMEA/H/C/000618,erlotinib,erlotinib,"Carcinoma, Non-Small-Cell Lung
Pancreatic Neoplasms",L01XE03,,Roche Registration GmbH,28,18/09/2005,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
MabThera,EMEA/H/C/000165,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Arthritis, Rheumatoid
Leukemia, Lymphocytic, Chronic, B-Cell",L01XC02,,Roche Registration GmbH,43,01/06/1998,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Spinraza,EMEA/H/C/004312,nusinersen sodium,nusinersen,"Muscular Atrophy, Spinal",M09,,Biogen Idec Ltd,4,29/05/2017,"Innovation House
70 Norden Road
Berkshire
Maidenhead
SL6 4AY
United Kigndom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan,EMEA/H/C/004240,"efavirenz
emtricitabine
tenofovir disoproxil maleate",efavirenz / emtricitabine / tenofovir disoproxil,HIV Infections,J05AR06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,2,04/09/2017,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Bortezomib Hospira,EMEA/H/C/004207,bortezomib,bortezomib,Multiple Myeloma,L01XX32,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pfizer Europe MA EEIG,4,21/07/2016,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Mekinist,EMEA/H/C/002643,trametinib,trametinib,Melanoma,L01XE25,,Novartis Europharm Limited,14,29/06/2014,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Herceptin,EMEA/H/C/000278,trastuzumab,trastuzumab,"Stomach Neoplasms
Breast Neoplasms",L01XC03,,Roche Registration GmbH,34,27/08/2000,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Sprycel,EMEA/H/C/000709,dasatinib,dasatinib,"Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myelogenous, Chronic, BCR-ABL Positive",L01XE06,,Bristol-Myers Squibb Pharma EEIG,30,19/11/2006,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Ulipristal Acetate Gedeon Richter,EMEA/H/C/005017,ulipristal acetate,ulipristal acetate,Leiomyosarcoma,G03XB02,,Gedeon Richter Plc.,0,26/08/2018,"Gyomroi ut 19-21
1103 Budapest
Hungary",,,,,,,,,Hungary
Micardis,EMEA/H/C/000209,telmisartan,telmisartan,Hypertension,C09CA07,,Boehringer Ingelheim International GmbH,23,15/12/1998,"Bingerstr. 173
55216 Ingelheim am Rheim
Germany",,,,,,,,,Germany
Jetrea,EMEA/H/C/002381,ocriplasmin,ocriplasmin,Retinal Diseases,S01XA22,,ThromboGenics NV,10,12/03/2013,"Gaston Geenslaan 1
B-3001 Leuven
Belgium",,,,,,,,,Belgium
Zavicefta,EMEA/H/C/004027,"Ceftazidime
avibactam",ceftazidime / avibactam,"Pneumonia, Bacterial
Soft Tissue Infections
Pneumonia
Urinary Tract Infections
Gram-Negative Bacterial Infections",J01,,Pfizer Ireland Pharmaceuticals,5,23/06/2016,"Operations Support Group
Ringaskiddy, County Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Telmisartan Teva,EMEA/H/C/001146,telmisartan,telmisartan,Hypertension,C09CA07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,10,25/01/2010,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Hepsera,EMEA/H/C/000485,adefovir dipivoxil,adefovir dipivoxil,"Hepatitis B, Chronic",J05AF08,,Gilead Sciences Ireland UC,25,05/03/2003,"Carrigtohill
County Cork, T45 DP77
Ireland",,,,,,,,,Ireland
Atosiban SUN,EMEA/H/C/002329,atosiban acetate,atosiban,Premature Birth,G02CX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sun Pharmaceutical Industries Europe B.V.,5,30/07/2013,"Polarisavenue 87
2132JH Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
Tasmar,EMEA/H/C/000132,tolcapone,tolcapone,Parkinson Disease,N04BX01,,Meda AB,22,26/08/1997,"Pipers väg 2A
SE-Solna 170 09
Sweden",,,,,,,,,Sweden
Mircera,EMEA/H/C/000739,Methoxy polyethylene glycol-epoetin beta,methoxy polyethylene glycol-epoetin beta,"Anemia
Kidney Failure, Chronic",B03XA03,,Roche Registration GmbH,23,19/07/2007,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Flixabi,EMEA/H/C/004020,infliximab,infliximab,"Spondylitis, Ankylosing
Arthritis, Rheumatoid
Crohn Disease
Colitis, Ulcerative
Arthritis, Psoriatic
Psoriasis",L04AB02,,Samsung Bioepis UK Limited (SBUK),6,25/05/2016,"5th Floor, Profile West 950 Great West Road
Brentford Middlesex TW8 9ES
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,United Kingdom
Amgevita,EMEA/H/C/004212,adalimumab,adalimumab,"Arthritis, Psoriatic
Colitis, Ulcerative
Arthritis, Juvenile Rheumatoid
Spondylitis, Ankylosing
Psoriasis
Crohn Disease
Arthritis, Rheumatoid",L04AB04,,Amgen Europe B.V.,3,21/03/2017,"Minervum 7061
NL-4817 ZK Breda
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Strimvelis,EMEA/H/C/003854,autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells,autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence,Severe Combined Immunodeficiency,L03,,Orchard Therapeutics (Netherlands) BV,2,25/05/2016,"Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Lojuxta,EMEA/H/C/002578,Lomitapide,lomitapide,Hypercholesterolemia,C10AX12,,Amryt Pharmaceuticals DAC,10,30/07/2013,"90 Harcourt Street
Dublin 2
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Ireland
Votubia,EMEA/H/C/002311,everolimus,everolimus,Tuberous Sclerosis,L01XE10,,Novartis Europharm Limited,24,01/09/2011,"Elm Park
Merrion Road
Dublin 4
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Bondronat,EMEA/H/C/000101,ibandronic acid,ibandronic acid,"Hypercalcemia
Breast Neoplasms
Neoplasm Metastasis
Fractures, Bone",M05BA06,,Atnahs Pharma UK Limited,26,24/06/1996,"Sovereign House
Miles Gray Road
Basildon
SS14 3FR
United Kingdom",,,,,,,,,United Kingdom
Intanza,EMEA/H/C/000957,"influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type)","influenza vaccine (split virion, inactivated)","Influenza, Human
Immunization",J07BB02,,Sanofi Pasteur Europe,18,23/02/2009,"2 Avenue Pont Pasteur
69007 Lyon
France",,,,,,,,,France
Travatan,EMEA/H/C/000390,travoprost,travoprost,"Glaucoma, Open-Angle
Ocular Hypertension",S01EE04,,Novartis Europharm Limited,28,26/11/2001,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Elmiron,EMEA/H/C/004246,pentosan polysulfate sodium,pentosan polysulfate sodium,"Cystitis, Interstitial",G04BX15,,bene-Arzneimittel GmbH,4,01/06/2017,"Herterichstrasse 1-3
81479 Munich
Germany",,,,,,,,,Germany
Tobi Podhaler,EMEA/H/C/002155,Tobramycin,tobramycin,"Cystic Fibrosis
Respiratory Tract Infections",J01GB01,,Novartis Europharm Limited,14,19/07/2011,"Elm Park
Merrion Road
Dublin 4
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Ratiograstim,EMEA/H/C/000825,filgrastim,filgrastim,"Neutropenia
Hematopoietic Stem Cell Transplantation
Cancer",L03AA02,,Ratiopharm GmbH,9,14/09/2008,"atiopharm GmbH
Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Entyvio,EMEA/H/C/002782,vedolizumab,vedolizumab,"Colitis, Ulcerative
Crohn Disease",L04AA,,Takeda Pharma A/S,10,21/05/2014,"Dybendal Alle 10
2630 Taastruup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Protopic,EMEA/H/C/000374,tacrolimus,tacrolimus,"Dermatitis, Atopic",D11AH01,,LEO Pharma A/S,23,27/02/2002,"Industriparken 55
2750 Ballerup
Denmark",,,,,,,,,Denmark
Nivestim,EMEA/H/C/001142,filgrastim,filgrastim,"Neutropenia
Hematopoietic Stem Cell Transplantation
Cancer",L03AA02,,Pfizer Europe MA EEIG ,17,07/06/2010,"Pfizer Europe MA EEIG
Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Belgium
Ocrevus,EMEA/H/C/004043,ocrelizumab,ocrelizumab,Multiple Sclerosis,L04AA,,Roche Registration GmbH,2,07/01/2018,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Eliquis,EMEA/H/C/002148,Apixaban,apixaban,"Arthroplasty
Venous Thromboembolism",B01AF02,,Bristol-Myers Squibb / Pfizer EEIG,16,17/05/2011,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Circadin,EMEA/H/C/000695,melatonin,melatonin,Sleep Initiation and Maintenance Disorders,N05CH01,,RAD Neurim Pharmaceuticals EEC Ltd,28,28/06/2007,"Reading
Berks RG1 1LX
United Kingdom",,,,,,,,,United Kingdom
Bronchitol,EMEA/H/C/001252,mannitol,mannitol,Cystic Fibrosis,R05CB16,,Pharmaxis Pharmaceuticals Limited,12,12/04/2012,"25 Moorgate
London EC2R 6AY
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Tecentriq,EMEA/H/C/004143,atezolizumab,atezolizumab,"Carcinoma, Transitional Cell
Carcinoma, Non-Small-Cell Lung",L01XC,,Roche Registration GmbH,4,20/09/2017,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Natpar,EMEA/H/C/003861,parathyroid hormone,parathyroid hormone,Hypoparathyroidism,H05AA03,,Shire Pharmaceuticals Ireland Ltd,4,23/04/2017,"5 Riverwalk Citywest
Business Campus
Dublin 24
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Ireland
Temodal,EMEA/H/C/000229,temozolomide,temozolomide,"Glioma
Glioblastoma",L01AX03,,Merck Sharp & Dohme B.V. ,31,25/01/1999,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Temozolomide Sun,EMEA/H/C/002198,temozolomide,temozolomide,"Glioma
Glioblastoma",L01AX03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sun Pharmaceutical Industries Europe B.V.,12,12/07/2011,"Polarisavenue 87
NL-2132 JH Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
Nevanac,EMEA/H/C/000818,nepafenac,nepafenac,"Pain, Postoperative
Ophthalmologic Surgical Procedures",S01BC10,,Novartis Europharm Limited,15,10/12/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Pergoveris,EMEA/H/C/000714,follitropin alfa / lutropin alfa,follitropin alfa / lutropin alfa,"Infertility, Female",G03GA30,,Merck Europe B.V. ,12,24/06/2007,"Merck Europe B.V.
Gustav Mahlerplein 102
1082 MA Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Pixuvri,EMEA/H/C/002055,pixantrone dimaleate,pixantrone dimaleate,"Lymphoma, Non-Hodgkin",L01DB11,,CTI Life Sciences Limited,18,09/05/2012,"Highlands House
Basingstoke Road
Spencers Wood, Reading
Berkshire RG7 1NT
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,"This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,United Kingdom
Avastin,EMEA/H/C/000582,bevacizumab,bevacizumab,"Carcinoma, Non-Small-Cell Lung
Breast Neoplasms
Ovarian Neoplasms
Colorectal Neoplasms
Carcinoma, Renal Cell",L01XC07,,Roche Registration GmbH,50,11/01/2005,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
CellCept,EMEA/H/C/000082,mycophenolate mofetil,mycophenolate mofetil,Graft Rejection,L04AA06,,Roche Registration GmbH,30,13/02/1996,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Tamiflu,EMEA/H/C/000402,oseltamivir,oseltamivir,"Influenza, Human",J05AH02,,Roche Registration GmbH,33,19/06/2002,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Glyxambi,EMEA/H/C/003833,"empagliflozin
linagliptin",empagliflozin / linagliptin,"Diabetes Mellitus, Type 2",A10BD19,,Boehringer Ingelheim International GmbH,4,10/11/2016,"Binger Strasse 173 55216
Ingelheim am Rhein
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Colobreathe,EMEA/H/C/001225,Colistimethate sodium,colistimethate sodium,Cystic Fibrosis,J01XB01,,Teva B.V.,9,12/02/2012,"Swensweg 5
2031 Haarlem
Netherlands",,,,,,,,,The Netherlands
Luveris,EMEA/H/C/000292,lutropin alfa,lutropin alfa,"Ovulation Induction
Infertility, Female",G03GA07,,Merck Europe B.V. ,19,28/11/2000,"Merck Europe B.V.
Gustav Mahlerplein 102
1082 MA Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Cystagon,EMEA/H/C/000125,mercaptamine bitartrate,mercaptamine bitartrate,Cystinosis,A16AA04,,Orphan Europe S.A.R.L.,14,22/06/1997,"Immeuble 'Le Wilson'
F-92058 Paris-La-Défense
France",,,,,,,,,France
Ciambra,EMEA/H/C/003788,pemetrexed disodium hemipentahydrate,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Menarini International Operations Luxembourg S.A.,2,01/12/2015,"1 Avenue de la Gare
L-1611
Luxembourg",,,,,,,,,Luxembourg
Cotellic,EMEA/H/C/003960,cobimetinib hemifumarate,cobimetinib,Melanoma,L01XE38,,Roche Registration GmbH,6,19/11/2015,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Brilique,EMEA/H/C/001241,ticagrelor,ticagrelor,"Peripheral Vascular Diseases
Acute Coronary Syndrome",B01AC24,,AstraZeneca AB,11,02/12/2010,"151 85 Södertälje
Sweden",,,,,,,,,Sweden
Telmisartan Actavis,EMEA/H/C/001168,telmisartan,telmisartan,Hypertension,C09CA07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,9,29/09/2010,"Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Retacrit,EMEA/H/C/000872,epoetin zeta,epoetin zeta,"Anemia
Blood Transfusion, Autologous
Kidney Failure, Chronic
Cancer",B03XA01,,Hospira UK Limited,22,17/12/2007,"Horizon, Honey Lane
Hurley, Maidenhead, SL6 6RJ
United Kingdom",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,United Kingdom
Onbrez Breezhaler,EMEA/H/C/001114,indacaterol maleate,indacaterol,"Pulmonary Disease, Chronic Obstructive",R03AC18,,Novartis Europharm Limited ,13,29/11/2009,"Elm Park, Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
ellaOne,EMEA/H/C/001027,ulipristal,ulipristal acetate,"Contraception, Postcoital",G03AD02,,Laboratoire HRA Pharma,18,14/05/2009,"5 rue Beranger
F-75003 Paris
France",,,,,,,,,France
Translarna,EMEA/H/C/002720,Ataluren,ataluren,"Muscular Dystrophy, Duchenne",,,PTC Therapeutics International Limited,9,30/07/2014,"5th Floor, 3 Grand Canal Plaza
Grand Canal Street Upper
Dublin 4
D04 EE70
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Ireland
Abraxane,EMEA/H/C/000778,paclitaxel,paclitaxel,"Breast Neoplasms
Pancreatic Neoplasms
Carcinoma, Non-Small-Cell Lung",L01CD01,,Celgene Europe B.V. ,22,10/01/2008,"Celgene Europe B.V.
Winthontlaan 6 N
3526KV Utrecht
The Netherlands",,,,,,,,,The Netherlands
Zalmoxis,EMEA/H/C/002801,Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2),allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2),"Hematopoietic Stem Cell Transplantation
Graft vs Host Disease",L01,,MolMed SpA,1,17/08/2016,"Via Olgettina 58
20132 Milan
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Italy
Imbruvica,EMEA/H/C/003791,Ibrutinib,ibrutinib,"Lymphoma, Mantle-Cell
Leukemia, Lymphocytic, Chronic, B-Cell",L01XE27,,Janssen-Cilag International NV,12,20/10/2014,"Turnhoutseweg 30
2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Visudyne,EMEA/H/C/000305,verteporfin,verteporfin,"Myopia, Degenerative
Macular Degeneration",S01LA01,,Novartis Europharm Limited,32,26/07/2000,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Mepsevii,EMEA/H/C/004438,vestronidase alfa,vestronidase alfa,Mucopolysaccharidosis VII,A16AB18,,Ultragenyx Germany GmbH,0,22/08/2018,"Stadtquartier Friedrichstrasse 191
10117 Berlin
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Germany
Gliolan,EMEA/H/C/000744,5-aminolevulinic acid hydrochloride,5-aminolevulinic acid hydrochloride,Glioma,L01XD04,,Medac GmbH,4,06/09/2007,"Fehlandtstrasse 3
D-20354 Hamburg
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Ibrance,EMEA/H/C/003853,palbociclib,palbociclib,Breast Neoplasms,L01XE33,,Pfizer Europe MA EEIG ,5,08/11/2016,"Pfizer Europe MA EEIG
Boulevard de la Plaine 17
1050 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Duzallo,EMEA/H/C/004412,"allopurinol
lesinurad",allopurinol / lesinurad,Gout,M04AA51,,Grunenthal GmbH,0,22/08/2018,"Zieglerstrasse 6
D-52078 Aachen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
HyQvia,EMEA/H/C/002491,Human normal immunoglobulin,human normal immunoglobulin,Immunologic Deficiency Syndromes,J06BA,,Baxalta Innovations GmbH,12,15/05/2013,"Industriestrasse 67
A-1221 Vienna
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Austria
Temozolomide Sandoz,EMEA/H/C/001128,temozolomide,temozolomide,"Glioma
Glioblastoma",L01AX03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sandoz GmbH,15,14/03/2010,"Biochemiestrasse 10
6250 Kundl
Austria",,,,,,,,,Austria
Vedrop,EMEA/H/C/000920,tocofersolan,tocofersolan,"Cholestasis
Vitamin E Deficiency",A11HA08,,Orphan Europe S.A.R.L.,12,23/07/2009,"Immeuble ""Le Wilson""
FR-92800 Puteaux
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,France
Plegridy,EMEA/H/C/002827,peginterferon beta-1a,peginterferon beta-1a,Multiple Sclerosis,L03AB13,,Biogen Netherlands B.V.,14,17/07/2014,"Prins Mauritslaan 13
1171 LP Badhoevedorp
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Revlimid,EMEA/H/C/000717,lenalidomide,lenalidomide,"Multiple Myeloma
Lymphoma, Mantle-Cell
Myelodysplastic Syndromes",L04AX04,,Celgene Europe BV,36,13/06/2007,"Winthontlaan 6 N
3526KV Utrecht
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Gardasil 9,EMEA/H/C/003852,"human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed)","human papillomavirus 9-valent vaccine (recombinant, adsorbed)","Condylomata Acuminata
Papillomavirus Infections
Immunization
Uterine Cervical Dysplasia",J07BM,,MSD VACCINS,8,09/06/2015,"162 avenue Jean Jaures
69007 Lyon
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Zelboraf,EMEA/H/C/002409,vemurafenib,vemurafenib,Melanoma,L01XE15,,Roche Registration GmbH,18,16/02/2012,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Eviplera,EMEA/H/C/002312,"emtricitabine
rilpivirine hydrochloride / tenofovir disoproxil fumarate",emtricitabine / rilpivirine / tenofovir disoproxil,HIV Infections,J05AR08,,Gilead Sciences International Ltd ,20,27/11/2011,"Gilead Sciences International Ltd
Cambridge
CB21 6GT
United Kingdom",,,,,,,,,United Kingdom
Sancuso,EMEA/H/C/002296,granisetron,granisetron,"Vomiting
Cancer",A04AA02,,Kyowa Kirin Holdings B.V.,11,19/04/2012,"Bloemlaan 2
21 32NP Hoofddorp
E-mail: medinfo@kyowakirin.com
The Netherlands",,,,,,,,,The Netherlands
Bonviva,EMEA/H/C/000501,ibandronic acid,ibandronic acid,"Osteoporosis, Postmenopausal",M05BA06,,Atnahs Pharma UK Limited,24,22/02/2004,"Sovereign House
Miles Gray Road
Basildon
SS14 3FR
United Kingdom",,,,,,,,,United Kingdom
Amglidia,EMEA/H/C/004379,glibenclamide,glibenclamide,Diabetes Mellitus,A10BB01,,Ammtek,1,23/05/2018,"15, rue Beranger
75003 Paris
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Humira,EMEA/H/C/000481,adalimumab,adalimumab,"Spondylitis, Ankylosing
Arthritis, Juvenile Rheumatoid
Uveitis
Colitis, Ulcerative
Psoriasis
Arthritis, Psoriatic
Crohn Disease
Arthritis, Rheumatoid",L04AB04,,AbbVie Deutschland GmbH Co. KG,68,07/09/2003,"Knollstrasse
67061 Ludwigshafen
Germany",,,,,,,,,Germany
DaTSCAN,EMEA/H/C/000266,ioflupane (123l),ioflupane (123l),"Tomography, Emission-Computed, Single-Photon
Lewy Body Disease
Parkinson Disease
Alzheimer Disease",V09AB03,,GE Healthcare Limited,20,26/07/2000,"Little Chalfont
Buckinghamshire
HP7 9NA
United Kingdom",,,,,,,,,United Kingdom
Fareston,EMEA/H/C/000091,toremifene,toremifene,Breast Neoplasms,L02BA02,,Orion Corporation,21,13/02/1996,"Orionintie 1
FI-02200 Espoo
Finland",,,,,,,,,Finland
Xyrem,EMEA/H/C/000593,sodium oxybate,sodium oxybate,"Cataplexy
Narcolepsy",N07XX04,,UCB Pharma Ltd,28,12/10/2005,"208 Bath Road
Slough
Berkshire
SL1 3WE
United Kingdom",,,,,,,,,United Kingdom
Relvar Ellipta,EMEA/H/C/002673,"fluticasone furoate
vilanterol",fluticasone furoate / vilanterol,"Pulmonary Disease, Chronic Obstructive",R03AK10,,Glaxo Group Ltd,16,12/11/2013,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Cubicin,EMEA/H/C/000637,daptomycin,daptomycin,"Gram-Positive Bacterial Infections
Bacteremia
Soft Tissue Infections
Endocarditis, Bacterial",J01XX09,,Merck Sharp & Dohme B.V.,30,18/01/2006,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Buccolam,EMEA/H/C/002267,midazolam,midazolam,Epilepsy,N05CD08,,Shire Services BVBA,8,04/09/2011,"Rue Montoyer 47
B-1000 Brussels
Belgium",,,,,,,,,Belgium
Prevymis,EMEA/H/C/004536,Letermovir,letermovir,Cytomegalovirus Infections,J05,,Merck Sharp & Dohme B.V.,1,07/01/2018,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Myocet,EMEA/H/C/000297,doxorubicin hydrochloride,doxorubicin,Breast Neoplasms,L01DB01,,Teva B.V.,20,12/07/2000,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Tesavel,EMEA/H/C/000910,sitagliptin,sitagliptin,"Diabetes Mellitus, Type 2",A10BH01,,Merck Sharp & Dohme B.V.,20,09/01/2008,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Tadalafil Mylan,EMEA/H/C/003787,tadalafil,tadalafil,Erectile Dysfunction,G04BE08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,7,20/11/2014,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Duavive,EMEA/H/C/002314,"oestrogens conjugated
bazedoxifene",oestrogens conjugated / bazedoxifene,Osteoporosis,G03CX,,Pfizer Europe MA EEIG,7,15/12/2014,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Emtricitabine/Tenofovir disoproxil Krka,EMEA/H/C/004215,"emtricitabine
tenofovir disoproxil succinate",emtricitabine / tenofovir disoproxil,HIV Infections,J05AR03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","KRKA, d.d., Novo mesto",3,08/12/2016,"Smarjeska cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Thalidomide Celgene (previously Thalidomide Pharmion),EMEA/H/C/000823,Thalidomide,thalidomide,Multiple Myeloma,L04AX02,,Celgene Europe BV ,22,15/04/2008,"Celgene Europe BV
Winthontlaan 6 N
3526 KV Utrecht
Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
ReFacto AF,EMEA/H/C/000232,moroctocog alfa,moroctocog alfa,Hemophilia A,B02BD02,,Pfizer Europe MA EEIG,35,13/04/1999,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Entresto,EMEA/H/C/004062,"sacubitril
valsartan",sacubitril / valsartan,Heart Failure,C09DX04,,Novartis Europharm Limited,7,18/11/2015,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Memantine ratiopharm,EMEA/H/C/002671,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Ratiopharm GmbH,6,12/06/2013,"Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Opatanol,EMEA/H/C/000407,olopatadine hydrochloride,olopatadine,"Conjunctivitis, Allergic",S01GX09,,Novartis Europharm Limited,18,16/05/2002,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Pregabalin Pfizer,EMEA/H/C/003880,pregabalin,pregabalin,"Anxiety Disorders
Epilepsy",N03AX16,,Pfizer Europe MA EEIG,12,09/04/2014,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Zoely,EMEA/H/C/001213,"Nomegestrol acetate
estradiol",nomegestrol / estradiol,Contraception,G03AA14,,Teva B.V.,15,26/07/2011,"Swensweg
2031GA Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Torisel,EMEA/H/C/000799,Temsirolimus,temsirolimus,"Carcinoma, Renal Cell
Lymphoma, Mantle-Cell",L01XE09,,Pfizer Europe MA EEIG,28,18/11/2007,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Mylotarg,EMEA/H/C/004204,gemtuzumab ozogamicin,gemtuzumab ozogamicin,"Leukemia, Myeloid, Acute",L01XC05,,Pfizer Europe MA EEIG,1,18/04/2018,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Inlyta,EMEA/H/C/002406,axitinib,axitinib,"Carcinoma, Renal Cell",L01XE17,,Pfizer Europe MA EEIG ,8,02/09/2012,"Pfizer Europe MA EEIG
Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Darunavir Mylan,EMEA/H/C/004068,darunavir,darunavir,HIV Infections,J05AE10,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,2,03/01/2017,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Brintellix,EMEA/H/C/002717,Vortioxetine,vortioxetine,"Depressive Disorder, Major",N06AX26,,H. Lundbeck A/S,11,17/12/2013,"Ottiliavej 9
DK-2500 Valby
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Otezla,EMEA/H/C/003746,apremilast,apremilast,"Arthritis, Psoriatic
Psoriasis",L04AA32,,Celgene Europe BV,5,15/01/2015,"Winthontlaan 6 N
3526KV Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Stocrin,EMEA/H/C/000250,efavirenz,efavirenz,HIV Infections,J05AG03,,Merck Sharp & Dohme B.V.,39,27/05/1999,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Aldara,EMEA/H/C/000179,imiquimod,imiquimod,"Condylomata Acuminata
Keratosis
Keratosis, Actinic
Carcinoma, Basal Cell",D06BB10,,Meda AB,24,17/09/1998,"Pipers väg 2A
170 73 Solna
Sweden",,,,,,,,,Sweden
Sivextro,EMEA/H/C/002846,tedizolid phosphate,tedizolid phosphate,"Soft Tissue Infections
Skin Diseases, Bacterial",J01,,Merck Sharp & Dohme B.V.,9,22/03/2015,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
PecFent,EMEA/H/C/001164,fentanyl,fentanyl,"Pain
Cancer",N02AB03,,Kyowa Kirin Holdings B.V.,17,31/08/2010,"Bloemlaan 2
21 32NP Hoofddorp
E-mail: medinfo@kyowakirin.com
The Netherlands",,,,,,,,,The Netherlands
Tybost,EMEA/H/C/002572,cobicistat on silicon dioxide,cobicistat,HIV Infections,V03AX03,,Gilead Sciences Ireland UC,11,18/09/2013,"Carrigtohill
Cork T45 DP77
Ireland",,,,,,,,,Ireland
Gilenya,EMEA/H/C/002202,fingolimod hydrochloride ,fingolimod,Multiple Sclerosis,L04AA27,,Novartis Europharm Limited,20,16/03/2011,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Tysabri,EMEA/H/C/000603,natalizumab,natalizumab,Multiple Sclerosis,L04AA23,,Biogen Netherlands B.V.,27,26/06/2006,"Prins Mauritslaan 13
1171 LP Badhoevedorp
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
GONAL-f,EMEA/H/C/000071,follitropin alfa,follitropin alfa,"Anovulation
Reproductive Techniques, Assisted
Infertility, Female
Hypogonadism",G03GA05,,Merck Europe B.V.,22,20/10/1995,"Gustav Mahlerplein 102
1082 MA Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Bosulif,EMEA/H/C/002373,bosutinib (as monohydrate),bosutinib,"Leukemia, Myeloid",L01XE14,,Pfizer Europe MA EEIG,16,26/03/2013,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,"This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Belgium
Riximyo,EMEA/H/C/004729,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Arthritis, Rheumatoid
Microscopic Polyangiitis
Wegener Granulomatosis",L01XC02,,Sandoz GmbH,2,14/06/2017,"Biochemiestrasse 10
6250 Kundl
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Genvoya,EMEA/H/C/004042,"elvitegravir
cobicistat
emtricitabine
tenofovir alafenamide",elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide,HIV Infections,J05AR,,Gilead Sciences Ireland UC,17,18/11/2015,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Mysimba,EMEA/H/C/003687,"bupropion hydrochloride
naltrexone hydrochloride",naltrexone / bupropion,"Obesity
Overweight",A08AA,,Orexigen Therapeutics Ireland Limited,10,25/03/2015,"2nd Floor, Palmerston House
Fenian Street
Dublin 2
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Numient,EMEA/H/C/002611,"levodopa
carbidopa",levodopa / carbidopa,Parkinson Disease,N04BA02,,Amneal Pharma Europe Ltd,3,18/11/2015,"70 Sir John Rogerson’s Quay
Dublin 2
Ireland",,,,,,,,,Ireland
Fampyra,EMEA/H/C/002097,Fampridine,fampridine,Multiple Sclerosis,N07XX07,,Blogen Netherlands B.V. ,12,19/07/2011,"Blogen Netherlands B.V.
Prins Mauritslaan 13
1171 LP Badhoevedorp
The Netherlands",,,,,,,,,The Netherlands
Truxima,EMEA/H/C/004112,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Arthritis, Rheumatoid
Wegener Granulomatosis
Leukemia, Lymphocytic, Chronic, B-Cell
Microscopic Polyangiitis",L01XC02,,Celltrion Healthcare Hungary Kft.,6,16/02/2017,"1062 Budapest
Váci út 1-3. WestEnd Office Building B torony
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Rituzena (previously Tuxella),EMEA/H/C/004724,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Microscopic Polyangiitis
Leukemia, Lymphocytic, Chronic, B-Cell
Wegener Granulomatosis",L01XC02,,Celltrion Healthcare Hungary Kft.,5,12/07/2017,"1062 Budapest
Váci út 1-3. WestEnd Office Building B torony
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Ritemvia,EMEA/H/C/004725,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Microscopic Polyangiitis
Wegener Granulomatosis",L01XC02,,Celltrion Healthcare Hungary Kft.,4,12/07/2017,"1062 Budapest
Váci út 1-3. WestEnd Office Building B torony
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Zonisamide Mylan,EMEA/H/C/004127,zonisamide,zonisamide,Epilepsy,N03AX15,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,2,30/03/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Nityr,EMEA/H/C/004582,nitisinone,nitisinone,Tyrosinemias,A16AX04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Cycle Pharmaceuticals Ltd,0,26/07/2018,"Bailey Grundy Barrett Building
Little St Mary's Lane
Cambridge
United Kingdom",,,,,,,,,United Kingdom
ATryn,EMEA/H/C/000587,Antithrombin alfa,antithrombin alfa,Antithrombin III Deficiency,B01AB02,,Laboratoire Francais du Fractionnement et des Biotechnologies,15,27/07/2006,"3 Avenue des Tropiques
ZA deCourtaboeuf
91940 Les Ulis
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,France
Aimovig,EMEA/H/C/004447,erenumab,erenumab,Migraine Disorders,N02CX07,,Novartis Europharm Limited,0,25/07/2018,"Vista Building Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Zometa,EMEA/H/C/000336,"zoledronic acid
zoledronic acid monohydrate",zoledronic acid,"Cancer
Fractures, Bone",M05BA08,,Novartis Europharm Limited,32,19/03/2001,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Mavenclad,EMEA/H/C/004230,Cladribine,cladribine,Multiple Sclerosis,L04AA40,,Merck Europe B.V.,2,21/08/2017,"Gustav Mahlerplein 102
1082 MA Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Firdapse (previously Zenas),EMEA/H/C/001032,amifampridine,amifampridine,Lambert-Eaton Myasthenic Syndrome,N07XX05,,BioMarin International Limited,15,22/12/2009,"Shanbally, Ringaskiddy
County Cork, P43 R298
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Ireland
Esmya,EMEA/H/C/002041,ulipristal acetate,ulipristal,Leiomyoma,G03XB02,,Gedeon Richter Ltd ,13,22/02/2012,"Gedeon Richter Ltd
Gyömroi út 19-21
HU-1103 Budapest
Hungary",,,,,,,,,Hungary
NovoEight,EMEA/H/C/002719,turoctocog alfa,turoctocog alfa,Hemophilia A,B02BD02,,Novo Nordisk A/S,6,13/11/2013,"Novo Alle
Bagsværd - 2880
Denmark",,,,,,,,,Denmark
Ariclaim,EMEA/H/C/000552,duloxetine,duloxetine,Diabetic Neuropathies,N06AX21,,Eli Lilly Nederland B.V.,26,10/08/2004,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
DuoResp Spiromax,EMEA/H/C/002348,"budesonide
formoterol fumarate dihydrate",budesonide / formoterol,"Pulmonary Disease, Chronic Obstructive
Asthma",R03AK07,,Teva Pharma B.V.,6,27/04/2014,"Computerweg 10
3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Azomyr,EMEA/H/C/000310,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Urticaria
Rhinitis, Allergic, Seasonal",R06AX27,,Merck Sharp & Dohme B.V. ,42,15/01/2001,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Cerdelga,EMEA/H/C/003724,eliglustat,eliglustat,Gaucher Disease,A16AX10,,Genzyme Europe BV,8,18/01/2015,"Gooimer 10
1411 DD Naarden
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Toviaz,EMEA/H/C/000723,fesoterodine fumarate,fesoterodine,"Urinary Bladder, Overactive",G04BD11,,Pfizer Europe MA EEIG,20,20/04/2007,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Tygacil,EMEA/H/C/000644,Tigecycline,tigecycline,"Bacterial Infections
Skin Diseases, Bacterial
Soft Tissue Infections",J01AA12,,Pfizer Europe MA EEIG,27,23/04/2006,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Taxespira (previously Docetaxel Hospira UK Limited ),EMEA/H/C/003925,docetaxel trihydrate,docetaxel,"Stomach Neoplasms
Prostatic Neoplasms
Breast Neoplasms
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hospira UK Limited,8,27/08/2015,"Horizon, Honey Lane
Hurley, Maidenhead, SL6 6RJ
United Kingdom",,,,,,,,,United Kingdom
Rixathon,EMEA/H/C/003903,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Arthritis, Rheumatoid
Leukemia, Lymphocytic, Chronic, B-Cell
Wegener Granulomatosis
Microscopic Polyangiitis",L01XC02,,Sandoz GmbH,2,14/06/2017,"Biochemiestrasse 10
6250 Kundl
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Lusduna,EMEA/H/C/004101,insulin glargine,insulin glargine,Diabetes Mellitus,A10AE04,,Merck Sharp & Dohme B.V.,2,03/01/2017,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Levetiracetam Sun,EMEA/H/C/002051,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sun Pharmaceutical Industries Europe B.V.,10,13/12/2011,"Polarisavenue 87
NL-2132 JH Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
Tegsedi,EMEA/H/C/004782,inotersen sodium,inotersen,Amyloidosis,N07,,Ionis USA Ltd,0,05/07/2018,"Tower 42 Level 30
International Finance Centre
25 Old Broad Street
London EC2N 1HQ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Emtriva,EMEA/H/C/000533,emtricitabine,emtricitabine,HIV Infections,J05AF09,,Gilead Sciences Ireland UC,27,24/10/2003,"Carrigtohill
County Cork, T45 DP77
Ireland",,,,,,,,,Ireland
Naglazyme,EMEA/H/C/000640,galsulfase,galsulfase,Mucopolysaccharidosis VI,A16AB,,BioMarin International Limited,13,23/01/2006,"Shanbally, Ringaskiddy
County Cork, P43 R298
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Ireland
Levetiracetam Accord,EMEA/H/C/002290,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd ,8,02/10/2011,"Accord Healthcare Ltd
5th Floor Charles House
108/110 Finchley Road
London
NW3 5JJ
United Kingdom",,,,,,,,,United Kingdom
Revatio,EMEA/H/C/000638,sildenafil,sildenafil,"Hypertension, Pulmonary",G04BE03,,Pfizer Europe MA EEIG,36,27/10/2005,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Myalepta,EMEA/H/C/004218,Metreleptin,metreleptin,"Lipodystrophy, Familial Partial",A16AA,,Aegerion Pharmaceuticals B.V. ,0,29/07/2018,"Aegerion Pharmaceuticals B.V.
Atrium Building, 8th Floor
Strawinskylaan 3127
1077 ZX Amsterdam
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,The Netherlands
Cetrotide,EMEA/H/C/000233,cetrorelix,cetrorelix,"Ovulation
Ovulation Induction",H01CC02,,Merck Serono Europe Ltd.,23,12/04/1999,"56, Marsh Wall
London
E14 9TP
United Kingdom",,,,,,,,,United Kingdom
Emtricitabine/Tenofovir disoproxil Krka d.d.,EMEA/H/C/004686,"emtricitabine
tenofovir disoproxil succinate",emtricitabine / tenofovir disoproxil,HIV Infections,J05AR03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","KRKA, d.d., Novo mesto",3,27/04/2017,"Smarjeska cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Metalyse,EMEA/H/C/000306,tenecteplase,tenecteplase,Myocardial Infarction,B01AD11,,Boehringer Ingelheim International GmbH,17,23/02/2001,"Binger Str 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Ristfor,EMEA/H/C/001235,"sitagliptin
metformin hydrochloride",sitagliptin / metformin hydrochloride,"Diabetes Mellitus, Type 2",A10BH01,,Merck Sharp & Dohme B.V.,18,15/03/2010,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Firmagon,EMEA/H/C/000986,degarelix,degarelix,Prostatic Neoplasms,L02BX02,,Ferring Pharmaceuticals A/S,13,16/02/2009,"Kay Fiskers Plads 11
DK-2300 Copenhagen S
Denmark",,,,,,,,,Denmark
Ilaris,EMEA/H/C/001109,Canakinumab,canakinumab,"Cryopyrin-Associated Periodic Syndromes
Arthritis, Juvenile Rheumatoid
Arthritis, Gouty",L04AC08,,Novartis Europharm Limited,20,22/10/2009,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Ameluz,EMEA/H/C/002204,5-aminolevulinic acid hydrochloride,5-aminolevulinic acid hydrochloride,"Keratosis, Actinic",L01XD04,,Biofrontera Bioscience GmbH,12,13/12/2011,"Hemmelrather Weg 201
D-51377 Leverkusen
Germany",,,,,,,,,Germany
Jentadueto,EMEA/H/C/002279,"linagliptin
Metformin",linagliptin / metformin hydrochloride,"Diabetes Mellitus, Type 2",A10BD11,,Boehringer Ingelheim International GmbH,14,19/07/2012,"Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Inflectra,EMEA/H/C/002778,infliximab,infliximab,"Arthritis, Psoriatic
Spondylitis, Ankylosing
Colitis, Ulcerative
Psoriasis
Crohn Disease
Arthritis, Rheumatoid",L04AB02,,Pfizer Europe MA EEIG,18,09/09/2013,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Belgium
Cystadane,EMEA/H/C/000678,Betaine anhydrous,betaine anhydrous,Homocystinuria,A16AA06,,Orphan Europe S.A.R.L.,11,14/02/2007,"Immeuble ""Le Wilson""
70, avenue du Général de Gaulle
FR-92800 Puteaux
France",,,,,,,,,France
Adcetris,EMEA/H/C/002455,Brentuximab vedotin,brentuximab vedotin,"Lymphoma, Non-Hodgkin
Hodgkin Disease",L01XC12,,Takeda Pharma A/S,23,24/10/2012,"Dybendal Alle 10
2630 Taastrup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Denmark
Carbaglu,EMEA/H/C/000461,carglumic acid,carglumic acid,"Amino Acid Metabolism, Inborn Errors
Propionic Acidemia",A16AA05,,Orphan Europe S.A.R.L.,16,23/01/2003,"Immeuble ""Le Wilson""
70, avenue du Général de Gaulle
FR-92800 Puteaux
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Vargatef,EMEA/H/C/002569,nintedanib,nintedanib,"Carcinoma, Non-Small-Cell Lung",L01XE3,,Boehringer Ingelheim International GmbH,9,20/11/2014,"Binger Strasse 173
55216 Ingelheim
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Taltz,EMEA/H/C/003943,ixekizumab,ixekizumab,Psoriasis,L04AC,,Eli Lilly Nederland B.V.,6,25/04/2016,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Halimatoz,EMEA/H/C/004866,adalimumab,adalimumab,"Hidradenitis Suppurativa
Psoriasis
Arthritis, Juvenile Rheumatoid
Uveitis
Arthritis, Rheumatoid
Spondylitis, Ankylosing
Arthritis, Psoriatic",L04AB04,,Sandoz GmbH,0,25/07/2018,"Biochemiestrasse 10
6250 Kundl
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Forsteo,EMEA/H/C/000425,teriparatide,teriparatide,"Osteoporosis
Osteoporosis, Postmenopausal",H05AA02,,Eli Lilly Nederland B.V.,20,09/06/2003,"Eli Lilly Nederland BV
Papendorpseweg 83
3528 BJ Utrecht
The Netherlands",,,,,,,,,The Netherlands
Matever,EMEA/H/C/002024,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pharmathen S.A.,17,02/10/2011,"6, Dervenakion
EL-15351 Pallini Attiki
Greece",,,,,,,,,Greece
Zydelig,EMEA/H/C/003843,Idelalisib,idelalisib,"Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell",L01XX47,,Gilead Sciences Ireland UC,14,17/09/2014,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Xagrid,EMEA/H/C/000480,Anagrelide,anagrelide,"Thrombocythemia, Essential",L01XX35,,Shire Pharmaceutical Contracts Limited,32,15/11/2004,"1 Kingdom Street
London W2 6BD
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
BiResp Spiromax,EMEA/H/C/003890,"budesonide
formoterol fumarate dihydrate",budesonide / formoterol,"Pulmonary Disease, Chronic Obstructive
Asthma",R03AK07,,Teva Pharma B.V.,6,27/04/2014,"Computerweg 10
3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Kentera (previously Oxybutynin Nicobrand),EMEA/H/C/000532,oxybutynin,oxybutynin,"Urinary Incontinence, Urge",G04BD04,,Nicobrand Ltd.,15,14/06/2004,"Nicobrand Limited
189 Castleroe Road
Coleraine BT51 3RP
Northern Ireland
United Kingdom",,,,,,,,,United Kingdom
Ofev,EMEA/H/C/003821,nintedanib,nintedanib,Idiopathic Pulmonary Fibrosis,L01XE,,Boehringer Ingelheim International GmbH,8,14/01/2015,"Binger Strasse 173 55216
Ingelheim am Rhein
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Ribavirin Teva Pharma B.V.,EMEA/H/C/001064,Ribavirin,ribavirin,"Hepatitis C, Chronic",J05AB04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,13,30/06/2009,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Repatha,EMEA/H/C/003766,Evolocumab,evolocumab,"Dyslipidemias
Hypercholesterolemia",C10AX13,,Amgen Europe B.V.,8,16/07/2015,"Minervum 7061
4817 ZK Breda
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Docetaxel Teva,EMEA/H/C/001107,docetaxel,docetaxel,"Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Adenocarcinoma
Prostatic Neoplasms
Stomach Neoplasms
Breast Neoplasms",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,16,26/01/2010,"Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Aplidin,,Plitidepsin,plitidepsin,Multiple Myeloma,L01,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,"Pharma Mar, S.A.",13/12/2017,,16/07/2018,
Ceplene,EMEA/H/C/000796,Histamine dihydrochloride,histamine dihydrochloride,"Leukemia, Myeloid, Acute",L03AX14,,Noventia Pharma Srl,12,06/10/2008,"Via Carlo Pisacane 31
47121 Forli
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Italy
Procysbi,EMEA/H/C/002465,mercaptamine bitartrate,mercaptamine,Cystinosis,A16AA04,,Chiesi Farmaceutici S.p.A,9,05/09/2013,"Via Palermo 26/A
43122 Parma
Italy",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Italy
Janumet,EMEA/H/C/000861,"sitagliptin
metformin hydrochloride",sitagliptin / metformin,"Diabetes Mellitus, Type 2",A10BD07,,Merck Sharp & Dohme B.V.,23,15/07/2008,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Vosevi,EMEA/H/C/004350,"Sofosbuvir
velpatasvir
voxilaprevi",sofosbuvir / velpatasvir / voxilaprevi,"Hepatitis C, Chronic",J05A,,Gilead Sciences Ireland UC,2,25/07/2017,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Clopidogrel HCS,EMEA/H/C/002255,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Acute Coronary Syndrome
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",HCS bvba ,8,27/10/2010,"HCS bvba
H. Kennisstraat 53
B-2650 Edegem
Belgium",,,,,,,,,Belgium
Zinplava,EMEA/H/C/004136,bezlotoxumab,bezlotoxumab,"Enterocolitis, Pseudomembranous",J06BB21,,Merck Sharp & Dohme B.V.,4,17/01/2017,"Waarderweg 39
2031 BN Haarlem
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Velmetia,EMEA/H/C/000862,"sitagliptin
metformin hydrochloride",sitagliptin / metformin,"Diabetes Mellitus, Type 2",A10BD07,,Merck Sharp & Dohme B.V.,25,16/07/2008,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron),EMEA/H/C/003918,dinutuximab beta,dinutuximab beta,Neuroblastoma,L01XC,,EUSA Pharma (UK) Limited,4,08/05/2017,"Breakspear Park
Breakspear Way
Hemel Hempstead HP2 4TZ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,United Kingdom
Victrelis,EMEA/H/C/002332,Boceprevir,boceprevir,"Hepatitis C, Chronic",J05AE,,Merck Sharp Dohme Ltd,22,17/07/2011,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Ozempic,EMEA/H/C/004174,semaglutide,semaglutide,Diabetes Mellitus,A10BJ06,,Novo Nordisk A/S,1,07/02/2018,"Novo Alle 1
2880 Bagsvaerd
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Glivec,EMEA/H/C/000406,imatinib,imatinib,"Precursor Cell Lymphoblastic Leukemia-Lymphoma
Gastrointestinal Stromal Tumors
Dermatofibrosarcoma
Myelodysplastic-Myeloproliferative Diseases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hypereosinophilic Syndrome",L01XE01,,Novartis Europharm Limited,33,06/11/2001,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Alsitek,,masitinib mesylate,masitinib,Amyotrophic Lateral Sclerosis,L01XE22,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,AB Science,19/04/2018,,25/07/2018,
Blitzima,EMEA/H/C/004723,rituximab,rituximab,"Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell",L01XC02,,Celltrion Healthcare Hungary Kft.,4,12/07/2017,"Váci út 1-3. West End Office
Building B torony
1062 Budapest
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Ultibro Breezhaler,EMEA/H/C/002679,"indacaterol
Glycopyrronium bromide",indacaterol / glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03AL04,,Novartis Europharm Limited,9,18/09/2013,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Ivemend,EMEA/H/C/000743,fosaprepitant,fosaprepitant,"Vomiting
Cancer",A04AD12,,Merck Sharp & Dohme B.V.,20,10/01/2008,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Actelsar HCT,EMEA/H/C/002676,"telmisartan
hydrochlorothiazide",telmisartan / hydrochlorothiazide,,C09DA07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group hf,8,12/03/2013,"Reykjavikurvegur 76-78
220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Advate,EMEA/H/C/000520,octocog alfa,octocog alfa,Hemophilia A,B02BD02,,Baxter AG,23,01/03/2004,"Industriestrasse 67
A-1221 Vienna
Austria",,,,,,,,,Austria
Epclusa,EMEA/H/C/004210,"Sofosbuvir
velpatasvir",sofosbuvir / velpatasvir,"Hepatitis C, Chronic",J05A,,Gilead Sciences Ireland UC,6,05/07/2016,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Xarelto,EMEA/H/C/000944,rivaroxaban,rivaroxaban,"Arthroplasty, Replacement
Venous Thromboembolism",B01AF01,,Bayer AG,27,29/09/2008,"51368 Leverkusen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Nexavar,EMEA/H/C/000690,sorafenib,sorafenib,"Carcinoma, Hepatocellular
Carcinoma, Renal Cell",L01XE05,,Bayer Pharma AG,27,18/07/2006,"13342 Berlin
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Extavia,EMEA/H/C/000933,interferon beta-1b,interferon beta-1b,Multiple Sclerosis,L03AB08,,Novartis Europharm Ltd,20,19/05/2008,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,,,,,,,,United Kingdom
Giotrif,EMEA/H/C/002280,afatinib,afatinib,"Carcinoma, Non-Small-Cell Lung",L01XE13,,Boehringer Ingelheim International GmbH,11,24/09/2013,"Binger Strasse 173
55216 Ingelheim
Germany",,,,,,,,,Germany
Effentora,EMEA/H/C/000833,fentanyl,fentanyl,"Pain
Cancer",N02AB03,,Teva B.V.,20,03/04/2008,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Briviact (in Italy: Nubriveo),EMEA/H/C/003898,Brivaracetam,brivaracetam,Epilepsy,N03AX23,,UCB Pharma SA,6,13/01/2016,"Allée de la Recherche 60
1070 Bruxelles
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
TachoSil,EMEA/H/C/000505,"human fibrinogen
human thrombin",human fibrinogen / human thrombin,"Hemostasis, Surgical",B02BC30,,Takeda Austria GmbH,22,07/06/2004,"St. Peter Strasse 25
A-4020 Linz
Austria",,,,,,,,,Austria
Daklinza,EMEA/H/C/003768,daclatasvir dihydrochloride,daclatasvir,"Hepatitis C, Chronic",J05AX14,,Bristol-Myers Squibb Pharma EEIG,13,22/08/2014,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Saxenda,EMEA/H/C/003780,liraglutide,liraglutide,"Obesity
Overweight",A10BJ02,,Novo Nordisk A/S,5,23/03/2015,"Novo Alle
2880 Bagsvaerd
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Rasagiline ratiopharm,EMEA/H/C/003957,rasagiline,rasagiline,Parkinson Disease,N04BD02,,Teva B.V.,5,11/01/2015,"Swensweg 5
2031 GA Haarlem
Netherlands",,,,,,,,,The Netherlands
Elaprase,EMEA/H/C/000700,idursulfase,idursulfase,Mucopolysaccharidosis II,A16AB09,,Shire Human Genetic Therapies AB,18,07/01/2007,"Vasagatan 7
111 20 Stockholm
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Sweden
Sutent,EMEA/H/C/000687,sunitinib,sunitinib,"Gastrointestinal Stromal Tumors
Carcinoma, Renal Cell
Neuroendocrine Tumors",L01XE04,,Pfizer Limited,33,18/07/2006,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Xeljanz,,Tofacitinib,tofacitinib,"Arthritis, Rheumatoid",,,,,,,,,,,Pfizer Limited,24/04/2013,,24/04/2013,
Maviret,EMEA/H/C/004430,"glecaprevir
pibrentasvir",glecaprevir / pibrentasvir,"Hepatitis C, Chronic",J05AX,,AbbVie Deutschland GmbH Co. KG,3,25/07/2017,"Knollstrasse
67061 Ludwigshafen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Insulatard,EMEA/H/C/000441,insulin human,insulin human (rDNA),Diabetes Mellitus,A10AC01,,Novo Nordisk A/S,18,07/10/2002,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Ozurdex,EMEA/H/C/001140,dexamethasone,dexamethasone,"Macular Edema
Uveitis",S01BA01,,Allergan Pharmaceuticals Ireland,9,26/07/2010,"Castlebar Road
Westport, Co Mayo
Ireland",,,,,,,,,Ireland
Revolade,EMEA/H/C/001110,Eltrombopag olamine,eltrombopag,"Purpura, Thrombocytopenic, Idiopathic",B02BX05,,Novartis Europharm Limited,21,10/03/2010,"Vista Building Elm Park
Merrion Road
Dublin 4
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Aloxi,EMEA/H/C/000563,palonosetron hydrochloride,palonosetron,"Vomiting
Cancer",A04AA05,,Helsinn Birex Pharmaceuticals Ltd.,21,21/03/2005,"Damastown
Mulhuddart
Dublin 15
Ireland",,,,,,,,,Ireland
Adrovance,EMEA/H/C/000759,"alendronate sodium trihydrate
colecalciferol",alendronic acid / colecalciferol,"Osteoporosis, Postmenopausal",M05BB03,,Merck Sharp & Dohme B.V.,18,03/01/2007,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Modigraf,EMEA/H/C/000954,tacrolimus,tacrolimus,Graft Rejection,L04AD02,,Astellas Pharma Europe B.V.,11,15/05/2009,"Elisabethhof 19
NL-2353 EW Leiderdorp
The Netherlands",,,,,,,,,The Netherlands
Advagraf,EMEA/H/C/000712,tacrolimus,tacrolimus,Graft Rejection,L04AD02,,Astellas Pharma Europe B.V.,17,23/04/2007,"Regulatory Affairs Europe
Elisabethhof 19
NL-2353 EW Leiderdorp
The Netherlands",,,,,,,,,The Netherlands
Alprolix,EMEA/H/C/004142,eftrenonacog alfa,eftrenonacog alfa,Hemophilia B,B02BD04,,Swedish Orphan Biovitrum AB (publ),3,11/05/2016,"SE-112 76 Stockholm
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Sweden
Docetaxel Kabi,EMEA/H/C/002325,docetaxel,docetaxel,"Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Adenocarcinoma
Prostatic Neoplasms
Breast Neoplasms",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Fresenius Kabi Deutschland GmbH,10,21/05/2012,"Else-Kröner-Straße 1,
61352 Bad Homburg v.d.Höhe
Germany",,,,,,,,,Germany
Dzuveo,EMEA/H/C/004335,sufentanil citrate,sufentanil,Pain,N01AH03,,FGK Representative Service GmbH,0,24/06/2018,"Heimeranstr. 35
80339 Muenchen
Germany",,,,,,,,,Germany
Iressa,EMEA/H/C/001016,gefitinib,gefitinib,"Carcinoma, Non-Small-Cell Lung",L01XE02,,AstraZeneca AB,12,23/06/2009,"151 85 Södertälje
Sweden",,,,,,,,,Sweden
Feraccru,EMEA/H/C/002733,ferric maltol,ferric maltol,"Anemia, Iron-Deficiency",B03AB,,Shield TX (UK) Limited,6,18/02/2016,"Northern Design Centre
Baltic Business Centre
Gateshead Quays NE8 3DF
United Kingdom",,,,,,,,,United Kingdom
Aerinaze,EMEA/H/C/000772,"desloratadine
pseudophedrine sulphate",desloratadine / pseudoephedrine,"Rhinitis, Allergic, Seasonal",R01BA52,,Merck Sharp & Dohme B.V. ,16,30/07/2007,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Spectrila,EMEA/H/C/002661,asparaginase,asparaginase,Precursor Cell Lymphoblastic Leukemia-Lymphoma,L01XX02,,Medac Gesellschaft fuer klinische Spezialpraeparate mbH,2,13/01/2016,"Theaterstrasse 6
22880 Wedel
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Rixubis,EMEA/H/C/003771,nonacog gamma,nonacog gamma,Hemophilia B,B02BD04,,Baxalta Innovations GmbH,6,18/12/2014,"Industriestrasse 67
1221 Vienna
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Austria
Controloc Control,EMEA/H/C/001097,pantoprazole,pantoprazole,Gastroesophageal Reflux,A02BC02,,Takeda GmbH,10,11/06/2009,"Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany",,,,,,,,,Germany
Seebri Breezhaler,EMEA/H/C/002430,Glycopyrronium bromide,glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03BB06,,Novartis Europharm Limited,8,27/09/2012,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Symtuza,EMEA/H/C/004391,"darunavir
cobicistat
emtricitabine
tenofovir alafenamide",darunavir / cobicistat / emtricitabine / tenofovir alafenamide,HIV Infections,J05,,Janssen-Cilag International N.V.,5,20/09/2017,"Turnhoutseweg 30
B-2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Granupas (previously Para-aminosalicylic acid Lucane),EMEA/H/C/002709,Para-aminosalicylic acid,para-aminosalicylic acid,Tuberculosis,J04AA01,,Eurocept International B. V.,5,06/04/2014,"Trapgans 5
1244 RL Ankeveen
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Trulicity,EMEA/H/C/002825,dulaglutide,dulaglutide,"Diabetes Mellitus, Type 2",A10BJ05,,Eli Lilly Nederland B.V.,9,20/11/2014,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Rezolsta,EMEA/H/C/002819,"darunavir
cobicistat",darunavir / cobicistat,HIV Infections,J05,,Janssen-Cilag International N.V.,6,19/11/2014,"Turnhoutseweg 30
2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Farydak,EMEA/H/C/003725,panobinostat lactate anhydrous,panobinostat,Multiple Myeloma,L01XX42,,Novartis Europharm Limited,5,27/08/2015,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Prezista,EMEA/H/C/000707,darunavir,darunavir,HIV Infections,J05AE10,,Janssen-Cilag International NV,43,11/02/2007,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Enbrel,EMEA/H/C/000262,etanercept,etanercept,"Spondylitis, Ankylosing
Arthritis, Juvenile Rheumatoid
Arthritis, Psoriatic
Psoriasis
Arthritis, Rheumatoid",L04AB01,,Pfizer Limited,56,02/02/2000,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Somac Control,EMEA/H/C/001098,pantoprazole,pantoprazole,Gastroesophageal Reflux,A02BC02,,Takeda GmbH,11,12/06/2009,"Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany",,,,,,,,,Germany
Pantozol Control,EMEA/H/C/001013,pantoprazole,pantoprazole,Gastroesophageal Reflux,A02BC02,,Takeda GmbH,12,11/06/2009,"Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany",,,,,,,,,Germany
Harvoni,EMEA/H/C/003850,"ledispavir 90 mg
sofosbuvir 400 mg",ledispavir 90 mg / sofosbuvir 400 mg,"Hepatitis C, Chronic",J05AX65,,Gilead Sciences Ireland UC,15,16/11/2014,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Miglustat Gen.Orph,EMEA/H/C/004366,miglustat,miglustat,Gaucher Disease,A16AX06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Gen.Orph,1,09/11/2017,"185 Bureaux de la Colline
92213 Saint Cloud Cedex
France",,,,,,,,,France
Byetta,EMEA/H/C/000698,exenatide,exenatide,"Diabetes Mellitus, Type 2",A10BJ01,,AstraZeneca AB,21,20/11/2006,"151 85 Sodertalje
Sweden",,,,,,,,,Sweden
Sylvant,EMEA/H/C/003708,siltuximab,siltuximab,Giant Lymph Node Hyperplasia,L04AC11,,Janssen-Cilag International NV,7,21/05/2014,"Turnhoutseweg 30
2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Nplate,EMEA/H/C/000942,romiplostim,romiplostim,"Purpura, Thrombocytopenic, Idiopathic",B02BX04,,Amgen Europe B.V.,19,04/02/2009,"Minervum 7061
NL-4817 ZK Breda
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Lamivudine Teva,EMEA/H/C/001113,lamivudine,lamivudine,"Hepatitis B, Chronic",J05AF05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,8,22/10/2009,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Topotecan Teva,EMEA/H/C/001071,topotecan,topotecan,"Ovarian Neoplasms
Uterine Cervical Neoplasms
Small Cell Lung Carcinoma",L01XX17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,8,20/09/2009,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
"Vantavo (previously Alendronate sodium and colecalciferol, MSD)",EMEA/H/C/001180,"alendronic acid
colecalciferol",alendronic acid / colecalciferol,"Osteoporosis, Postmenopausal",M05BB03,,Merck Sharp & Dohme B.V.,12,15/10/2009,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Temomedac,EMEA/H/C/001124,temozolomide,temozolomide,"Glioma
Glioblastoma",L01AX03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",medac Gesellschaft für klinische Spezialpräparate mbH,11,24/01/2010,"medac
Gesellschaft für klinische Spezialpräparate mbH
Fehlandtstr. 3
20354 Hamburg
Germany",,,,,,,,,Germany
Fosavance,EMEA/H/C/000619,"alendronic acid
colecalciferol",alendronic acid / colecalciferol,"Osteoporosis, Postmenopausal",M05BB03,,Merck Sharp & Dohme B.V.,20,23/08/2005,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Pemetrexed Sandoz,EMEA/H/C/004011,pemetrexed disodium hemipentahydrate,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sandoz GmbH,3,17/09/2015,"Biochemiestr. 10
6250 Kundl
Austria",,,,,,,,,Austria
Lantus,EMEA/H/C/000284,insulin glargine,insulin glargine,Diabetes Mellitus,A10AE04,,sanofi-aventis Deutschland GmbH,32,08/06/2000,"Industriepark Höchst
D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Xultophy,EMEA/H/C/002647,"insulin degludec
liraglutide",insulin degludec / liraglutide,"Diabetes Mellitus, Type 2",A10,,Novo Nordisk A/S,10,17/09/2014,"Novo Alle
Bagsværd - 2880
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Comtan,EMEA/H/C/000171,entacapone,entacapone,Parkinson Disease,N04BX02,,Novartis Europharm Limited,23,22/09/1998,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Verkazia,EMEA/H/C/004411,ciclosporin,ciclosporin,"Conjunctivitis
Keratitis",S01XA18,,Santen Oy,0,05/07/2018,"Niittyhaankatu
20 FI-33720
Tampere
Finland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Finland
Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz),EMEA/H/C/002785,"levodopa
carbidopa
entacapone",levodopa / carbidopa / entacapone,Parkinson Disease,N04BA03,,Orion Corporation,5,10/11/2013,"Orionintie 1
02 200 Espoo
Finland",,,,,,,,,Finland
Zykadia,EMEA/H/C/003819,ceritinib,ceritinib,"Carcinoma, Non-Small-Cell Lung",L01XE,,Novartis Europharm Limited,11,05/05/2015,"Vista Building Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Trajenta,EMEA/H/C/002110,linagliptin,linagliptin,"Diabetes Mellitus, Type 2",A10BH05,,Boehringer Ingelheim International GmbH,11,23/08/2011,"Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Pemetrexed Fresenius Kabi,EMEA/H/C/003895,pemetrexed,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Fresenius Kabi Deutschland GmbH,4,21/07/2016,"Else-Kroner-Strasse 1
61352 Bad Homburg v.d.Hohe
Germany",,,,,,,,,Germany
Azilect,EMEA/H/C/000574,rasagiline,rasagiline,Parkinson Disease,N04BD02,,Teva Pharma GmbH,20,20/02/2005,"Teva B.V.
Swensweg 5
2031GA Haarlem
Netherlands",,,,,,,,,The Netherlands
Neparvis,EMEA/H/C/004343,"sacubitril
valsartan",sacubitril / valsartan,Heart Failure,C09DX04,,Novartis Europharm Limited,7,25/05/2016,"Vista Building Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Skilarence,EMEA/H/C/002157,dimethyl fumarate,dimethyl fumarate,Psoriasis,-,,Almirall S.A,1,22/06/2017,"Ronda General Mitre
151 08022 Barcelona
Spain",,,,,,,,,Spain
Azarga,EMEA/H/C/000960,"brinzolamide
timolol maleate",brinzolamide / timolol,"Glaucoma, Open-Angle
Ocular Hypertension",S01ED51,,Novartis Europharm Limited,12,25/11/2008,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Azopt,EMEA/H/C/000267,brinzolamide,brinzolamide,"Glaucoma, Open-Angle
Ocular Hypertension",S01EC04,,Novartis Europharm Limited,24,08/03/2000,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,,,,,,,,United Kingdom
Mimpara,EMEA/H/C/000570,cinacalcet hydrochloride,cinacalcet,"Hypercalcemia
Parathyroid Neoplasms
Hyperparathyroidism",H05BX01,,Amgen Europe B.V.,20,21/10/2004,"Minervum 7061
NL-4817 ZK Breda
The Netherlands",,,,,,,,,The Netherlands
Prolia,EMEA/H/C/001120,denosumab,denosumab,"Bone Resorption
Osteoporosis, Postmenopausal",M05BX04,,Amgen Europe B.V.,19,25/05/2010,"Minervum 7061
NL-4817 ZK Breda
The Netherlands",,,,,,,,,The Netherlands
Mirapexin,EMEA/H/C/000134,pramipexole dihydrochloride monohydrate,pramipexole,"Restless Legs Syndrome
Parkinson Disease",N04BC05,,Boehringer Ingelheim International GmbH,32,22/02/1998,"D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Bexsero,EMEA/H/C/002333,recombinant Neisseria meningitidis group-B NHBA fusion protein / recombinant Neisseria meningitidis group-B NadA protein / recombinant Neisseria meningitidis group B fHbp fusion protein / outer membrane vesicles from Neisseria meningitidis group-B strain NZ98/254 measured as amount of total protein containing the PortA P1.4,"meningococcal group-B vaccine (rDNA, component, adsorbed)","Meningitis, Meningococcal",J07AH09,,GSK Vaccines S.r.l.,18,13/01/2013,"Via Fiorentina, 1
IT-53100 Siena
Italy",,,,,,,,,Italy
Lopinavir/Ritonavir Mylan,EMEA/H/C/004025,lopinavir/ritonavir,lopinavir/ritonavir,HIV Infections,J05AR10,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,6,13/01/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Solymbic,EMEA/H/C/004373,adalimumab,adalimumab,"Arthritis, Psoriatic
Spondylitis, Ankylosing
Crohn Disease
Colitis, Ulcerative
Hidradenitis Suppurativa
Psoriasis
Arthritis, Rheumatoid",L04AB04,,Amgen Europe B.V.,2,21/03/2017,"Minervum 7061
4817 ZK Breda
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Aranesp,EMEA/H/C/000332,darbepoetin alfa,darbepoetin alfa,"Anemia
Cancer
Kidney Failure, Chronic",B03XA02,,Amgen Europe B.V.,40,07/06/2001,"Minervum 7061
NL-4817 ZK Breda
The Netherlands",,,,,,,,,The Netherlands
Aerius,EMEA/H/C/000313,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Urticaria
Rhinitis, Allergic, Seasonal",R06AX27,,Merck Sharp & Dohme B.V. ,41,14/01/2001,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Temozolomide Hexal,EMEA/H/C/001127,temozolomide,temozolomide,"Glioma
Glioblastoma",L01AX03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hexal AG,14,14/03/2010,"Industriestrasse 25
D-83607 Holzkirchen
Germany",,,,,,,,,Germany
Axura,EMEA/H/C/000378,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,,Merz Pharmaceuticals GmbH,24,16/05/2002,"Eckenheimer Landstr. 100
D-60318 Frankfurt
Germany",,,,,,,,,Germany
Imlygic,EMEA/H/C/002771,talimogene laherparepvec,talimogene laherparepvec,Melanoma,L01XX51,,Amgen Europe B.V.,4,15/12/2015,"Minervum 7061
4817 ZK Breda
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Darunavir Krka d.d.,EMEA/H/C/004891,darunavir,darunavir,HIV Infections,J05AE10,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","KRKA, d.d., Novo mesto",1,17/01/2018,"Smarjeska cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Darunavir Krka,EMEA/H/C/004273,darunavir,darunavir,HIV Infections,J05AE10,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","KRKA, d.d., Novo mesto",1,25/01/2018,"Smarjeska cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Docetaxel Accord,EMEA/H/C/002539,docetaxel,docetaxel,"Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Adenocarcinoma
Prostatic Neoplasms
Breast Neoplasms",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,10,21/05/2012,"Ground Floor
Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Maci,EMEA/H/C/002522,autologous cultured chondrocytes,matrix-applied characterised autologous cultured chondrocytes,"Fractures, Cartilage",M09AX02,,Vericel Denmark ApS,4,26/06/2013,"Amaliegade 10,
DK-1256 Copenhagen K
Denmark",,,,,,,,,Denmark
Suboxone,EMEA/H/C/000697,"buprenorphine
naloxone",buprenorphine / naloxone,Opioid-Related Disorders,N07BC51,,Indivior Europe Limited,14,25/09/2006,"27 Windsor Place
Dublin 2
Ireland",,,,,,,,,Ireland
Ravicti,EMEA/H/C/003822, glycerol phenylbutyrate, glycerol phenylbutyrate,"Urea Cycle Disorders, Inborn",A16AX09,,Horizon Pharma Ireland Limited,8,26/11/2015,"Connaught House
1 Burlington Road
Dublin
D04C5Y6
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Dificlir,EMEA/H/C/002087,fidaxomicin,fidaxomicin,Clostridium Infections,A07AA12,,Astellas Pharma Europe BV,10,04/12/2011,"Sylviusweg 62
2333 BE Leiden
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Cayston,EMEA/H/C/000996,aztreonam lysine,aztreonam,"Cystic Fibrosis
Respiratory Tract Infections",J01DF01,,Gilead Sciences Ireland UC,16,20/09/2009,"Carrigtohill
County Cork, T45 DP77
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Pantoloc Control,EMEA/H/C/001100,pantoprazole,pantoprazole,Gastroesophageal Reflux,A02BC02,,Takeda GmbH,14,11/06/2009,"Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany",,,,,,,,,Germany
Cystadrops,EMEA/H/C/003769,mercaptamine hydrochloride,mercaptamine,Cystinosis,S01XA21,,Orphan Europe S.A.R.L.,2,18/01/2017,"Immeuble ""Le Wilson"" 70
Avenue du Général de Gaulle
FR-92800 Puteaux
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Panretin,EMEA/H/C/000279,alitretinoin,alitretinoin,"Sarcoma, Kaposi",L01XX22,,Eisai Ltd,15,10/10/2000,"European Knowledge Centre
Mosquito Way
Hatfield
Hertfordshire
AL10 9SN
United Kingdom",,,,,,,,,United Kingdom
Gazyvaro,EMEA/H/C/002799,Obinutuzumab,obinutuzumab,"Leukemia, Lymphocytic, Chronic, B-Cell",L01XC15,,Roche Registration GmbH,6,22/07/2014,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Yondelis,EMEA/H/C/000773,trabectedin,trabectedin,"Ovarian Neoplasms
Sarcoma",L01CX01,,Pharma Mar S.A.,23,17/09/2007,"Polígono Industrial La Mina
Avda. de los Reyes, 1
E-28770 Colmenar Viejo (Madrid)
Spain",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Spain
Efficib,EMEA/H/C/000896,"sitagliptin
metformin hydrochloride",sitagliptin / metformin,"Diabetes Mellitus, Type 2",A10BD07,,Merck Sharp Dohme Ltd,23,15/07/2008,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Jardiance,EMEA/H/C/002677,empagliflozin,empagliflozin,"Diabetes Mellitus, Type 2",A10BK03,,Boehringer Ingelheim International GmbH,15,21/05/2014,"Binger Strasse 173
55216 Ingelheim
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Silgard,EMEA/H/C/000732,human papillomavirus type 11 L1 protein / human papillomavirus type 16 L1 protein / human papillomavirus type 18 L1 protein / human papillomavirus type 6 L1 protein,"human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)","Papillomavirus Infections
Uterine Cervical Dysplasia
Condylomata Acuminata
Immunization",J07BM01,,Merck Sharp Dohme Ltd,33,19/09/2006,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Zinbryta,EMEA/H/C/003862,daclizumab,daclizumab,Multiple Sclerosis,L04AC01,,Biogen Idec Ltd,8,30/06/2016,"Innovation House
70 Norden Road
Maidenhead
Berkshire SL6 4AY
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Synjardy,EMEA/H/C/003770,"empagliflozin
Metformin",empagliflozin / metformin,"Diabetes Mellitus, Type 2",A10BD20,,Boehringer Ingelheim GmbH,13,26/05/2015,"Binger Strasse 173
55216 Ingelheim am Rhein
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Gardasil,EMEA/H/C/000703,"human papillomavirus type 6 L1 protein
human papillomavirus type 11 L1 protein
human papillomavirus type 16 L1 protein
human papillomavirus type 18 L1 protein","human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)","Papillomavirus Infections
Uterine Cervical Dysplasia
Condylomata Acuminata
Immunization",J07BM01,,MSD VACCINS,38,20/09/2006,"162 avenue Jean Jaurès
69007 Lyon Cedex 07
France",,,,,,,,,France
Adenuric,EMEA/H/C/000777,febuxostat,febuxostat,Gout,M04AA03,,Menarini International Operations Luxembourg S.A. (MIOL),17,20/04/2008,"1 Avenue de la Gare
L-1611 Luxembourg",,,,,,,,,Luxembourg
Ebilfumin,EMEA/H/C/003717,oseltamivir,oseltamivir,"Influenza, Human",J05AH02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,8,21/05/2014,"Reykjavikurvegur 76-78
220 Hafnarfjordur
Iceland",,,,,,,,,Iceland
Lokelma,EMEA/H/C/004029,sodium zirconium cyclosilicate,sodium zirconium cyclosilicate,Hyperkalemia,V03AE10,,AstraZeneca AB,1,21/03/2018,"SE-151-85 Sodertalje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Bemfola,EMEA/H/C/002615,follitropin alfa,follitropin alfa,Anovulation,G03GA05,,Gedeon Richter Plc.,7,26/03/2014,"Gyomroi ut 19-21
1103 Budapest
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Cervarix,EMEA/H/C/000721,"human papillomavirus1 type 16 L1 protein
human papillomavirus type 18 L1 protein","human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)","Papillomavirus Infections
Uterine Cervical Dysplasia
Immunization",J07BM02,,GlaxoSmithKline Biologicals S.A.,31,19/09/2007,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Viramune,EMEA/H/C/000183,nevirapine,nevirapine,HIV Infections,J05AG01,,Boehringer Ingelheim International GmbH,36,04/02/1998,"D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Reagila,EMEA/H/C/002770,cariprazine hydrochloride,cariprazine,Schizophrenia,N05AX15,,Gedeon Richter,2,12/07/2017,"Gyomroi ut 19-21
1103 Budapest
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Hungary
Ristaben,EMEA/H/C/001234,sitagliptin,sitagliptin,"Diabetes Mellitus, Type 2",A10BH01,,Merck Sharp Dohme Ltd,18,14/03/2010,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Zarzio,EMEA/H/C/000917,filgrastim,filgrastim,"Neutropenia
Hematopoietic Stem Cell Transplantation
Cancer",L03AA02,,Sandoz GmbH,15,05/02/2009,"Biochemiestrasse 10
AT-6250 Kundl
Austria",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Biktarvy,EMEA/H/C/004449,"bictegravir
emtricitabine
tenofovir alafenamide
fumarate",bictegravir / emtricitabine / tenofovir alafenamide,HIV Infections,J05AR,,Gilead Sciences International Limited,0,20/06/2018,"Flowers Building
Granta Park
Abington
Cambridge CB21 6GT
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Pregabalin Zentiva k.s.,EMEA/H/C/004277,pregabalin,pregabalin,"Anxiety Disorders
Neuralgia
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Zentiva k.s.,3,26/02/2017,"U Kabelovny 130
Dolni Mecholupy 102 37
Prague 10
Czech Republic",,,,,,,,,Czech Republic
Twynsta,EMEA/H/C/001224,"telmisartan
amlodipine",telmisartan / amlodipine,Hypertension,C09DB04,,Boehringer Ingelheim International GmbH,9,06/10/2010,"Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Akynzeo,EMEA/H/C/003728,"netupitant
palonosetron hydrochloride",netupitant / palonosetron,"Vomiting
Cancer
Nausea",A04AA,,Helsinn Birex Pharmaceuticals Ltd,3,26/05/2015,"Damastown
Mulhuddart
15 Dublin
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
NovoMix,EMEA/H/C/000308,insulin aspart,insulin aspart,Diabetes Mellitus,A10AD05,,Novo Nordisk A/S,26,31/07/2000,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Eporatio,EMEA/H/C/001033,epoetin theta,epoetin theta,"Kidney Failure, Chronic
Anemia
Cancer",B03XA01,,Ratiopharm GmbH,11,28/10/2009,"Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Temozolomide Teva,EMEA/H/C/001126,temozolomide,temozolomide,"Glioma
Glioblastoma",L01AX03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,17,28/01/2010,"Teva B.V.
Swensweg 5
203-GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Cuprymina,EMEA/H/C/002136,copper (64Cu) chloride,copper (64Cu) chloride,Radionuclide Imaging,-,,Sparkle S.r.l  ,6,23/08/2012,"Sparkle S.r.l
Via Livatino 33
62100 Macerata (MC)
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Italy
Incresync,EMEA/H/C/002178,"alogliptin
pioglitazone",alogliptin / pioglitazone,"Diabetes Mellitus, Type 2",A10BD09,,Takeda Pharma A/S,6,19/09/2013,"Dybendal Alle 10
2630 Taastrup
Denmark",,,,,,,,,Denmark
Filgrastim Hexal,EMEA/H/C/000918,filgrastim,filgrastim,"Neutropenia
Hematopoietic Stem Cell Transplantation
Cancer",L03AA02,,Hexal AG,14,05/02/2009,"Industriestrasse 25
D-83607 Holzkirchen
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Grepid,EMEA/H/C/001059,clopidogrel besilate,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pharmathen S.A.,16,27/07/2009,"6, Dervenakion str.
Pallini Attiki
Greece",,,,,,,,,Greece
Trelegy Ellipta,EMEA/H/C/004363,"fluticasone furoate, umeclidinium bromide, vilanterol trifenatate",fluticasone furoate / umeclidinium / vilanterol,"Pulmonary Disease, Chronic Obstructive",R03AL08,,GlaxoSmithKline Trading Services,1,14/11/2017,"Currabinny
Carrigaline
County Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Zerbaxa,EMEA/H/C/003772,"ceftolozane sulfate
tazobactam sodium",ceftolozane / tazobactam,Bacterial Infections,J01,,Merck Sharp Dohme Limited,7,17/09/2015,"Hertford Road
Hoddesdon EN11 9BU
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Elebrato Ellipta,EMEA/H/C/004781,"fluticasone furoate
umeclidinium bromide
vilanterol trifenatate",fluticasone furoate / umeclidinium / vilanterol,"Pulmonary Disease, Chronic Obstructive",R03AL08,,GlaxoSmithKline Trading Services Limited,1,14/11/2017,"Currabinny
Carrigaline
County Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Quinsair,EMEA/H/C/002789,levofloxacin,levofloxacin,"Cystic Fibrosis
Respiratory Tract Infections",J01MA12,,Horizon Pharma Europe BV,7,25/03/2015,"Chiesi Orphan B.V.
Graadt van Roggenweg 340
3531 AH Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Copalia,EMEA/H/C/000774,"amlodipine (as besylate)
valsartan",amlodipine / valsartan,Hypertension,C09DB01,,Novartis Europharm Limited,21,15/01/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Neofordex,EMEA/H/C/004071,dexamethasone,dexamethasone,Multiple Myeloma,H02AB02,,Laboratoires CTRS ,3,15/03/2016,"Laboratoires CTRS
63 rue de l’Est
92100 Boulogne Billancourt
France",,,,,,,,,France
Lamivudine/Zidovudine Teva,EMEA/H/C/001236,"lamivudine
zidovudine",lamivudine / zidovudine,HIV Infections,J05AR01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V. ,9,27/02/2011,"Teva Pharma B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Busulfan Fresenius Kabi,EMEA/H/C/002806,busulfan,busulfan,Hematopoietic Stem Cell Transplantation,L01AB01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Fresenius Kabi Deutschland GmbH,4,21/09/2014,"Else-Kröner-Straße 1,
61352 Bad Homburg v.d.Höhe
Germany",,,,,,,,,Germany
Emend,EMEA/H/C/000527,Aprepitant,aprepitant,"Vomiting
Postoperative Nausea and Vomiting
Cancer",A04AD12,,Merck Sharp & Dohme B.V.,24,10/11/2003,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Siklos,EMEA/H/C/000689,hydroxycarbamide,hydroxycarbamide,"Anemia, Sickle Cell",L01XX05,,Addmedica,15,28/06/2007,"101 rue Saint Lazare
FR-75009 Paris
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Ritonavir Mylan,EMEA/H/C/004549,ritonavir,ritonavir,HIV Infections,J05AE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,1,09/11/2017,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Instanyl,EMEA/H/C/000959,Fentanyl citrate,fentanyl,"Pain
Cancer",N02AB03,,Takeda Pharma A/S,20,19/07/2009,"Langebjerg 1
DK-4000 Roskilde
Denmark",,,,,,,,,Denmark
Lamivudine Teva Pharma B.V.,EMEA/H/C/001111,lamivudine,lamivudine,HIV Infections,J05AF05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,12,09/12/2009,"Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Pregabalin Zentiva,EMEA/H/C/003900,pregabalin,pregabalin,"Anxiety Disorders
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Zentiva, k.s.",4,16/07/2015,"U kabelovny 130
Dolní Měcholupy
Praha 10
102 37
Czech Republic",,,,,,,,,Czech Republic
Zutectra,EMEA/H/C/001089,human hepatitis-B immunoglobulin,human hepatitis-B immunoglobulin,"Immunization, Passive
Hepatitis B
Liver Transplantation",J06BB04,,Biotest Pharma GmbH,12,29/11/2009,"Landsteinerstrasse 5
D-63303 Dreieich
Germany",,,,,,,,,Germany
Signifor,EMEA/H/C/002052,pasireotide,pasireotide,"Acromegaly
Pituitary ACTH Hypersecretion",H01CB05,,Novartis Europharm Limited,11,24/04/2012,"Elm Park
Merrion Road
Dublin 4
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Mixtard,EMEA/H/C/000428,insulin human,insulin human (rDNA),Diabetes Mellitus,A10AD01,,Novo Nordisk A/S,17,06/10/2002,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Starlix,EMEA/H/C/000335,nateglinide,nateglinide,"Diabetes Mellitus, Type 2",A10BX03,,Novartis Europharm Limited,13,02/04/2001,"Vista Building Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Actraphane,EMEA/H/C/000427,insulin human,insulin human (rDNA),Diabetes Mellitus,A10AD01,,Novo Nordisk A/S,17,06/10/2002,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Jakavi,EMEA/H/C/002464,ruxolitinib (as phosphate),ruxolitinib,Myeloproliferative Disorders,L01XE18,,Novartis Europharm Limited,16,22/08/2012,"Elm Park
Merrion Road
Dublin 4
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Invanz,EMEA/H/C/000389,ertapenem sodium,ertapenem,"Community-Acquired Infections
Streptococcal Infections
Staphylococcal Infections
Gram-Negative Bacterial Infections
Surgical Wound Infection
Pneumonia, Bacterial",J01DH03,,Merck Sharp & Dohme B.V.,21,18/04/2002,"Waarderweg 39
2031 BN Haarlem
The Netherlands",,,,,,,,,The Netherlands
Pemetrexed Krka,EMEA/H/C/003958,pemetrexed disodium,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",KRKA d.d.,0,21/05/2018,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Mirvaso,EMEA/H/C/002642,brimonidine tartrate,brimonidine,Skin Diseases,D11AX21,,Galderma International,8,20/02/2014,"Tour Europlaza
La Défense 4
20 avenue André Prothin
92927 La Défense Cedex
France",,,,,,,,,France
Cabometyx,EMEA/H/C/004163,cabozantinib s-malate,cabozantinib,"Carcinoma, Renal Cell",L01XE26,,Ipsen Pharma,2,08/09/2016,"65 Quai Georges Gorse
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Edurant,EMEA/H/C/002264,rilpivirine hydrochloride,rilpivirine,HIV Infections,J05AG05,,Janssen-Cilag International N.V.   ,13,27/11/2011,"Janssen-Cilag International N.V.
Turnhoutseweg 30
BE-2340 Beerse
Belgium",,,,,,,,,Belgium
Clopidogrel Zentiva (previously Clopidogrel Winthrop),EMEA/H/C/000975,clopidogrel,clopidogrel,"Stroke
Peripheral Vascular Diseases
Myocardial Infarction
Acute Coronary Syndrome",B01AC04,,Zentiva k.s.,22,15/07/2008,"U kabelovny 130
102 37 Prague 10
Czech Republic",,,,,,,,,Czech Republic
Norvir,EMEA/H/C/000127,ritonavir,ritonavir,HIV Infections,J05AE03,,AbbVie Deutschland GmbH Co. KG,59,25/08/1996,"Knollstrasse
67061 Ludwigshafen
Germany",,,,,,,,,Germany
Vemlidy,EMEA/H/C/004169,tenofovir alafenamide fumarate,tenofovir alafenamide,Hepatitis B,J05AF,,Gilead Sciences Ireland UC,4,08/01/2017,"Carrigtohill
County Cork, T45 DP77
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Levemir,EMEA/H/C/000528,Insulin detemir,insulin detemir,Diabetes Mellitus,A10AE05,,Novo Nordisk A/S,26,31/05/2004,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Oslif Breezhaler,EMEA/H/C/001210,indacaterol maleate,indacaterol,"Pulmonary Disease, Chronic Obstructive",R03AC18,,Novartis Europharm Limited ,12,29/11/2009,"Elm Park, Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Insuman,EMEA/H/C/000201,insulin human,insulin human,Diabetes Mellitus,A10AB01,,Sanofi-aventis Deutschland GmbH,26,21/02/1997,"D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Semglee,EMEA/H/C/004280,insulin glargine,insulin glargine,Diabetes Mellitus,A10AE04,,Mylan S.A.S,1,22/03/2018,"117 Allee des Parcs
69800
Saint-Priest
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,France
Aubagio,EMEA/H/C/002514,Teriflunomide,teriflunomide,Multiple Sclerosis,L04AA31,,Sanofi-aventis Groupe  ,9,25/08/2013,"Sanofi-aventis Groupe
174, avenue de France
F-75013 Paris
France",,,,,,,,,France
Jylamvo,EMEA/H/C/003756,Methotrexate,methotrexate,"Arthritis, Psoriatic
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Psoriasis
Arthritis, Rheumatoid
Arthritis",L01BA01,,Therakind Limited,1,28/03/2017,"314 Regents Park Road
London N3 2JX
United Kingdom",,,,,,,,,United Kingdom
Keppra,EMEA/H/C/000277,levetiracetam,levetiracetam,Epilepsy,N03AX14,,UCB Pharma SA,43,28/09/2000,"Allée de la Recherche 60
B-1070 Bruxelles
Belgium",,,,,,,,,Belgium
Rubraca,EMEA/H/C/004272,rucaparib camsylate,rucaparib,Ovarian Neoplasms,L01XX,,Clovis Oncology UK Limited,0,23/05/2018,"Sheraton House
Castle Park
Cambridge CB3 0AX
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,United Kingdom
Synagis,EMEA/H/C/000257,palivizumab,palivizumab,Respiratory Syncytial Virus Infections,J06BB16,,AbbVie Deutschland GmbH Co. KG,39,12/08/1999,"Knollstrasse
67061 Ludwigshafen
Germany",,,,,,,,,Germany
Silodyx,EMEA/H/C/001209,silodosin,silodosin,Prostatic Hyperplasia,G04CA04,,Recordati Ireland Ltd,12,28/01/2010,"Raheens East
Ringaskiddy, Co. Cork
Ireland",,,,,,,,,Ireland
Eucreas,EMEA/H/C/000807,"vildagliptin
metformin hydrochloride",vildagliptin / metformin,"Diabetes Mellitus, Type 2",A10BD08,,Novartis Europharm Limited,17,13/11/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Oncaspar,EMEA/H/C/003789,pegaspargase,pegaspargase,Precursor Cell Lymphoblastic Leukemia-Lymphoma,L01XX24,,Baxalta Innovations GmbH,5,13/01/2016,"Industriestrasse 67
1221 Vienna
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Austria
Alofisel,EMEA/H/C/004258,darvadstrocel,darvadstrocel,Rectal Fistula,L04,,Takeda Pharma A/S,1,22/03/2018,"Dybendal Alle 10
2630 Taastrup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Denmark
Riluzole Zentiva,EMEA/H/C/002622,Riluzole,riluzole,Amyotrophic Lateral Sclerosis,N07XX02,,Zentiva k.s.,9,06/05/2012,"U kabelovny 130
102 37 Prague 10
Czech Republic",,,,,,,,,Czech Republic
Sebivo,EMEA/H/C/000713,telbivudine,telbivudine,"Hepatitis B, Chronic",J05AF11,,Novartis Europharm Limited,20,24/04/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Armisarte (previously Pemetrexed Actavis),EMEA/H/C/004109,pemetrexed diacid monohydrate,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,,Actavis Group PTC ehf,5,17/01/2016,"Reykjavikurvegi 76-78
220 Hafnarfjordur
Iceland",,,,,,,,,Iceland
Votrient,EMEA/H/C/001141,pazopanib,pazopanib,"Carcinoma, Renal Cell",L01XE11,,Novartis Europharm Limited ,20,13/06/2010,"Elm Park, Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
SonoVue,EMEA/H/C/000303,sulphur hexafluoride,sulphur hexafluoride,"Ultrasonography
Echocardiography",V08DA04,,Bracco International B.V.,16,26/03/2001,"Strawinskylaan 3051
NL - 1077 ZX Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Xgeva,EMEA/H/C/002173,denosumab,denosumab,"Fractures, Bone
Neoplasm Metastasis",M05BX04,,Amgen Europe B.V.,16,12/07/2011,"Minervum 7061
NL-4817 ZK Breda
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Juluca,EMEA/H/C/004427," dolutegravir sodium,rilpivirine hydrochloride",dolutegravir / rilpivirine,HIV Infections,J05AR,,ViiV Healthcare UK Limited,0,15/05/2018,"980 Great West Road
Brentford TW8 9GS
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Pemetrexed Hospira,EMEA/H/C/003970,pemetrexed,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hospira UK Limited,5,19/11/2015,"Horizon Honey Lane
Maidenhead
Hurley SL6 6RJ
United Kingdom",,,,,,,,,United Kingdom
Rydapt,EMEA/H/C/004095,Midostaurin,midostaurin,"Leukemia, Myeloid, Acute
Mastocytosis",L01XE,,Novartis Europharm Ltd,2,17/09/2017,"Frimley Business Park
Camberley GU16 7SR
United Kigdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
NovoRapid,EMEA/H/C/000258,insulin aspart,insulin aspart,Diabetes Mellitus,A10AB05,,Novo Nordisk A/S,28,06/09/1999,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Elonva,EMEA/H/C/001106,corifollitropin alfa,corifollitropin alfa,"Reproductive Techniques, Assisted
Ovulation Induction",G03GA09,,Merck Sharp Dohme Limited,13,24/01/2010,"Hertford Road
EN11 9BU Hoddesdon
United Kingdom",,,,,,,,,United Kingdom
Prometax,EMEA/H/C/000255,rivastigmine,rivastigmine,"Alzheimer Disease
Parkinson Disease
Dementia",N06DA03,,Novartis Europharm Limited,34,03/12/1998,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Desloratadine Teva,EMEA/H/C/002419,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Rhinitis, Allergic, Seasonal",R06AX27,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V,12,23/11/2011,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Celsentri,EMEA/H/C/000811,maraviroc,maraviroc,HIV Infections,J05AX09,,ViiV Healthcare UK Limited ,22,17/09/2007,"ViiV Healthcare UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Segluromet,EMEA/H/C/004314,ertugliflozin l-pyroglutamic acid / metformin hydrochloride,ertugliflozin / metformin hydrochloride,"Diabetes Mellitus, Type 2",A10BD23,,Merck Sharp Dohme Limited,1,22/03/2018,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Olysio,EMEA/H/C/002777,simeprevir,simeprevir,"Hepatitis C, Chronic",J05AE14,,Janssen-Cilag International N.V.,13,13/05/2014,"Turnhoutseweg 30
B-2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Hexyon,EMEA/H/C/002796,"Diphtheria toxoid
filamentous haemagglutinin
hepatitis B surface antigen
pertussis toxoid
tetanus toxoid
Haemophilus influenzae type b polysaccharide
polyribosylribitol phosphate conjugated to tetanus protein
type 1 (mahoney)
type 2 (mef-1)
type 3 (saukett)","diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)","Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Poliomyelitis
Diphtheria",J07CA09,,Sanofi Pasteur Europe,18,16/04/2013,"14 Espace Henry Valllée
69007 Lyon
France",,,,,,,,,France
Simulect,EMEA/H/C/000207,basiliximab,basiliximab,"Graft Rejection
Kidney Transplantation",L04AC02,,Novartis Europharm Limited,22,09/10/1998,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Imvanex,EMEA/H/C/002596,modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus,modified vaccinia Ankara virus,Smallpox,J07BX,,Bavarian Nordic A/S,13,31/07/2013,"Hejreskovvej 10 A
Kvistgård, 3490
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Denmark
Edarbi,EMEA/H/C/002293,Azilsartan medoxomil,azilsartan medoxomil,Hypertension,C09CA09,,Takeda Pharma A/S,7,06/12/2011,"Dybendal Alle 10
2630 Taastruup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Neuraceq,EMEA/H/C/002553,florbetaben (18F),florbetaben (18F),"Radionuclide Imaging
Alzheimer Disease",V09AX06,,Life Radiopharma Berlin GmbH,13,19/02/2014,"Max-Planck-Straße 4
D-12489 Berlin
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Clopidogrel Mylan,EMEA/H/C/001134,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,11,20/09/2009,"Mylan S.A.S
117 allée des Parcs
F-69 800 Saint Priest
France",,,,,,,,,France
Ulunar Breezhaler,EMEA/H/C/003875,"Glycopyrronium bromide
indacaterol maleate",indacaterol / glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03AL04,,Novartis Europharm Limited,8,22/04/2014,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Clopidogrel Krka,EMEA/H/C/001056,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",11,22/09/2009,"KRKA d.d., Novo mesto
Šmarješka cesta 6
SI-8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Urorec,EMEA/H/C/001092,silodosin,silodosin,Prostatic Hyperplasia,G04CA04,,Recordati Ireland Ltd,14,28/01/2010,"Raheens East
Ringaskiddy, Co. Cork
Ireland",,,,,,,,,Ireland
Vibativ,EMEA/H/C/001240,telavancin,telavancin,"Pneumonia, Bacterial
Cross Infection",J01XA03,,Theravance Biopharma Ireland Umited,10,01/09/2011,"Connaught House 1
Burlington Road
Fourth Floor
D04 C5Y6
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Zyllt,EMEA/H/C/001058,clopidogrel hydrogen sulphate,clopidogrel,"Peripheral Vascular Diseases
Stroke
Acute Coronary Syndrome
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",10,28/09/2009,"KRKA d.d., Novo mesto
Šmarješka cesta 6
SI-8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Trumenba,EMEA/H/C/004051,Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A; Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B,"meningococcal group b vaccine (recombinant, adsorbed)","Meningitis, Meningococcal",J07AH09,,Pfizer Limited,3,24/05/2017,"821 Ramsgate Road Sandwich
Kent CT13 9NJ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Constella,EMEA/H/C/002490,linaclotide,linaclotide,Irritable Bowel Syndrome,A06AX04,,Allergan Pharmaceuticals International Limited,16,25/11/2012,"Clonshaugh Business Technology Park
Dublin 17
D17 E400
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Kineret,EMEA/H/C/000363,anakinra,anakinra,"Arthritis, Rheumatoid",L04AC03,,Swedish Orphan Biovitrum AB (publ),23,07/03/2002,"112 76 Stockholm
Sweden",,,,,,,,,Sweden
Clopidogrel TAD,EMEA/H/C/001136,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Tad Pharma GmbH,8,22/09/2009,"TAD Pharma GmbH
Heinz-Lohmann-Strasse 5
D-27472 Cuxhaven
Germany",,,,,,,,,Germany
Pregabalin Sandoz GmbH,EMEA/H/C/004070,pregabalin,pregabalin,"Anxiety Disorders
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sandoz GmbH,4,18/06/2015,"Biochemiestr. 10
6250 Kundl
Austria",,,,,,,,,Austria
Pregabalin Mylan Pharma,EMEA/H/C/003962,pregabalin,pregabalin,"Anxiety Disorders
Neuralgia
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Generics UK Limited,3,24/06/2015,"Station Close
Potters Bar
Hertfordshire
EN6 1TL
United Kingdom",,,,,,,,,United Kingdom
Erelzi,EMEA/H/C/004192,etanercept,etanercept,"Arthritis, Psoriatic
Psoriasis
Arthritis, Juvenile Rheumatoid
Arthritis, Rheumatoid
Spondylitis, Ankylosing",L04AB01,,Sandoz GmbH,3,22/06/2017,"Biochemiestrasse 10
6250 Kundl
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Rivastigmine Actavis,EMEA/H/C/002036,rivastigmine hydrogen tartrate,rivastigmine,"Dementia
Alzheimer Disease
Parkinson Disease",N06DA03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,13,15/06/2011,"Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Pemetrexed Accord,EMEA/H/C/004072,pemetrexed disodium hemipentahydrate,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,2,17/01/2016,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Vivanza,EMEA/H/C/000488,vardenafil,vardenafil,Erectile Dysfunction,G04BE09,,Bayer Pharma AG ,24,03/03/2003,"Bayer Pharma AG
D-13342 Berlin
Germany",,,,,,,,,Germany
Leflunomide Winthrop,EMEA/H/C/001129,leflunomide,leflunomide,"Arthritis, Rheumatoid
Arthritis, Psoriatic",L04AA13,,Sanofi-Aventis Deutschland GmbH,14,07/01/2010,"Industriepark Höchst
Brüningstrasse 50
D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Imatinib medac,EMEA/H/C/002692,imatinib,imatinib,"Precursor Cell Lymphoblastic Leukemia-Lymphoma
Dermatofibrosarcoma
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Myelodysplastic-Myeloproliferative Diseases
Hypereosinophilic Syndrome",L01XE01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Medac,5,24/09/2013,"Gesellschaft fuer Spezialpraeparaten mbH
Theater strasse 6
22880 Wedel
Germany",,,,,,,,,Germany
Prandin,EMEA/H/C/000362,repaglinide,repaglinide,"Diabetes Mellitus, Type 2",A10BX02,,Novo Nordisk A/S,16,28/01/2001,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Insulin lispro Sanofi,EMEA/H/C/004303,insulin lispro,insulin lispro,Diabetes Mellitus,A10AB04,,sanofi-aventis groupe,2,18/07/2017,"54 rue La Boetie
75008 Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,France
Apidra,EMEA/H/C/000557,insulin glulisine,insulin glulisine,Diabetes Mellitus,A10AB06,,sanofi-aventis Deutschland GmbH,26,26/09/2004,"Sanofi-Aventis Deutschland GmbH
Brueningstrasse 50,
D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Ocaliva,EMEA/H/C/004093,Obeticholic acid,obeticholic acid,"Liver Cirrhosis, Biliary",A05AA04,,Intercept Pharma Ltd,2,11/12/2016,"2 Pancras Square
London N1C 4AG
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,United Kingdom
Nitisinone MDK (previously Nitisinone MendeliKABS),EMEA/H/C/004281,nitisinone,nitisinone,Tyrosinemias,A16AX04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",MendeliKABS Europe Ltd,1,23/08/2017,"The Light Box111
Power RdUnit G. 07
Chiswick
London
W4 5PY
United Kingdom",,,,,,,,,United Kingdom
Vokanamet,EMEA/H/C/002656,"canagliflozin
metformin hydrochloride",canagliflozin / metformin,"Diabetes Mellitus, Type 2",A10BD16,,Janssen-Cilag International N.V.,12,22/04/2014,"Turnhoutseweg 30
B-2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Leganto,EMEA/H/C/002380,rotigotine,rotigotine,"Restless Legs Syndrome
Parkinson Disease",N04BC09,,UCB Pharma S.A.  ,16,16/06/2011,"UCB Pharma S.A.
Allee de la Recherche 60
B-1070 Bruxelles
Belgium",,,,,,,,,Belgium
Ivabradine Accord,EMEA/H/C/004241,ivabradine hydrochloride,ivabradine,"Angina Pectoris
Heart Failure",C01EB17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,1,21/05/2017,"Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Imatinib Teva,EMEA/H/C/002585,imatinib,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic-Myeloproliferative Diseases
Hypereosinophilic Syndrome
Dermatofibrosarcoma",L01XE01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,11,07/01/2013,"Swensweg 5
2031 Haarlem
The Netherlands",,,,,,,,,The Netherlands
Clopidogrel ratiopharm GmbH,EMEA/H/C/001165,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Acute Coronary Syndrome
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Archie Samiel s.r.o.,10,27/07/2009,"Slunná 16
61700 Brno
Czech Republic",,,,,,,,,Czech Republic
Kinzalkomb,EMEA/H/C/000415,"telmisartan
hydrochlorothiazide",telmisartan / hydrochlorothiazide,Hypertension,C09DA07,,Bayer AG,33,18/04/2002,"51368 Leverkusen
Germany",,,,,,,,,Germany
Clopidogrel ratiopharm,EMEA/H/C/004006,clopidogrel hydrogen sulphate,clopidogrel,"Myocardial Infarction
Acute Coronary Syndrome
Peripheral Vascular Diseases
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,6,18/02/2015,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Lacosamide Accord,EMEA/H/C/004443,lacosamide,lacosamide,Epilepsy,N03AX18,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,1,17/09/2017,"Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Emadine,EMEA/H/C/000223,emedastine,emedastine,"Conjunctivitis, Allergic",S01GX06,,Novartis Europharm Limited,21,26/01/1999,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Sildenafil Actavis,EMEA/H/C/001090,sildenafil,sildenafil,Erectile Dysfunction,G04BE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,11,10/12/2009,"Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Ruconest,EMEA/H/C/001223,Recombinant human C1-inhibitor,conestat alfa,"Angioedemas, Hereditary",B06AC04,,Pharming Group N.V.,9,28/10/2010,"Darwinweg 24
NL-2333 CR Leiden
The Netherlands",,,,,,,,,The Netherlands
Arava,EMEA/H/C/000235,leflunomide,leflunomide,"Arthritis, Rheumatoid
Arthritis, Psoriatic",L04AA13,,Sanofi-aventis Deutschland GmbH,34,02/09/1999,"D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Xermelo,EMEA/H/C/003937,telotristat etiprate,telotristat ethyl,"Carcinoid Tumor
Neuroendocrine Tumors",A16AX,,Ipsen Pharma,2,17/09/2017,"65, quai Georges Gorse
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Vpriv,EMEA/H/C/001249,velaglucerase alfa,velaglucerase alfa,Gaucher Disease,A16AB10,,Shire Pharmaceuticals Ireland Ltd ,11,26/08/2010,"Shire Pharmaceuticals Ireland Ltd
Miesian Plaza Blocks 2 and 3
50-58 Baggot Street Lower
Dublin 2
D02 Y754
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Levitra,EMEA/H/C/000475,vardenafil,vardenafil,Erectile Dysfunction,G04BE09,,Bayer AG ,27,05/03/2003,"Bayer AG
51368 Leverkusen
Germany",,,,,,,,,Germany
Methylthioninium chloride Proveblue,EMEA/H/C/002108,methylthioninium chloride,methylthioninium chloride,Methemoglobinemia,V03AB17,,Provepharm SAS,19,05/05/2011,"ProveCube
22 Rue Marc Donadille
13013 Marseille
France",,,,,,,,,France
Esbriet,EMEA/H/C/002154,Pirfenidone,pirfenidone,Idiopathic Pulmonary Fibrosis,L04AX05,,Roche Registration GmbH,21,27/02/2011,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Ivabradine Anpharm,EMEA/H/C/004187,ivabradine,ivabradine,"Angina Pectoris
Heart Failure",C01EB17,,"""Anpharm"" Przedsiębiorstwo Farmaceutyczne S.A.",3,08/09/2015,"ul. Annopol 6B
Warszawa 03-236
Poland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Poland
Procoralan,EMEA/H/C/000597,ivabradine hydrochloride,ivabradine,"Angina Pectoris
Heart Failure",C01EB17,,Les Laboratoires Servier,19,24/10/2005,"50, rue Carnot
F-92284 Suresnes Cedex
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Atriance,EMEA/H/C/000752,nelarabine,nelarabine,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,L01BB07,,Novartis Europharm Limited,19,21/08/2007,"Elm Park
Merrion Road
Dublin 4
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Ireland
Icandra (previously Vildagliptin / metformin hydrochloride Novartis),EMEA/H/C/001050,"vildagliptin
metformin hydrochloride",vildagliptin / metformin,"Diabetes Mellitus, Type 2",A10BD08,,Novartis Europharm Limited,17,30/11/2008,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Alimta,EMEA/H/C/000564,pemetrexed,pemetrexed,"Mesothelioma
Carcinoma, Non-Small-Cell Lung",L01BA04,,Eli Lilly Nederland B.V.,22,20/09/2004,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Biopoin,EMEA/H/C/001036,epoetin theta,epoetin theta,"Kidney Failure, Chronic
Anemia
Cancer",B03XA01,,Teva GmbH,13,22/10/2009,"Graf-Arco-Straße 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Kogenate Bayer,EMEA/H/C/000275,octocog alfa,octocog alfa,Hemophilia A,B02BD02,,Bayer AG ,30,03/08/2000,"Bayer AG
51368 Leverkusen
Germany",,,,,,,,,Germany
Fycompa,EMEA/H/C/002434,perampanel,perampanel,"Epilepsies, Partial",N03AX22,,Eisai Europe Ltd,14,23/07/2012,"European Knowledge Centre
Mosquito Way
Hatfield
Hertfordshire
AL10 9SN
United Kingdom",,,,,,,,,United Kingdom
Velphoro,EMEA/H/C/002705,"mixture of polynuclear iron(III)-oxyhydroxide, sucrose and starches","mixture of polynuclear iron(III)-oxyhydroxide, sucrose and starches","Hyperphosphatemia
Renal Dialysis",V03AE05,,Vifor Fresenius Medical Care Renal Pharma France,5,25/08/2014,"100-101 Terrasse Boieldieu
Tour Franklin- La Défense 8
92042 Paris la Défense Cedex
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Trydonis,EMEA/H/C/004702,"Beclometasone dipropionate
formoterol fumarate dihydrate
glycopyrronium",beclometasone / formoterol / glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03AL09,,Chiesi Farmaceutici S.p.A.,0,25/04/2018,"Via Palermo 26/A
43122 Parma
Italy",,,,,,,,,Italy
Spedra,EMEA/H/C/002581,avanafil,avanafil,Erectile Dysfunction,G04BE10,,Menarini International Operations Luxembourg S.A.,11,20/06/2013,"1, Avenue de la Gare
L-1611 Luxembourg
Luxembourg",,,,,,,,,Luxembourg
Voncento,EMEA/H/C/002493,"Human coagulation factor VIII
human von willebrand factor",human coagulation factor VIII / human von willebrand factor,"Hemophilia A
von Willebrand Diseases",B02BD06,,CSL Behring GmbH,10,11/08/2013,"Emil-von-Behring-Straße 76
35041 Marburg
Germany",,,,,,,,,Germany
Firazyr,EMEA/H/C/000899,icatibant,icatibant,"Angioedemas, Hereditary",B06AC02,,Shire Orphan Therapies GmbH ,15,10/07/2008,"Shire Orphan Therapies GmbH
Friedrichstrasse 149
D-10117 Berlin
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Hizentra,EMEA/H/C/002127,human normal immunoglobulin (SCIg),human normal immunoglobulin (SCIg),Immunologic Deficiency Syndromes,J06BA01,,CSL Behring GmbH,16,14/04/2011,"Emil-von-Behring-Strasse 76
D-35041 Marburg
Germany",,,,,,,,,Germany
Insulin Human Winthrop,EMEA/H/C/000761,insulin human,insulin human,Diabetes Mellitus,A10AB01,,sanofi-aventis Deutschland GmbH,15,16/01/2007,"Industriepark Höchst
D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Iblias,EMEA/H/C/004147,octocog alfa,octocog alfa,Hemophilia A,B02BD02,,Bayer AG,4,17/02/2016,"Kaiser-Wilhelm-Allee 1
51373 Leverkusen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Fiasp,EMEA/H/C/004046,insulin aspart,insulin aspart,Diabetes Mellitus,A10AB05,,Novo Nordisk A/S,1,08/01/2017,"Novo Alle
2880 Bagsvaerd
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG),EMEA/H/C/000211,telmisartan,telmisartan,Hypertension,C09CA07,,Bayer AG,29,15/12/1998,"51368 Leverkusen
Germany",,,,,,,,,Germany
Tivicay,EMEA/H/C/002753,Dolutegravir,dolutegravir,HIV Infections,J05AX12,,ViiV Healthcare,13,15/01/2014,"80 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Plavix,EMEA/H/C/000174,clopidogrel hydrogen sulfate,clopidogrel,"Stroke
Peripheral Vascular Diseases
Atrial Fibrillation
Myocardial Infarction
Acute Coronary Syndrome",B01AC04,,Sanofi Clir SNC,37,15/07/1998,"54, rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Raxone,EMEA/H/C/003834,idebenone,idebenone,"Optic Atrophy, Hereditary, Leber",N06BX13,,Santhera Pharmaceuticals (Deutschland) GmbH,1,07/09/2015,"Marie-Curie Strasse 8
79539 Lorrach
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Germany
Kengrexal,EMEA/H/C/003773,cangrelor,cangrelor,"Acute Coronary Syndrome
Vascular Surgical Procedures",B01,,Chiesi Farmaceutici S.p.A.,6,22/03/2015,"Via Palermo 26/A
43122 Parma
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Italy
Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.),EMEA/H/C/004836,"beclometasone dipropionate anhydrous
formoterol fumarate dihydrate
glycopyrronium",beclometasone / formoterol / glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03AL09,,Chiesi Farmaceutici S.p.A.,0,23/04/2018,"Via Palermo 26/A
43122 Parma
Italy",,,,,,,,,Italy
Hycamtin,EMEA/H/C/000123,topotecan,topotecan,"Ovarian Neoplasms
Uterine Cervical Neoplasms
Small Cell Lung Carcinoma",L01XX17,,Novartis Europharm Limited,29,11/11/1996,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Thyrogen,EMEA/H/C/000220,thyrotropin alfa,thyrotropin alfa,Thyroid Neoplasms,H01AB01,,Genzyme Europe B.V.,22,08/03/2000,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Pritor,EMEA/H/C/000210,telmisartan,telmisartan,Hypertension,C09CA07,,Bayer AG,28,10/12/1998,"51368 Leverkusen
Germany",,,,,,,,,Germany
Daxas,EMEA/H/C/001179,roflumilast,roflumilast,"Pulmonary Disease, Chronic Obstructive",R03DX07,,AstraZeneca AB,12,04/07/2010,"SE-151 85 Södertälje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Alpivab,EMEA/H/C/004299,Peramivir,peramivir,"Influenza, Human",J05AH03,,Biocryst UK Limited,0,12/04/2018,"c/o Morgan Lewis Bockius Condor House
5-10 St. Paul's Churchyard
London EC4M 8AL
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Helicobacter Test INFAI,EMEA/H/C/000140,13C-urea,13C-urea,"Breath Tests
Helicobacter Infections",V04CX,,"INFAI, Institut für biomedizinische Analytik NMR-Imaging GmbH",15,13/08/1997,"Universitässtrasse 142
D-44799 Bochum
Germany",,,,,,,,,Germany
INOmax,EMEA/H/C/000337,Nitric oxide,nitric oxide,"Hypertension, Pulmonary
Respiratory Insufficiency",R07AX,,Linde Healthcare AB,19,31/07/2001,"S-18181 Lidingö
Sweden",,,,,,,,,Sweden
Xeloda,EMEA/H/C/000316,capecitabine,capecitabine,"Colonic Neoplasms
Breast Neoplasms
Colorectal Neoplasms
Stomach Neoplasms",L01BC06,,Roche Registration GmbH,23,01/02/2001,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Ziagen,EMEA/H/C/000252,abacavir,abacavir,HIV Infections,J05AF06,,ViiV Healthcare UK Limited,35,07/07/1999,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Fuzeon,EMEA/H/C/000514,enfuvirtide,enfuvirtide,HIV Infections,J05AX07,,Roche Registration GmbH,19,27/05/2003,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Tasigna,EMEA/H/C/000798,nilotinib,nilotinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",L01XE08,,Novartis Europharm Ltd,32,18/11/2007,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Menveo,EMEA/H/C/001095,"meningococcal group A, C, W-135 and Y conjugate vaccine","meningococcal group A, C, W-135 and Y conjugate vaccine","Immunization
Meningitis, Meningococcal",J07AH08,,GSK Vaccines S.r.l.,22,14/03/2010,"via Fiorentina 1
53100 Siena
Italy",,,,,,,,,Italy
Marixino (previously Maruxa),EMEA/H/C/002658,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","KRKA, d.d.",6,28/04/2013,",
Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Latuda,EMEA/H/C/002713,lurasidone,lurasidone,Schizophrenia,N05AE05,,Aziende Chimiche Riunite Angelini Francesco S.p.A.,13,20/03/2014,"Viale Amelia 70
00181
Roma
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Italy
Cinryze,EMEA/H/C/001207,C1 inhibitor (human),C1 inhibitor (human),"Angioedemas, Hereditary",B06AC01,,Shire Services BVBA,16,14/06/2011,"Rue Montoyer 47
B-1000 Brussels
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Leflunomide ratiopharm,EMEA/H/C/002035,leflunomide,leflunomide,"Arthritis, Rheumatoid",L04AA13,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Ratiopharm GmbH,12,28/11/2010,"Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Teysuno,EMEA/H/C/001242,"tegafur
gimeracil
oteracil",tegafur / gimeracil / oteracil,Stomach Neoplasms,L01BC53,,Nordic Group BV,15,13/03/2011,"Siriusdreef 22
2132 WT Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
Xtandi,EMEA/H/C/002639,enzalutamide,enzalutamide,Prostatic Neoplasms,L02BB04,,Astellas Pharma Europe B.V.,13,20/06/2013,"Sylviusweg 62
2333 BE Leiden
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Lutathera,EMEA/H/C/004123,lutetium (177Lu) oxodotreotide,lutetium (177Lu) oxodotreotide,Neuroendocrine Tumors,V10XX04,,Advanced Accelerator Applications,1,26/09/2017,"20 rue Diesel
01630 Saint Genis Pouilly
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Evotaz,EMEA/H/C/003904,"atazanavir sulfate
cobicistat",atazanavir / cobicistat,HIV Infections,J05AR,,Bristol-Myers Squibb Pharma EEIG,6,12/07/2015,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Lamzede,EMEA/H/C/003922,velmanase alfa,velmanase alfa,alpha-Mannosidosis,A16AB15,,Chiesi Farmaceutici S.p.A.,0,23/03/2018,"Via Palermo 26/A
43122 Parma
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Italy
Faslodex,EMEA/H/C/000540,fulvestrant,fulvestrant,Breast Neoplasms,L02BA03,,AstraZeneca AB,19,09/03/2004,"SE-151 85 Södertälje
Sweden",,,,,,,,,Sweden
Lumark,EMEA/H/C/002749,"lutetium, isotope of mass 177","lutetium, isotope of mass 177",Radionuclide Imaging,V09,,I.D.B. Radiopharmacy B.V.,4,18/06/2015,"I.D.B. Holland B.V.
Weverstraat 17
5111 PV Baarle-Nassau
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Amlodipine / Valsartan Mylan,EMEA/H/C/004037,"Amlodipine besilate
valsartan",amlodipine / valsartan,Hypertension,C09DB01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,2,21/03/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Sildenafil ratiopharm,EMEA/H/C/001080,sildenafil,sildenafil,Erectile Dysfunction,G04BE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Ratiopharm GmbH,15,22/12/2009,"Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Adynovi,EMEA/H/C/004195,rurioctocog alfa pegol,rurioctocog alfa pegol,Hemophilia A,B02BD02,,Baxalta Innovations GmbH,1,07/01/2018,"Industriestrasse 67
A-1221 Vienna
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Austria
Zoledronic acid Teva,EMEA/H/C/002439,zoledronic acid,zoledronic acid,"Fractures, Bone
Cancer",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,10,15/08/2012,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Afstyla,EMEA/H/C/004075,lonoctocog alfa,lonoctocog alfa,Hemophilia A,B02BD02,,CSL Behring GmbH,2,04/01/2017,"Emil-von-Behring Strasse 76
35041 Marburg
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Nuwiq,EMEA/H/C/002813,simoctocog alfa,simoctocog alfa,Hemophilia A,B02BD02,,Octapharma AB,5,21/07/2014,"Lars Forssells gata
23 112 75 Stockholm
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Hemangiol,EMEA/H/C/002621,propranolol hydrochloride,propranolol,Hemangioma,C07AA05,,Pierre Fabre Dermatologie,3,22/04/2014,"Les Cauquillous
81506 Lavaur
France",,,,,,,,,France
Zinforo,EMEA/H/C/002252,Ceftaroline fosamil,ceftaroline fosamil,"Community-Acquired Infections
Skin Diseases, Infectious
Pneumonia",J01DI02,,Pfizer Ireland Pharmaceuticals,16,22/08/2012,"Operations Services Group
Ringaskiddy
County Cork
Ireland",,,,,,,,,Ireland
Dasselta,EMEA/H/C/002310,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Rhinitis, Allergic, Seasonal
Urticaria",R06AX27,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",10,27/11/2011,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Terrosa,EMEA/H/C/003916,teriparatide,teriparatide,Osteoporosis,H05AA02,,Gedeon Richter Plc.,2,04/01/2017,"Gyomroi ut 19-21
1103 Budapest
Hungary","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Hungary
Pioglitazone Actavis,EMEA/H/C/002324,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf  ,6,14/03/2012,"Actavis Group PTC ehf
Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
EndolucinBeta,EMEA/H/C/003999,lutetium (177 Lu) chloride,lutetium (177 Lu) chloride,Radionuclide Imaging,V10X,,ITG Isotope Technologies Garching GmbH,2,05/07/2016,"Lichtenbergstrasse 1
D-85748 Garching
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Sialanar,EMEA/H/C/003883,Glycopyrronium bromide,glycopyrronium,Sialorrhea,A03AB02,,Proveca Limited,2,14/09/2016,"Neo
Charlotte Street
Manchester
M1 4ET
United Kingdom",,,,,,,,,United Kingdom
Myclausen,EMEA/H/C/001218,mycophenolate mofetil,mycophenolate mofetil,Graft Rejection,L04AA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Passauer Pharma GmbH,13,06/10/2010,"Eiderstedter Weg 3
14129 Berlin
Germany",,,,,,,,,Germany
Litak,EMEA/H/C/000504,Cladribine,cladribine,"Leukemia, Hairy Cell",L01BB04,,Lipomed GmbH,7,13/04/2004,"Hegenheimer Strasse 2
D-79576 Weil/Rhein
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Pregabalin Sandoz,EMEA/H/C/004010,pregabalin,pregabalin,"Anxiety Disorders
Neuralgia
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sandoz GmbH,3,18/06/2015,"Biochemiestr. 10
6250 Kundl
Austria",,,,,,,,,Austria
Omidria,EMEA/H/C/003702,"ketorolac
phenylephrine",phenylephrine / ketorolac,"Lens Implantation, Intraocular
Pain, Postoperative",S01,,Omeros London Limited,2,27/07/2015,"2nd Floor Berkley Square
House London
W1J 6BD
United Kingdom",,,,,,,,,United Kingdom
Masipro,,masitinib mesylate,masitinib,Mastocytosis,L01XE22,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,AB Science,17/05/2017,,13/09/2017,
M-M-RVaxPro,EMEA/H/C/000604,"measles virus Enders’ Edmonston strain (live, attenuated)
mumps virus Jeryl Lynn (level B) strain (live, attenuated)
rubella virus Wistar RA 27/3 strain (live, attenuated)","measles, mumps and rubella vaccine (live)","Rubella
Mumps
Immunization
Measles",J07BD52,,MSD VACCINS,20,04/05/2006,"162 avenue Jean Jaurès
69007 Lyon
France",,,,,,,,,France
Lonquex,EMEA/H/C/002556,lipegfilgrastim,lipegfilgrastim,Neutropenia,L03AA14,,Sicor Biotech UAB,12,24/07/2013,"Molėtų pl. 5
LT-08409 Vilnius
Lithuania","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Lithuania
Evarrest,EMEA/H/C/002515,"human fibrinogen
human thrombin",human fibrinogen / human thrombin,Hemostasis,B02BC30,,Omrix Biopharmaceuticals N. V.,4,25/09/2013,"Leonardo Da Vinci Laan 15
1831 Diegem
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Cyramza,EMEA/H/C/002829,Ramucirumab,ramucirumab,Stomach Neoplasms,L01XC,,Eli Lilly Nederland B.V.,7,18/12/2014,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
IDflu,EMEA/H/C/000966,"influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type)","influenza vaccine (split virion, inactivated)","Influenza, Human
Immunization",J07BB02,,Sanofi Pasteur S.A.,13,23/02/2009,"2, avenue Pont Pasteur
F-69007 Lyon
France",,,,,,,,,France
Wakix,EMEA/H/C/002616,pitolisant,pitolisant,Narcolepsy,N07XX11,,Bioprojet Pharma,5,31/03/2016,"9 rue Rameau
Paris 75002
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Leflunomide medac,EMEA/H/C/001227,leflunomide,leflunomide,"Arthritis, Rheumatoid",L04AA13,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",medac Gesellschaft für klinische Spezialpräparate mbH,14,26/07/2010,"Theaterstrasse 6
22880 Wedel
Germany",,,,,,,,,Germany
Shingrix,EMEA/H/C/004336,Varicella Zoster Virus glycoprotein E antigen,"herpes zoster vaccine (recombinant, adjuvanted)",Herpes Zoster,J07BK03,,GlaxoSmithkline Biologicals SA,0,21/03/2018,"Rue de l'Institut 89
1330 Rixensart
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Erivedge,EMEA/H/C/002602,vismodegib,vismodegib,"Carcinoma, Basal Cell",L01XX43,,Roche Registration GmbH,10,11/07/2013,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Tasermity,EMEA/H/C/003968,sevelamer hydrochloride,sevelamer hydrochloride,"Hyperphosphatemia
Renal Dialysis",V03AE02,,Genzyme Europe BV,4,25/02/2015,"Gooimeer 10
1411 DD Naarden
Netherlands",,,,,,,,,The Netherlands
Pioglitazone Teva Pharma,EMEA/H/C/002410,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,9,25/03/2012,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Savene,EMEA/H/C/000682,dexrazoxane hydrochloride,dexrazoxane,Extravasation of Diagnostic and Therapeutic Materials,V03AF02,,Clinigen Healthcare Ltd,12,27/07/2006,"Pitcairn House
Crown Square
First Avenue
Staffordshire
Burton-on-Trent
DE14 2WW
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Pegasys,EMEA/H/C/000395,peginterferon alfa-2a,peginterferon alfa-2a,"Hepatitis C, Chronic
Hepatitis B, Chronic",L03AB11,,Roche Registration GmbH,36,19/06/2002,"Emil-Barell-Strasse 1
79639 Grenzach-Wyhlen
Germany",,,,,,,,,Germany
Izba,EMEA/H/C/002738,travoprost,travoprost,"Ocular Hypertension
Glaucoma, Open-Angle",S01EE04,,Novartis Europharm Limited,3,19/02/2014,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,,,,,,,,United Kingdom
Fotivda,EMEA/H/C/004131,tivozanib,tivozanib hydrochloride monohydrate,"Carcinoma, Renal Cell",L01XE,,EUSA Pharma (UK) Limited,1,23/08/2017,"Breakspear Park
Breakspear Way
Hemel Hempstead HP2 4TZ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Sifrol,EMEA/H/C/000133,pramipexole dihydrochloride monohydrate,pramipexole,"Restless Legs Syndrome
Parkinson Disease",N04BC05,,Boehringer Ingelheim International GmbH,29,13/10/1997,"D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
DuoTrav,EMEA/H/C/000665,"travoprost
timolol",travoprost / timolol,"Glaucoma, Open-Angle
Ocular Hypertension",S01ED51,,Novartis Europharm Limited,15,23/04/2006,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,,,,,,,,United Kingdom
Taxotere,EMEA/H/C/000073,docetaxel,docetaxel,"Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Adenocarcinoma
Prostatic Neoplasms
Stomach Neoplasms
Breast Neoplasms",L01CD02,,Aventis Pharma S.A.,43,26/11/1995,"20 avenue Raymond Aron
92165 Antony Cedex
France",,,,,,,,,France
Reyataz,EMEA/H/C/000494,atazanavir sulphate,atazanavir sulphate,HIV Infections,J05AE08,,Bristol-Myers Squibb Pharma EEIG,47,01/03/2004,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Docetaxel Winthrop,EMEA/H/C/000808,docetaxel,docetaxel,"Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Adenocarcinoma
Prostatic Neoplasms
Stomach Neoplasms
Breast Neoplasms",L01CD02,,Aventis Pharma S.A.,27,19/04/2007,"20 avenue Raymond Aron
92165 Antony Cedex
France",,,,,,,,,France
Abasaglar (previously Abasria),EMEA/H/C/002835,insulin glargine,insulin glargine,Diabetes Mellitus,A10AE04,,Eli Lilly Nederland B.V.,6,09/09/2014,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Actrapid,EMEA/H/C/000424,human insulin,human insulin (rDNA),Diabetes Mellitus,A10AB01,,Novo Nordisk A/S,15,06/10/2002,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Sycrest,EMEA/H/C/001177,asenapine maleate ,asenapine,Bipolar Disorder,N05AH05,,N.V. Organon,15,31/08/2010,"Kloosterstraat 6
NL-5349 AB Oss
The Netherlands",,,,,,,,,The Netherlands
Oprymea,EMEA/H/C/000941,pramipexole dihydrochloride monohydrate,pramipexole,Parkinson Disease,N04BC05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",18,11/09/2008,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Fanaptum,,iloperidone,iloperidone,Schizophrenia,N05AX14,,,,,,,,,,Vanda Pharmaceuticals Ltd,19/07/2017,,14/01/2018,
Capecitabine Teva,EMEA/H/C/002362,capecitabine,capecitabine,"Colonic Neoplasms
Breast Neoplasms
Colorectal Neoplasms
Stomach Neoplasms",L01BC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,9,19/04/2012,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Mvasi,EMEA/H/C/004728,bevacizumab,bevacizumab,"Carcinoma, Renal Cell
Peritoneal Neoplasms
Ovarian Neoplasms
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Fallopian Tube Neoplasms",L01XC07,,Amgen Europe B.V.,1,14/01/2018,"Minervum 7061
4817 ZK Breda
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Movymia,EMEA/H/C/004368,teriparatide,teriparatide,Osteoporosis,H05AA02,,STADA Arzneimittel AG,3,10/01/2017,"Stadastrasse 2-18
Bad Vilbel
Hessen
61118
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Stalevo,EMEA/H/C/000511,"levodopa
carbidopa
entacapone",levodopa / carbidopa / entacapone,Parkinson Disease,N04BA03,,Orion Corporation,23,16/10/2003,"Orionintie 1
FI-02200 Espoo
Finland",,,,,,,,,Finland
Ifirmacombi,EMEA/H/C/002302,"irbesartan
hydrochlorothiazide",irbesartan / hydrochlorothiazide,Hypertension,C09DA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",6,03/03/2011,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Adempas,EMEA/H/C/002737,riociguat,riociguat,"Hypertension, Pulmonary",C02KX05,,Bayer AG,8,27/03/2014,"51368 Leverkusen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Crysvita,EMEA/H/C/004275,Burosumab,burosumab,"Hypophosphatemia, Familial
Hypophosphatemic Rickets, X-Linked Dominant",M05BX05,,Kyowa Kirin Limited,0,18/02/2018,"Galabank Business Park
Galashiels TD1 1QH
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,United Kingdom
Tolucombi,EMEA/H/C/002549,"telmisartan
hydrochlorothiazide",telmisartan / hydrochlorothiazide,Hypertension,C09DA07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",6,12/03/2013,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen),EMEA/H/C/003803,aripiprazole,aripiprazole,"Schizophrenia
Bipolar Disorder",N05AX12,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,6,29/06/2015,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Emselex,EMEA/H/C/000554,darifenacin hydrobromide,darifenacin hydrobromide,"Urinary Incontinence, Urge
Urinary Bladder, Overactive",G04BD10,,Merus Labs Luxco II S.à R.L.,21,21/10/2004,"26-28 rue Edward Steichen
L-2540 Luxembourg",,,,,,,,,Luxembourg
Evoltra,EMEA/H/C/000613,clofarabine,clofarabine,Precursor Cell Lymphoblastic Leukemia-Lymphoma,L01BB06,,Genzyme Europe B.V.,25,28/05/2006,"Gooimer 10
NL-1411 DD Naarden
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,The Netherlands
Aripiprazole Accord,EMEA/H/C/004021,aripiprazole,aripiprazole,"Schizophrenia
Bipolar Disorder",N05AX12,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,5,15/11/2015,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Aripiprazole Sandoz,EMEA/H/C/004008,aripiprazole,aripiprazole,"Schizophrenia
Bipolar Disorder",N05AX12,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sandoz GmbH,5,19/08/2015,"Biochemiestr. 10
6250 Kundl
Austria",,,,,,,,,Austria
Zyclara,EMEA/H/C/002387,imiquimod,imiquimod,"Keratosis
Keratosis, Actinic",D06BB10,,Meda AB,7,22/08/2012,"Pipers väg 2A
SE-170 09 Solna
Sweden",,,,,,,,,Sweden
Palonosetron Hospira,EMEA/H/C/004069,palonosetron hydrochloride,palonosetron,"Nausea
Vomiting
Cancer",A04AA05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hospira UK Limited,3,07/04/2016,"Horizon
Honey Lane
Hurley SL6 6RJ
United Kingdom",,,,,,,,,United Kingdom
Synflorix,EMEA/H/C/000973,"pneumococcal polysaccharide serotype 1 / pneumococcal polysaccharide serotype 1, 4, 5, 6b, 7f, 9v, 14, 18c, 19f, 23f / pneumococcal polysaccharide serotype 14 / pneumococcal polysaccharide serotype 18c / pneumococcal polysaccharide serotype 19f
pneumococcal polysaccharide serotype 23f / pneumococcal polysaccharide serotype 4 / pneumococcal polysaccharide serotype 5 / pneumococcal polysaccharide serotype 6b / pneumococcal polysaccharide serotype 7f / pneumococcal polysaccharide serotype 9v",pneumococcal polysaccharide conjugate vaccine (adsorbed),"Pneumococcal Infections
Immunization",J07AL52,,GlaxoSmithKline Biologicals S.A.,30,29/03/2009,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Epivir,EMEA/H/C/000107,lamivudine,lamivudine,HIV Infections,J05AF05,,ViiV Healthcare UK Limited ,39,07/08/1996,"ViiV Healthcare UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Olanzapine Teva,EMEA/H/C/000810,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma,23,11/12/2007,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Aripiprazole Zentiva,EMEA/H/C/003899,aripiprazole,aripiprazole,"Schizophrenia
Bipolar Disorder",N05AX12,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Zentiva, k.s.",5,24/06/2015,"U kabelovny 130
Dolni Mecholupy
102 37 Prague 10
Czech Republic",,,,,,,,,Czech Republic
Pregabalin Accord,EMEA/H/C/004024,pregabalin,pregabalin,"Anxiety Disorders
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Limited,5,27/08/2015,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Ristempa,EMEA/H/C/003910,pegfilgrastim,pegfilgrastim,Neutropenia,L03AA13,,Amgen Europe B.V.,3,12/04/2015,"Minervum 7061
4817 ZK Breda
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Javlor,EMEA/H/C/000983,vinflunine,vinflunine,"Carcinoma, Transitional Cell
Urologic Neoplasms",L01CA05,,Pierre Fabre Médicament,8,21/09/2009,"45, place Abel Gance
F-92100 Boulogne
France",,,,,,,,,France
Zubsolv,EMEA/H/C/004407,"buprenorphine hydrochloride, naloxone hydrochloride dihydrate",buprenorphine / naloxone,Opioid-Related Disorders,N07BC51,,Mundipharma Corporation Limited,1,09/11/2017,"Milton Road
Cambridge Science Park
Cambridge CB4 0AB
United Kingdom",,,,,,,,,United Kingdom
Elocta,EMEA/H/C/003964,efmoroctocog alfa,efmoroctocog alfa,Hemophilia A,B02BD02,,Swedish Orphan Biovitrum AB (publ),4,18/11/2015,"SE-112 76
112 76 Stockholm
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
NutropinAq,EMEA/H/C/000315,somatropin,somatropin,"Turner Syndrome
Dwarfism, Pituitary",H01AC01,,Ipsen Pharma,15,15/02/2001,"65, quai Georges Gorse
F-92100 Boulogne-Billancourt
France",,,,,,,,,France
Levodopa/Carbidopa/Entacapone Orion,EMEA/H/C/002441,"levodopa
carbidopa
entacapone",levodopa / carbidopa / entacapone,Parkinson Disease,N04BA03,,Orion Corporation,9,23/08/2011,"Orionintie 1
FI-02200 Espoo
Finland",,,,,,,,,Finland
Fabrazyme,EMEA/H/C/000370,agalsidase beta,agalsidase beta,Fabry Disease,A16AB04,,Genzyme Europe B.V.,25,03/08/2001,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Resolor,EMEA/H/C/001012,Prucalopride succinate,prucalopride,Constipation,A06AX05,,Shire Pharmaceuticals Ireland Ltd,20,14/10/2009,"Block 2-3, Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 Y754 
Ireland",,,,,,,,,Ireland
Odomzo,EMEA/H/C/002839,sonidegib diphosphate,sonidegib,"Carcinoma, Basal Cell",L01XX,,Sun Pharmaceutical Industries Europe B.V.,5,13/08/2015,"Polarisavenue 87
2132JH Hoofddorp
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Tenofovir disoproxil Zentiva,EMEA/H/C/004120,tenofovir disoproxil phosphate,tenofovir disoproxil,HIV Infections,J05AF07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Zentiva k.s.,3,14/09/2016,"U Kabelovny 130
Dolni Mecholupy 102 37
Prague 10
Czech Republic",,,,,,,,,Czech Republic
Olumiant,EMEA/H/C/004085,baricitinib,baricitinib,"Arthritis, Rheumatoid",L04AA37,,Eli Lilly Nederland B.V.,3,12/02/2017,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Mycamine,EMEA/H/C/000734,micafungin,micafungin,Candidiasis,J02AX05,,Astellas Pharma Europe B.V.,12,24/04/2008,"Elisabethhof 19
NL-2353 EW Leiderdorp
The Netherlands",,,,,,,,,The Netherlands
Nimvastid,EMEA/H/C/001029,rivastigmine,rivastigmine,"Dementia
Alzheimer Disease
Parkinson Disease",N06DA03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",8,10/05/2009,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Anagrelide Mylan,EMEA/H/C/004585,Anagrelide hydrochloride,anagrelide,"Thrombocythemia, Essential",L01XX35,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,0,14/02/2018,"117 Allee des Parcs
69800 Saint-Priest
France",,,,,,,,,France
Iscover,EMEA/H/C/000175,clopidogrel,clopidogrel,"Stroke
Peripheral Vascular Diseases
Atrial Fibrillation
Myocardial Infarction
Acute Coronary Syndrome",B01AC04,,Sanofi-Aventis Groupe,38,14/07/1998,"54 rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Zeffix,EMEA/H/C/000242,lamivudine,lamivudine,"Hepatitis B, Chronic",J05AF05,,Glaxo Group Ltd,21,28/07/1999,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Corlentor,EMEA/H/C/000598,ivabradine hydrochloride,ivabradine,"Angina Pectoris
Heart Failure",C01EB17,,Les Laboratoires Servier,23,24/10/2005,"50, rue Carnot
F-92284 Suresnes Cedex
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
DuoPlavin,EMEA/H/C/001143,"clopidogrel
acetylsalicylic acid",clopidogrel / acetylsalicylic acid,"Acute Coronary Syndrome
Myocardial Infarction",B01AC30,,Sanofi Pharma Bristol-Myers Squibb SNC,17,14/03/2010,"54, rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Combivir,EMEA/H/C/000190,"lamivudine
zidovudine",lamivudine / zidovudine,HIV Infections,J05AR01,,ViiV Healthcare UK Limited ,27,17/03/1998,"ViiV Healthcare UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Voriconazole Accord,EMEA/H/C/002669,voriconazole,voriconazole,"Aspergillosis
Candidiasis
Mycoses",J02AC03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,9,16/05/2013,"Sage House
319 Pinner road
North Harrow
Middlesex HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Trizivir,EMEA/H/C/000338,"abacavir (as sulfate)
lamivudine
zidovudine",abacavir (as sulfate) / lamivudine / zidovudine,HIV Infections,J05AR04,,ViiV Healthcare BV,32,27/12/2000,"Huis ter Heideweg 62
3705 LZ Zeist
The Netherlands",,,,,,,,,The Netherlands
Eurartesim,EMEA/H/C/001199,piperaquine tetraphosphate / artenimol,piperaquine tetraphosphate / artenimol,Malaria,P01BF05,,Alfasigma S.p.A.,9,27/10/2011,"Viale Sarca 223
20126 Milan
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Italy
Kivexa,EMEA/H/C/000581,"abacavir
lamivudine",abacavir / lamivudine,HIV Infections,J05AR02,,ViiV Healthcare UK Limited ,28,16/12/2004,"ViiV Healthcare UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Efavirenz/Emtricitabine/Tenofovir disoproxil Krka,EMEA/H/C/004274,"efavirenz
emtricitabine
tenofovir disoproxil succinate",efavirenz / emtricitabine / tenofovir disoproxil,HIV Infections,J05AR06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","KRKA, d.d., Novo mesto",0,07/02/2018,"Smarjeska cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Revestive,EMEA/H/C/002345,teduglutide,teduglutide,Malabsorption Syndromes,A16AX08,,Shire Pharmaceuticals Ireland Ltd,12,29/08/2012,"Block 2-3, Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 Y754 
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Ventavis,EMEA/H/C/000474,iloprost,iloprost,"Hypertension, Pulmonary",B01AC11,,Bayer AG,25,15/09/2003,"51368 Leverkusen
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Xadago,EMEA/H/C/002396,safinamide methanesulfonate,safinamide,Parkinson Disease,N04B,,Zambon SpA,7,23/02/2015,"Via Lillo Del Duca 10
20091 Bresso (Milan)
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Italy
Brinavess,EMEA/H/C/001215,Vernakalant hydrochloride,vernakalant hydrochloride,Atrial Fibrillation,C01BG11,,Cardiome UK Limited,11,31/08/2010,"Lakeside House
1 Furzeground Way
Stockley Park
Uxbridge
Middlesex
UB11 1BD
United Kingdom",,,,,,,,,United Kingdom
Trisenox,EMEA/H/C/000388,Arsenic trioxide,arsenic trioxide,"Leukemia, Promyelocytic, Acute",L01XX27,,Teva B.V.,24,04/03/2002,"Swensweg 5
2031 GA Haarlem
Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
LeukoScan,EMEA/H/C/000111,sulesomab,sulesomab,"Osteomyelitis
Radionuclide Imaging",VO4D,,Immunomedics GmbH,7,14/02/1997,"Otto-Röhm-Straße 69
D-64293 Darmstadt
Germany",,,,,,,,,Germany
Idelvion,EMEA/H/C/003955,albutrepenonacog alfa,albutrepenonacog alfa,Hemophilia B,B02BD04,,CSL Behring GmbH,3,10/05/2016,"Emil-von-Behring-Straße 76
35041 Marburg
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Renagel,EMEA/H/C/000254,sevelamer,sevelamer,"Renal Dialysis
Hyperphosphatemia",V03AE02,,Genzyme Europe B.V.,29,28/01/2000,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Hexacima,EMEA/H/C/002702,"diphtheria toxoid / tetanus toxoid
two-component acellular pertussis (pertussis toxoid and filamentous haemagglutinin ) / inactivated poliomyelitis virus types 1,2 and 3 / Haemophilus influenzae type-b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein
hepatitis-B surface antigen","diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type-b conjugate vaccine (adsorbed)","Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Poliomyelitis
Diphtheria",J07CA09,,Sanofi Pasteur,17,16/04/2013,"14 Espace Henry Vallée
69007Lyon
France",,,,,,,,,France
Benepali,EMEA/H/C/004007,etanercept,etanercept,"Arthritis, Psoriatic
Arthritis, Rheumatoid
Psoriasis",L04AB01,,Samsung Bioepis UK Limited5th FloorProfile West950 Great West RoadBrentfordTW8 9ESUnited Kingdom,6,13/01/2016,,"This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,
Libertek,EMEA/H/C/002399,roflumilast,roflumilast,"Pulmonary Disease, Chronic Obstructive",R03DX08,,AstraZeneca AB,11,27/02/2011,"SE-151-85 Sodertalje
Sweden",,,,,,,,,Sweden
Zejula,EMEA/H/C/004249,niraparib tosylate monohydrate,niraparib,"Fallopian Tube Neoplasms
Peritoneal Neoplasms
Ovarian Neoplasms",L01XX,,Tesaro UK Limited,3,15/11/2017,"55 Baker Street
London
W1U 7EU
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Vizarsin,EMEA/H/C/001076,sildenafil,sildenafil,Erectile Dysfunction,G04BE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",14,20/09/2009,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Victoza,EMEA/H/C/001026,liraglutide,liraglutide,"Diabetes Mellitus, Type 2",A10BJ02,,Novo Nordisk A/S,18,29/06/2009,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Daliresp,EMEA/H/C/002398,roflumilast,roflumilast,"Pulmonary Disease, Chronic Obstructive",R03DX07,,AstraZeneca AB,9,27/02/2011,"SE-151-85 Sodertalje
Sweden",,,,,,,,,Sweden
Zalasta,EMEA/H/C/000792,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Krka,15,27/09/2007,"Smarjeska cesta 6
SI-8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Rebif,EMEA/H/C/000136,interferon beta-1a,interferon beta-1a,Multiple Sclerosis,L03AB07,,Merck Serono Europe Ltd,32,03/05/1998,"56 Marsh Wall
London E14 9TP
United Kingdom",,,,,,,,,United Kingdom
Jevtana,EMEA/H/C/002018,cabazitaxel,cabazitaxel,Prostatic Neoplasms,L01CD,,sanofi-aventis groupe ,16,16/03/2011,"sanofi-aventis groupe
54, rue la Boétie
F-75008 Paris
France",,,,,,,,,France
Nyxoid,EMEA/H/C/004325,Naloxone hydrochloride dihydrate,naloxone,Opioid-Related Disorders,V03AB15,,Mundipharma Corporation Limited,1,09/11/2017,"Milton Road
Cambridge Science Park
Cambridge CB4 0AB
United Kingdom",,,,,,,,,United Kingdom
Twinrix Adult,EMEA/H/C/000112,"hepatitis A virus (inactivated)
hepatitis B surface antigen",hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed),"Hepatitis B
Hepatitis A
Immunization",J07BC20,,GlaxoSmithKline Biologicals S.A.,19,19/09/1996,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Onzeald,,etirinotecan pegol,etirinotecan pegol,Breast Neoplasms,L01,,,,,,,,,,Nektar Therapeutics UK Limited,08/11/2017,,07/01/2018,
Fulvestrant Mylan,EMEA/H/C/004649,fulvestrant,fulvestrant,Breast Neoplasms,L02BA03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,0,07/01/2018,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Memantine LEK,EMEA/H/C/002630,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pharmathen S.A.,4,21/04/2013,"6, Dervenakion str.
15351 Pallini
Attiki
Greece",,,,,,,,,Greece
Multaq,EMEA/H/C/001043,dronedarone,dronedarone,Atrial Fibrillation,C01BD07,,Sanofi-aventis groupe,12,25/11/2009,"54 rue La Boétie
75008 Paris
France",,,,,,,,,France
Toujeo (previously Optisulin),EMEA/H/C/000309,insulin glargine,insulin glargine,Diabetes Mellitus,A10AE04,,Sanofi-aventis Deutschland GmbH,24,26/06/2000,"D-65926 Frankfurt am Main
Germany",,,,,,,,,Germany
Tracleer,EMEA/H/C/000401,bosentan monohydrate,bosentan,"Scleroderma, Systemic
Hypertension, Pulmonary",C02KX01,,Actelion Registration Ltd,32,14/05/2002,"Gewerbestrasse 16
CH-4123 Allschwil
Switzerland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Switzerland
Besponsa,EMEA/H/C/004119,inotuzumab ozogamicin,inotuzumab ozogamicin,Precursor Cell Lymphoblastic Leukemia-Lymphoma,L01XC,,Pfizer Limited,2,28/06/2017,"821 Ramsgate Road Sandwich
Kent CT13 9NJ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Replagal,EMEA/H/C/000369,agalsidase alfa,agalsidase alfa,Fabry Disease,A16AB03,,Shire Human Genetic Therapies AB,21,03/08/2001,"Vasagatan 7
111 20 Stockholm
Sweden",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Sweden
Qtern,EMEA/H/C/004057,"Saxagliptin
dapagliflozin propanediol monohydrate",saxagliptin / dapagliflozin,"Diabetes Mellitus, Type 2",A10BD21,,Astra Zeneca AB,2,14/07/2016,"51 85 Södertälje
Sweden",,,,,,,,,Sweden
Tacforius,EMEA/H/C/004435,tacrolimus monohydrate,tacrolimus,"Liver Transplantation
Kidney Transplantation",L04AD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,0,07/12/2017,"Swensweg 5
2031 GA Haarlem
Netherlands",,,,,,,,,The Netherlands
EnCyzix,,enclomifene citrate,enclomifene,Hypogonadism,G03X,,,,,,,,,,Renable Pharma Limited,,,24/01/2018,
Imatinib Actavis,EMEA/H/C/002594,imatinib,imatinib,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic-Myeloproliferative Diseases
Hypereosinophilic Syndrome
Dermatofibrosarcoma",L01XE01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,9,16/04/2013,"Reykjavíkurvegur 76-78
Hafnarfjörður
Iceland",,,,,,,,,Iceland
Tepadina,EMEA/H/C/001046,thiotepa,thiotepa,Hematopoietic Stem Cell Transplantation,L01AC01,,Adienne S.r.l.,11,14/03/2010,"Via Galileo Galilei, 19
20867 Caponago (MB)
Italy",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Italy
Ledaga,EMEA/H/C/002826,Chlormethine,chlormethine,Mycosis Fungoides,L01AA05,,Actelion Registration Ltd.,2,02/03/2017,"Chiswick Tower
13th Floor 389
Chiswick High Road
London W4 4AL
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Adasuve,EMEA/H/C/002400,loxapine,loxapine,"Schizophrenia
Bipolar Disorder",N05AH01,,Ferrer Internacional s.a.,10,20/02/2013,"Gran Via Carlos III, 94
08028 Barcelona
Spain",,,,,,,,,Spain
Lartruvo,EMEA/H/C/004216,Olaratumab,olaratumab,Sarcoma,L01XC27,,Eli Lilly Nederland B.V.,3,09/11/2016,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,The Netherlands
Neupro,EMEA/H/C/000626,rotigotine,rotigotine,"Restless Legs Syndrome
Parkinson Disease",N04BC09,,UCB Pharma S.A.,27,14/02/2006,"Allée de la Recherche 60
B-1070 Bruxelles
Belgium",,,,,,,,,Belgium
Irbesartan/Hydrochlorothiazide Teva,EMEA/H/C/001112,"irbesartan
hydrochlorothiazide",irbesartan / hydrochlorothiazide,Hypertension,C09DA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,13,25/11/2009,"Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Rilutek,EMEA/H/C/000109,Riluzole,riluzole,Amyotrophic Lateral Sclerosis,N07XX02,,Aventis Pharma S.A.,25,09/06/1996,"20 avenue Raymond Aron
92165 Antony Cedex
France",,,,,,,,,France
Emtricitabine/Tenofovir disoproxil Zentiva,EMEA/H/C/004137,"emtricitabine, tenofovir disoproxil phosphate",emtricitabine / tenofovir disoproxil,HIV Infections,J05AR03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Zentiva k.s.,1,08/11/2016,"U kabelovny 130
Dolni Mecholupy
102 37 Prague 10
Czech Republic",,,,,,,,,Czech Republic
Clopidogrel Teva (hydrogen sulphate),EMEA/H/C/001053,clopidogrel hydrogen sulphate,clopidogrel,"Acute Coronary Syndrome
Peripheral Vascular Diseases
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,11,27/07/2009,"TEVA Pharma B.V.
Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Ebymect,EMEA/H/C/004162,"dapagliflozin propanediol monohydrate
metformin hydrochloride",dapagliflozin / metformin,"Diabetes Mellitus, Type 2",A10BD15,,AstraZeneca AB,8,15/11/2015,"SE-151-85 Sodertalje
Sweden",,,,,,,,,Sweden
Jorveza,EMEA/H/C/004655,budesonide,budesonide,Esophageal Diseases,A07EA06,,Dr. Falk Pharma GmbH,0,08/01/2018,"Leinenweber str. 5
79108 Freiburg
Germany",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Germany
Zostavax,EMEA/H/C/000674,"varicella-zoster virus (live, attenuated)",zoster vaccine (live),"Herpes Zoster
Immunization",J07BK02,,MSD VACCINS,26,18/05/2006,"162 avenue Jean Jaurès
69007 Lyon
France",,,,,,,,,France
Fasturtec,EMEA/H/C/000331,rasburicase,rasburicase,Hyperuricemia,V03AF07,,Sanofi-aventis groupe ,24,22/02/2001,"Sanofi-aventis groupe
54, rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Levetiracetam Hospira,EMEA/H/C/002783,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hospira UK Limited,7,07/01/2014,"Horizon, Honey Lane
Hurley, Maidenhead, SL6 6RJ
United Kingdom",,,,,,,,,United Kingdom
VeraSeal,EMEA/H/C/004446,"human fibrinogen, human thrombin",human fibrinogen / human thrombin,"Hemostasis, Surgical",B02BC,,"Instituto Grifols, S.A.",0,09/11/2017,"Poligono Levante
c/Can Guasc 2
Barcelona 08150
Parets del Valles
Spain","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Spain
Tenofovir disoproxil Mylan,EMEA/H/C/004049,tenofovir disoproxil,tenofovir disoproxil,HIV Infections,J05AF07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,3,07/12/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Desloratadine ratiopharm,EMEA/H/C/002404,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Urticaria
Rhinitis, Allergic, Seasonal",R06AX27,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Ratiopharm GmbH,7,12/01/2012,"Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Helixate NexGen,EMEA/H/C/000276,octocog alfa,octocog alfa,Hemophilia A,B02BD02,,Bayer AG ,31,03/08/2000,"Bayer AG
51368 Leverkusen
Germany",,,,,,,,,Germany
Repaglinide Krka,EMEA/H/C/001066,repaglinide,repaglinide,"Diabetes Mellitus, Type 2",A10BX02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",5,03/11/2009,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Brineura,EMEA/H/C/004065,cerliponase alfa,cerliponase alfa,Neuronal Ceroid-Lipofuscinoses,A16AB,,BioMarin International Limited,1,29/05/2017,"Shanbally
Ringaskiddy Cork Co.
Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Ireland
Lyrica,EMEA/H/C/000546,pregabalin,pregabalin,"Epilepsy
Anxiety Disorders
Neuralgia",N03AX16,,Pfizer Limited,38,05/07/2004,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Nemdatine,EMEA/H/C/002680,memantine,memantine,Alzheimer Disease,N06DX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf.,7,22/04/2013,"Reykjavíkurvegi 76-78
220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Olanzapine Mylan,EMEA/H/C/000961,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Generics [UK] Ltd.,12,06/10/2008,"Generics [UK] Limited
Station Close
Potters Bar
Hertfordshire
EN6 1TL
United Kingdom",,,,,,,,,United Kingdom
Rapiscan,EMEA/H/C/001176,regadenoson,regadenoson,Myocardial Perfusion Imaging,C01EB21,,GE Healthcare AS ,8,05/09/2010,"GE Healthcare AS
Nycoveien 1
NO-0485 Oslo
Norway",,,,,,,,,Norway
Ixiaro,EMEA/H/C/000963,"Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)","Japanese-encephalitis vaccine (inactivated, adsorbed)","Encephalitis, Japanese
Immunization",J07BA02,,Valneva Austria GmbH,13,30/03/2009,"Campus Vienna Biocenter 6
A-1030 Vienna
Austria",,,,,,,,,Austria
Pioglitazone Teva,EMEA/H/C/002297,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,9,25/03/2012,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Evista,EMEA/H/C/000184,raloxifene hydrochloride,raloxifene,"Osteoporosis, Postmenopausal",G03XC01,,Daiichi Sankyo Europe GmbH,21,04/08/1998,"Zielstattstrasse 48
D-81379 Munich
Germany",,,,,,,,,Germany
HBVaxPro,EMEA/H/C/000373,"hepatitis B, recombinant surface antigen",hepatitis-B vaccine (rDNA),"Hepatitis B
Immunization",J07BC01,,MSD VACCINS,24,26/04/2001,"162 avenue Jean Jaurès
69007 Lyon
France",,,,,,,,,France
Lymphoseek,EMEA/H/C/002085,tilmanocept,tilmanocept,Radionuclide Imaging,V09IA09,,Norgine BV,4,18/11/2014,"Hogehilweg 7
1101 CAAmsterdam Zuidoost
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Komboglyze,EMEA/H/C/002059,metformin hydrochloride / saxagliptin hydrochloride,saxagliptin / metformin hydrochloride,"Diabetes Mellitus, Type 2",A10BD10,,AstraZeneca AB ,14,23/11/2011,"AstraZeneca AB
151 85 Södertälje
Sweden",,,,,,,,,Sweden
Clopidogrel Acino,EMEA/H/C/001166,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Acute Coronary Syndrome
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Acino AG,6,27/07/2009,"Am Windfeld 35
DE-83714 Miesbach
Germany",,,,,,,,,Germany
Karvezide,EMEA/H/C/000221,"irbesartan
hydrochlorothiazide",irbesartan / hydrochlorothiazide,Hypertension,C09DA04,,Sanofi-aventis groupe,34,15/10/1998,"54 rue La Boétie
75008 Paris
France",,,,,,,,,France
Edistride,EMEA/H/C/004161,dapagliflozin propanediol monohydrate,dapagliflozin,"Diabetes Mellitus, Type 2",A10BK01,,AstraZeneca AB,7,08/11/2015,"85 Sodertalje
SE-151
Sweden",,,,,,,,,Sweden
Betmiga,EMEA/H/C/002388,Mirabegron,mirabegron,"Urinary Bladder, Overactive",G04BD12,,Astellas Pharma Europe B.V.,10,19/12/2012,"Sylviusweg 62
2333 BE Leiden
The Netherlands",,,,,,,,,The Netherlands
Selincro,EMEA/H/C/002583,Nalmefene hydrochloride dihydrate,nalmefene,Alcohol-Related Disorders,N07BB05,,H. Lundbeck A/S,9,24/02/2013,"Ottiliavej 9
DK-2500 Valby
Denmark",,,,,,,,,Denmark
Benlysta,EMEA/H/C/002015,belimumab,belimumab,"Lupus Erythematosus, Systemic",L04AA26,,Glaxo Group Ltd.,16,12/07/2011,"Glaxo Wellcome House
Berkeley Avenue
Greenford
Middlesex
UB6 0NN
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Ketoconazole HRA,EMEA/H/C/003906,Ketoconazole,ketoconazole,Cushing Syndrome,J02AB02,,Laboratoire HRA Pharma,7,18/11/2014,"15 rue Béranger
75003 Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Prepandrix,EMEA/H/C/000822,A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2),"prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,GlaxoSmithKline Biologicals S.A.,12,13/05/2008,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Zevalin,EMEA/H/C/000547,ibritumomab tiuxetan,ibritumomab tiuxetan,"Lymphoma, Follicular",V10XX02,,Spectrum Pharmaceuticals B.V.,21,16/01/2004,"Prins Bernhardplein 200
1097 JB Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Xiapex,EMEA/H/C/002048,collagenase Clostridium histolyticum,collagenase Clostridium histolyticum,Dupuytren Contracture,M09AB02,,Swedish Orphan Biovitrum AB,18,27/02/2011,"Tomtebodavagen 23A
SE-112 76 Stockholm
Sweden",,,,,,,,,Sweden
Optimark,EMEA/H/C/000745,gadoversetamide,gadoversetamide,Magnetic Resonance Imaging,V08CA06,,Mallinckrodt Deutschland GmbH,14,22/07/2007,"Guerbet
15, rue des Vanesses
93420 Villepinte
France",,,,,,,,,France
Forxiga,EMEA/H/C/002322,dapagliflozin propanediol monohydrate,dapagliflozin,"Diabetes Mellitus, Type 2",A10BK01,,AstraZeneca AB,12,11/11/2012,"151 85 Sodertalje
Sweden",,,,,,,,,Sweden
Somatropin Biopartners,EMEA/H/C/002196,somatropin,somatropin,Growth,H01AC01,,BioPartners GmbH,3,04/08/2013,"Kaiserpassage 11
D-72764 Reutlingen
Germany",,,,,,,,,Germany
Intuniv,EMEA/H/C/003759,guanfacine hydrochloride,guanfacine,Attention Deficit Disorder with Hyperactivity,C02AC02,,Shire Pharmaceuticals Ireland Ltd,5,17/09/2015,"Block 2-3, Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 Y754 
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Adlumiz,,anamorelin hydrochloride,anamorelin,"Cachexia
Anorexia
Carcinoma, Non-Small-Cell Lung",V03,,,,,,,,,,,17/05/2017,,15/11/2017,
Olanzapine Glenmark Europe,EMEA/H/C/001086,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Glenmark Pharmaceuticals Europe Limited ,9,02/12/2009,"Glenmark Pharmaceuticals Europe Limited
Laxmi House
2 B Draycott Avenue
Kenton
Middlesex
HA3 0BU
United Kingdom",,,,,,,,,United Kingdom
Tookad,EMEA/H/C/004182,padeliporfin di-potassium,padeliporfin,Prostatic Neoplasms,L01XD07,,STEBA Biotech S.A,0,09/11/2017,"7 place du theatre
L-2613 Luxembourg
Luxembourg","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Luxembourg
Vipdomet,EMEA/H/C/002654,"alogliptin benzoate
metformin hydrochloride",alogliptin / metformin,"Diabetes Mellitus, Type 2",A10BD13,,Takeda Pharma A/S,5,18/09/2013,"Dybendal Alle 10
2630 Taastrup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Twinrix Paediatric,EMEA/H/C/000129,"hepatitis-A virus (inactivated)
hepatitis-B surface antigen",hepatitis-A (inactivated) and hepatitis-B (rDNA) (HAB) vaccine (adsorbed),"Immunization
Hepatitis B
Hepatitis A",J07BC20,,GlaxoSmithKline Biologicals S.A.,19,09/02/1997,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Prevenar,EMEA/H/C/000323,"pneumococcal polysaccharide serotype 4 / pneumococcal polysaccharide serotype 6B / pneumococcal polysaccharide serotype 9V / pneumococcal polysaccharide serotype 14
pneumococcal oligosaccharide serotype 18C / pneumococcal polysaccharide serotype 19F / pneumococcal polysaccharide serotype 23F","pneumococcal saccharide conjugated vaccine, adsorbed","Pneumococcal Infections
Immunization",J07AL02,,Pfizer Limited,23,01/02/2001,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Fendrix,EMEA/H/C/000550,hepatitis B surface antigen,"hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)","Hepatitis B
Immunization",J07BC01,,GlaxoSmithKline Biologicals S.A.,10,01/02/2005,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Increlex,EMEA/H/C/000704,Mecasermin,mecasermin,Laron Syndrome,H01AC03,,Ipsen Pharma,20,02/08/2007,"65, quai Georges Gorse
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,France
Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau),EMEA/H/C/004061,Chenodeoxycholic acid,chenodeoxycholic acid,"Xanthomatosis, Cerebrotendinous
Metabolism, Inborn Errors",A05AA01,,Leadiant GmbH,3,09/04/2017,"Liebherrstrasse 22
80538 München
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Germany
Vyndaqel,EMEA/H/C/002294,tafamidis,tafamidis,Amyloidosis,N07XX08,,Pfizer Ltd,12,15/11/2011,"Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,United Kingdom
Glubrava,EMEA/H/C/000893,"metformin hydrochloride
pioglitazone hydrochloride",pioglitazone / metformin,"Diabetes Mellitus, Type 2",A10BD05,,Takeda Pharma A/S,15,10/12/2007,"Dybendal Alle 10
2630 Taastrup
Denmark",,,,,,,,,Denmark
Yellox,EMEA/H/C/001198,bromfenac sodium sesquihydrate,bromfenac,"Pain, Postoperative
Ophthalmologic Surgical Procedures",S01BC11,,PharmaSwiss Ceska Republika s.r.o,8,17/05/2011,"Jankovcova 1569/2c
Lighthouse
17000 Prague 7
Czech Republic",,,,,,,,,Czech Republic
Optruma,EMEA/H/C/000185,raloxifene hydrochloride,raloxifene,"Osteoporosis, Postmenopausal",G03XC01,,Eli Lilly Nederland B.V.,22,04/08/1998,"Eli Lilly Nederland BV
Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Silapo,EMEA/H/C/000760,epoetin zeta,epoetin zeta,"Anemia
Blood Transfusion, Autologous
Cancer
Kidney Failure, Chronic",B03XA01,,Stada Arzneimittel AG,13,17/12/2007,"Stada R AG
Stadastrasse 2-18
D-61118 Bad Vilbel
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Vantobra,EMEA/H/C/002633,Tobramycin,tobramycin,"Cystic Fibrosis
Respiratory Tract Infections",J01GB01,,Pari Pharma GmbH,3,17/03/2015,"Moosstrasse 3
82319 Starnberg
Germany",,,,,,,,,Germany
Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech,,human IgG1 monoclonal antibody specific for human interleukin-1 alpha,human IgG1 monoclonal antibody specific for human interleukin-1 alpha,Colorectal Neoplasms,L01,,,,,,,,,,XBiotech Germany GmbH,17/05/2017,,13/09/2017,
CoAprovel,EMEA/H/C/000222,"irbesartan
hydrochlorothiazide",irbesartan / hydrochlorothiazide,Hypertension,C09DA04,,Sanofi Clir SNC,33,14/10/1998,"54, rue La Boétie
F-75008 Paris
France",,,,,,,,,France
RotaTeq,EMEA/H/C/000669,"rotavirus serotype G1, serotype G2, serotype G3, serotype G4, serotype P1","rotavirus vaccine, live","Immunization
Rotavirus Infections",J07BH02,,MSD VACCINS,26,26/06/2006,"162 avenue Jean Jaurès
69007 Lyon
France",,,,,,,,,France
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop),EMEA/H/C/000783,"irbesartan
hydrochlorothiazide",irbesartan / hydrochlorothiazide,Hypertension,C09DA04,,sanofi-aventis groupe ,22,18/01/2007,"sanofi-aventis groupe
54 rue La Boétie,
75008 Paris - France",,,,,,,,,France
Varuby,EMEA/H/C/004196,rolapitant,rolapitant,"Vomiting
Nausea
Cancer",A04AD,,Tesaro UK Limited,1,19/04/2017,"55 Baker Street
London
W1U 7EU
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Ibandronic acid Accord,EMEA/H/C/002638,ibandronic acid,ibandronic acid,"Wounds and Injuries
Breast Diseases
Neoplastic Processes
Calcium Metabolism Disorders
Neoplasms by Site
Water-Electrolyte Imbalance",M05BA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,7,18/11/2012,"Ground Floor, Sage House
319 Pinner Road
North Harrow
Middx HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Glybera,EMEA/H/C/002145,alipogene tiparvovec,alipogene tiparvovec,Hyperlipoproteinemia Type I,C10AX10,,uniQure biopharma B.V. ,8,24/10/2012,"uniQure biopharma B.V.
Meibergdreef 61
NL-1105 BA Amsterdam
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,The Netherlands
Intelence,EMEA/H/C/000900,Etravirine,etravirine,HIV Infections,J05AG04,,Janssen-Cilag International NV,22,27/08/2008,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Voriconazole Hikma (previously Voriconazole Hospira),EMEA/H/C/003737,voriconazole,voriconazole,"Bacterial Infections and Mycoses
Aspergillosis
Candidiasis",J02AC03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Hikma Farmaceutica (Portugal) S.A.,4,27/05/2015,"Estrada do Rio da Mo, 8, 8A-B – Fervenca
2705-906 Terrugem SNT
Portugal",,,,,,,,,Portugal
Peyona (previously Nymusa),EMEA/H/C/001014,Caffeine citrate,caffeine,Apnea,N06BC01,,Chiesi Farmaceutici SpA,8,01/07/2009,"Via Palermo 26/A
IT-43100 Parma
Italy",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Italy
Nulojix,EMEA/H/C/002098,belatacept,belatacept,"Graft Rejection
Kidney Transplantation",L04AA28,,Bristol-Myers Squibb Pharma EEIG,9,17/06/2011,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel Teva Pharma (previously Clopidogrel HCS),EMEA/H/C/001133,clopidogrel hydrochloride,clopidogrel,"Myocardial Infarction
Peripheral Vascular Diseases
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,9,20/09/2009,"Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Zoledronic acid Mylan,EMEA/H/C/002482,zoledronic acid,zoledronic acid,"Fractures, Bone",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,7,22/08/2012,"117 allée des Parcs
F-69 800 Saint Priest
France",,,,,,,,,France
Febuxostat Mylan,EMEA/H/C/004374,febuxostat,febuxostat,"Hyperuricemia
Arthritis, Gouty
Gout",M04AA03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,0,14/06/2017,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Aprovel,EMEA/H/C/000141,irbesartan,irbesartan,Hypertension,C09CA04,,Sanofi Clir SNC,36,26/08/1997,"54, rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Eperzan,EMEA/H/C/002735,Albiglutide,albiglutide,"Diabetes Mellitus, Type 2",A10BJ04,,GlaxoSmithKline Trading Services Limited,8,20/03/2014,"Currabinny
Carrigaline
County Cork
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Aerivio Spiromax,EMEA/H/C/002752,"salmeterol xinafoate
fluticasone propionate",salmeterol / fluticasone propionate,"Pulmonary Disease, Chronic Obstructive
Asthma",R03AK06,,Teva B.V.,2,17/08/2016,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Zaltrap,EMEA/H/C/002532,aflibercept,aflibercept,Colorectal Neoplasms,L01XX44,,Sanofi-Aventis Groupe,7,31/01/2013,"54 rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Suliqua,EMEA/H/C/004243,"insulin glargine
lixisenatide",insulin glargine / lixisenatide,"Diabetes Mellitus, Type 2",A10AE,,sanofi-aventis groupe,2,11/01/2017,"54 rue La Boetie
75008 Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Entecavir Mylan,EMEA/H/C/004377,entecavir monohydrate,entecavir,Hepatitis B,J05AF10,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,0,17/09/2017,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Ranexa (previously Latixa),EMEA/H/C/000805,ranolazine,ranolazine,Angina Pectoris,C01EB18,,Menarini International Operations Luxembourg S.A. (MIOL),15,08/07/2008,"Menarini International Operations Luxembourg S.A.
1, Avenue de la Gare
L-1611 Luxembourg
Luxembourg",,,,,,,,,Luxembourg
Orphacol,EMEA/H/C/001250,cholic acid,cholic acid,"Digestive System Diseases
Metabolism, Inborn Errors",A05AA03,,Laboratoires CTRS,4,12/09/2013,"Laboratoire CTRS
69, rue d'Aguesseau
92100 Boulogne-Billancourt
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,France
Vizamyl,EMEA/H/C/002557,flutemetamol (18F),flutemetamol (18F),"Radionuclide Imaging
Alzheimer Disease",V09AX04,,GE Healthcare Ltd,7,21/08/2014,"Amersham Place
Little Chalfont
Buckinghamshire
HP7 9NA
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Thymanax,EMEA/H/C/000916,Agomelatine,Agomelatine,"Depressive Disorder, Major",N06AX22,,Servier (Ireland) Industries Ltd,18,18/02/2009,"Gorey Road
Arklow, Co. Wicklow
Ireland",,,,,,,,,Ireland
Lyxumia,EMEA/H/C/002445,lixisenatide,lixisenatide,"Diabetes Mellitus, Type 2",A10BJ03,,Sanofi-aventis groupe,8,31/01/2013,"54 rue La Boétie
75008 Paris
France",,,,,,,,,France
Myozyme,EMEA/H/C/000636,alglucosidase alfa,alglucosidase alfa,Glycogen Storage Disease Type II,A16AB07,,Genzyme Europe B.V.,14,28/03/2006,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Stayveer,EMEA/H/C/002644,bosentan monohydrate,bosentan monohydrate,"Hypertension, Pulmonary
Scleroderma, Systemic",C02KX01,,Marklas Nederlands BV   ,7,23/06/2013,"Marklas Nederlands BV
Beneluxlaan 2b
3446 GR Woerden
The Netherlands",,,,,,,,,The Netherlands
NovoNorm,EMEA/H/C/000187,repaglinide,repaglinide,"Diabetes Mellitus, Type 2",A10BX02,,Novo Nordisk A/S,16,16/08/1998,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Ucedane,EMEA/H/C/004019,carglumic acid,carglumic acid,"Hyperammonemia
Amino Acid Metabolism, Inborn Errors",A16AA05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Lucane Pharma,1,22/06/2017,"172 rue de Charonne
Paris 75011
France",,,,,,,,,France
Valdoxan,EMEA/H/C/000915,Agomelatine,Agomelatine,"Depressive Disorder, Major",N06AX22,,Les Laboratoires Servier,18,18/02/2009,"50, rue Carnot
F-92284 Suresnes Cedex
France",,,,,,,,,France
Kevzara,EMEA/H/C/004254,sarilumab,sarilumab,"Arthritis, Rheumatoid",L04AC14,,sanofi-aventis groupe,1,22/06/2017,"54 Rue La Boetie
75008 Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Ceprotin,EMEA/H/C/000334,human protein C,human protein C,"Purpura Fulminans
Protein C Deficiency",B01AD12,,Baxter AG,11,15/07/2001,"Industriestrasse 67
A-1221 Vienna
Austria",,,,,,,,,Austria
Evicel,EMEA/H/C/000898,"human fibrinogen
human thrombin",human fibrinogen / human thrombin,"Hemostasis, Surgical",B02BC,,Omrix Biopharmaceuticals N. V.,13,05/10/2008,"Leonardo Da Vinci Laan15
B-1831 Diegem
Belgium",,,,,,,,,Belgium
Zoledronic Acid Accord,EMEA/H/C/002667,zoledronic acid monohydrate,zoledronic acid,"Hypercalcemia
Fractures, Bone
Cancer",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Limited,4,15/01/2014,"Sage House
319 Pinner Road
North Harrow
HA1 4HF
United Kigndom",,,,,,,,,United Kingdom
Zontivity,EMEA/H/C/002814,vorapaxar sulfate,vorapaxar,Myocardial Infarction,B01,,Merck Sharp Dohme Limited,2,18/01/2015,"Hertford Road
EN11 9BU Hoddesdon
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Hetlioz,EMEA/H/C/003870,tasimelteon,tasimelteon,"Sleep Disorders, Circadian Rhythm",N05CH,,Vanda Pharmaceuticals Ltd,2,02/07/2015,"25 Old Broad Street
Level 21A
London EC2N 1HQ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Levetiracetam ratiopharm,EMEA/H/C/002244,levetiracetam,levetiracetam,Epilepsy,N03AX14,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",ratiopharm GmbH     ,7,25/08/2011,"atiopharm GmbH
Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,,,,,,Germany
Onglyza,EMEA/H/C/001039,Saxagliptin,saxagliptin,"Diabetes Mellitus, Type 2",A10BH03,,AstraZeneca AB,16,30/09/2009,"151 85 Södertälje
Sweden",,,,,,,,,Sweden
Qutenza,EMEA/H/C/000909,capsaicin,capsaicin,Neuralgia,N01BX04,,Grunenthal GmbH,11,14/05/2009,"Zieglerstrasse 6
52078 Aachen
Germany",,,,,,,,,Germany
Thorinane,EMEA/H/C/003795,enoxaparin sodium,enoxaparin sodium,Venous Thromboembolism,B01AB05,,Pharmathen S.A.,2,14/09/2016,"Techdow Pharma Netherlands B. V.
Strawinskylaan 1143, Toren C-11
1077XX Amsterdam
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Cerezyme,EMEA/H/C/000157,imiglucerase,imiglucerase,Gaucher Disease,A16AB02,,Genzyme Europe B.V.,22,16/11/1997,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Glidipion (previously Pioglitazone Actavis Group),EMEA/H/C/002558,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf   ,6,14/03/2012,"Actavis Group PTC ehf
Reykjavíkurvegur 76 - 78
IS-220 Hafnarfjörður
Iceland",,,,,,,,,Iceland
Lonsurf,EMEA/H/C/003897,"trifluridine
tipiracil hydrochloride",trifluridine / tipiracil,Colorectal Neoplasms,L01BC,,Les Laboratoires Servier,2,24/04/2016,"50 rue Carnot
92284 Suresnes cedex
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Betaferon,EMEA/H/C/000081,interferon beta-1b,interferon beta-1b,Multiple Sclerosis,L03AB08,,Bayer AG ,29,29/11/1995,"Bayer AG
51368 Leverkusen
Germany",,,,,,,,,Germany
Avamys,EMEA/H/C/000770,fluticasone furoate,fluticasone furoate,"Rhinitis, Allergic, Seasonal
Rhinitis, Allergic, Perennial",R01AD12,,Glaxo Group Limited,17,11/01/2008,"980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
SomaKit TOC,EMEA/H/C/004140,edotreotide,edotreotide,"Neuroendocrine Tumors
Radionuclide Imaging",V09IX,,Advanced Accelerator Applications,2,08/12/2016,"20 rue Diesel
01630 Saint Genis Pouilly
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Memantine Accord,EMEA/H/C/002766,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Limited,3,03/12/2013,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Kisqali,EMEA/H/C/004213,ribociclib succinate,ribociclib,Breast Neoplasms,L01XE,,Novartis Europharm Ltd,0,21/08/2017,"Frimley Business Park
Camberley GU16 7SR
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Busilvex,EMEA/H/C/000472,busulfan,busulfan,Hematopoietic Stem Cell Transplantation,L01AB01,,Pierre Fabre Médicament,16,08/07/2003,"45, place Abel Gance
92654 Boulogne Billancourt Cedex
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Dacogen,EMEA/H/C/002221,Decitabine,decitabine,"Leukemia, Myeloid",L01BC08,,Janssen-Cilag International N V  ,10,19/09/2012,"Janssen-Cilag International N V
Turnhoutseweg 30
BE-2340 Beerse
Belgium",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Belgium
Alli (previously Orlistat GSK),EMEA/H/C/000854,orlistat,orlistat,Obesity,A08AB01,,Glaxo Group Limited,15,22/07/2007,"Glaxo Group Ltd
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
PegIntron,EMEA/H/C/000280,peginterferon alfa-2b,peginterferon alfa-2b,"Hepatitis C, Chronic",L03AB10,,Merck Sharp Dohme Limited ,35,24/05/2000,"Merck Sharp Dohme Limited
Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Ammonaps,EMEA/H/C/000219,Sodium phenylbutyrate,sodium phenylbutyrate,"Ornithine Carbamoyltransferase Deficiency Disease
Citrullinemia
Carbamoyl-Phosphate Synthase I Deficiency Disease",A16AX03,,Swedish Orphan Biovitrum International AB,15,07/12/1999,"SE-112 76 Stockholm
Sweden",,,,,,,,,Sweden
Arzerra,EMEA/H/C/001131,ofatumumab,ofatumumab,"Leukemia, Lymphocytic, Chronic, B-Cell",L01XC10,,Novartis Europharm Ltd,16,18/04/2010,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Empliciti,EMEA/H/C/003967,Elotuzumab,elotuzumab,Multiple Myeloma,L01XC,,Bristol-Myers Squibb,2,10/05/2016,"Uxbridge Business Park
Sanderson Road, Uxbridge
Middlesex UB8 1DH
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Picato,EMEA/H/C/002275,Ingenol mebutate,ingenol mebutate,"Keratosis, Actinic",D06BX02,,LEO Laboratories Ltd.,7,14/11/2012,"285 Cashel Road
Crumlin, Dublin 12
Ireland",,,,,,,,,Ireland
Cyanokit,EMEA/H/C/000806,hydroxocobalamin,hydroxocobalamin,Poisoning,V03AB33,,SERB SA,9,22/11/2007,"Avenue Louise 480
1050 Brussels
Belgium",,,,,,,,,Belgium
Ferriprox,EMEA/H/C/000236,Deferiprone,deferiprone,"beta-Thalassemia
Iron Overload",V03AC02,,Apotex Europe BV,22,24/08/1999,"Archimedesweg 2
2333 CN Leiden
The Netherlands",,,,,,,,,The Netherlands
Trimbow,EMEA/H/C/004257,"Beclometasone dipropionate
formoterol fumarate dihydrate
Glycopyrronium bromide",beclometasone / formoterol / glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03,,Chiesi Farmaceutici S.p.A.,0,16/07/2017,"Via Palermo 26/A
43122 Parma
Italy",,,,,,,,,Italy
Orencia,EMEA/H/C/000701,Abatacept,abatacept,,L04AA24,,,25,20/05/2007,,,,,,,,,,
DepoCyte,EMEA/H/C/000317,cytarabine,cytarabine,Meningeal Neoplasms,L01BC01,,Pacira Limited,15,10/07/2001,"3 Glory Park Avenue
Wooburn Green
High Wycombe
Buckinghamshire
HP10 0DF
United Kingdom",,,,,,,,,United Kingdom
Enurev Breezhaler,EMEA/H/C/002691,Glycopyrronium bromide,glycopyrronium bromide,"Pulmonary Disease, Chronic Obstructive",R03BB06,,Novartis Europharm Ltd,6,27/09/2012,"Novartis Europharm Limited
Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Clopidogrel BGR (previously Zylagren),EMEA/H/C/001138,clopidogrel hydrogen sulphate,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Biogaran,12,20/09/2009,"15, boulevard Charles de Gaulle
92707 Colombes Cedex
France",,,,,,,,,France
Refixia,EMEA/H/C/004178,Nonacog beta pegol,nonacog beta pegol,Hemophilia B,B02BD04,,Novo Nordisk A/S,0,01/06/2017,"Novo Alle
2880 Bagsvaerd
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Veltassa,EMEA/H/C/004180,patiromer sorbitex calcium,patiromer,Hyperkalemia,V03AE09,,Vifor Fresenius Medical Care Renal Pharma France,0,19/07/2017,"100-101 Terrasse Boieldieu
Tour Franklin La Defense 8
Paris La Defense
Cedex 92042
Paris
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Xaluprine (previously Mercaptopurine Nova Laboratories),EMEA/H/C/002022,6-mercaptopurine monohydrate,mercaptopurine,"Leukemia, Lymphoid",L01BB02,,Nova Laboratories Ltd,7,08/03/2012,"Martin House
Gloucester Crescent
Wigston
Leicester LE18 4YL
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
NovoThirteen,EMEA/H/C/002284,catridecacog,catridecacog,"Blood Coagulation Disorders, Inherited",B02BD11,,Novo Nordisk A/S,5,02/09/2012,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Evra,EMEA/H/C/000410,"norelgestromin
ethinyl estradiol",norelgestromin / ethinyl estradiol,Contraception,G03AA13,,Janssen-Cilag International NV,19,21/08/2002,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Oxervate,EMEA/H/C/004209,recombinant human Nerve Growth factor (rhNGF),cenegermin,Keratitis,S01,,Dompe farmaceutici s.p.a.,0,05/07/2017,"20122 Milano
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Italy
Kiovig,EMEA/H/C/000628,human normal immunoglobulin (IVIg),human normal immunoglobulin,"Purpura, Thrombocytopenic, Idiopathic
Bone Marrow Transplantation
Immunologic Deficiency Syndromes
Guillain-Barre Syndrome
Mucocutaneous Lymph Node Syndrome",J06BA02,,Baxter AG,19,18/01/2006,"Industriestrasse 67
A-1221 Vienna
Austria",,,,,,,,,Austria
Erbitux,EMEA/H/C/000558,cetuximab,cetuximab,"Head and Neck Neoplasms
Colorectal Neoplasms",L01XC06,,Merck KGaA,25,28/06/2004,"64271 Darmstadt
Germany",,,,,,,,,Germany
Clopidogrel Krka d.d. (previously Zopya),EMEA/H/C/001137,clopidogrel hydrochloride,clopidogrel,,B01AC03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",,7,20/09/2009,,,,,,,,,,
Memantine Merz,EMEA/H/C/002711,memantine hydrochloride,memantine hydrochloride,Alzheimer Disease,N06DX01,,Merz Pharmaceuticals GmbH  ,5,21/11/2012,"Merz Pharmaceuticals GmbH
Eckenheimer Landstr. 100
D-60318 Frankfurt
Germany",,,,,,,,,Germany
Zalviso,EMEA/H/C/002784,sufentanil,sufentanil,"Pain, Postoperative",N01AH03,,Grünenthal GmbH,2,17/09/2015,"Zieglerstr. 6
D-52078Aachen
Germany",,,,,,,,,Germany
Onivyde,EMEA/H/C/004125,irinotecan hydrochloride trihydrate,irinotecan hydrochloride trihydrate,Pancreatic Neoplasms,L01XX19,,Baxalta Innovations GmbH,1,13/10/2016,"Industriestrasse 67
A-1221Vienna
AUSTRIA",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Austria
Removab,EMEA/H/C/000972,Catumaxomab,catumaxomab,"Ascites
Cancer",L01XC09,,Neovii Biotech GmbH,5,19/04/2009,"Am Haag 6-7
82166 Graefelfing
Germany",,,,,,,,,Germany
Tadalafil Lilly,EMEA/H/C/004666,tadalafil,tadalafil,Erectile Dysfunction,G04BE08,,Eli Lilly Nederland B.V.,1,22/03/2017,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Obizur,EMEA/H/C/002792,susoctocog alfa,susoctocog alfa,Hemophilia A,B02,,Baxalta Innovations GmbH,3,11/11/2015,"Industriestrasse 67
A-1221 Vienna
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Austria
Aflunov,EMEA/H/C/002094,influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23),"prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,Seqirus S.r.l. ,8,28/11/2010,"Seqirus S.r.l.
Via Fiorentina 1
I-53100
Siena
Italy",,,,,,,,,Italy
Talmanco (previously Tadalafil Generics),EMEA/H/C/004297,tadalafil,tadalafil,"Hypertension, Pulmonary",G04BE08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,2,09/01/2017,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune),EMEA/H/C/003963,reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain,"pandemic influenza vaccine (H5N1) (live attenuated, nasal)","Influenza, Human",J07BB03,,AstraZeneca AB,2,19/05/2016,"5E-151 85 Sodertalje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,"This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Sweden
Holoclar,EMEA/H/C/002450,ex vivo expanded autologous human corneal epithelial cells containing stem cells,ex vivo expanded autologous human corneal epithelial cells containing stem cells,"Stem Cell Transplantation
Corneal Diseases",S01XA19,,Chiesi Farmaceutici S.p.A.,3,16/02/2015,"Via Palermo 26/A
43122 Parma
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ","This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Italy
Noxafil,EMEA/H/C/000610,posaconazole,posaconazole,"Candidiasis
Mycoses
Coccidioidomycosis
Aspergillosis",J02AC04,,Merck Sharp Dohme Ltd,22,25/10/2005,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Zurampic,EMEA/H/C/003932,lesinurad,lesinurad,Hyperuricemia,M04AB05,,Grünenthal GmbH,3,17/02/2016,"Zieglerstr. 6
D-52078Aachen
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Avonex,EMEA/H/C/000102,interferon beta-1a,interferon beta-1a,Multiple Sclerosis,L03AB07,,Biogen Idec Ltd,28,12/03/1997,"Innovation House
70 Norden Road
Maidenhead
Berkshire SL6 4AY
United Kingdom",,,,,,,,,United Kingdom
Yargesa,EMEA/H/C/004016,miglustat,miglustat,Gaucher Disease,A16AX06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",JensonR+ Limited,1,22/03/2017,"Fishleigh Court
Fishleigh Road
Barnstaple EX31 3UD
United Kingdom",,,,,,,,,United Kingdom
Sabervel,EMEA/H/C/002510,irbesartan,irbesartan,Hypertension,C09CA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pharmathen S.A.,2,13/04/2012,"6, Dervenakion
EL-15351 Pallini Attiki
Greece",,,,,,,,,Greece
Rekovelle,EMEA/H/C/003994,follitropin delta,follitropin delta,Anovulation,G03GA,,Ferring Pharmaceuticals A/S,1,11/12/2016,"Kay Fiskers Plads 11
2300 Copenhagen
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Zoledronic acid medac,EMEA/H/C/002359,zoledronic acid monohydrate,zoledronic acid,"Fractures, Bone
Cancer",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",medac Gesellschaft für klinische Spezialpräparate mbH,10,02/08/2012,"Fehlandtstraße 3
D-20354 Hamburg
Germany",,,,,,,,,Germany
Optaflu,EMEA/H/C/000758,"influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013–like strain(B/Utah/9/2014, wild type)","influenza vaccine (surface antigen, inactivated, prepared in cell cultures)","Influenza, Human
Immunization",J07BB02,,Seqirus GmbH,16,31/05/2007,"Emil-von-Behring Strasse 76
35041 Marburg
Germany",,,,,,,,,Germany
Emtricitabine/Tenofovir disoproxil Mylan,EMEA/H/C/004050,"emtricitabine
tenofovir disoproxil maleate",emtricitabine / tenofovir disoproxil,HIV Infections,J05AR03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,1,15/12/2016,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
ProQuad,EMEA/H/C/000622,"virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella","measles, mumps, rubella and varicella vaccine (live)","Chickenpox
Rubella
Measles
Mumps
Immunization",J07BD54,,MSD VACCINS,23,05/04/2006,"162 avenue Jean Jaurès
69007 Lyon
France",,,,,,,,,France
Capecitabine Medac,EMEA/H/C/002568,capecitabine,capecitabine,Colorectal Neoplasms,L01BC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",medac Gesellschaft für klinische Spezialpräparate mbH,7,18/11/2012,"Fehlandtstraße 3
D-20354 Hamburg
Germany",,,,,,,,,Germany
Pemetrexed Lilly,EMEA/H/C/004114,pemetrexed,pemetrexed,"Carcinoma, Non-Small-Cell Lung
Mesothelioma",L01BA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Eli Lilly Netherlands,3,14/09/2015,"Grootslag 1-5
PO Box 379
NL-3991 RA Houten
The Netherlands",,,,,,,,,The Netherlands
Ganfort,EMEA/H/C/000668,"bimatoprost
timolol",bimatoprost / timolol,"Glaucoma, Open-Angle
Ocular Hypertension",S01ED51,,Allergan Pharmaceuticals Ireland,15,18/05/2006,"Castlebar Road
Westport, Co Mayo
Ireland",,,,,,,,,Ireland
MicardisPlus,EMEA/H/C/000413,"telmisartan
hydrochlorothiazide",telmisartan / hydrochlorothiazide,Hypertension,C09DA07,,Boehringer Ingelheim International GmbH,26,18/04/2002,"Bingerstr. 173
55216 Ingelheim am Rheim
Germany",,,,,,,,,Germany
Duloxetine Zentiva,EMEA/H/C/003935,duloxetine,duloxetine,"Anxiety Disorders
Depressive Disorder, Major
Neuralgia
Diabetes Mellitus",N06AX21,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Zentiva, k.s.",2,19/08/2015,"U kabelovny
130 Dolni Mecholupy
102 37 Praha 10
Czech Republic",,,,,,,,,Czech Republic
Zoledronic acid Teva Pharma,EMEA/H/C/002437,zoledronic acid,zoledronic acid,"Osteoporosis
Osteitis Deformans
Osteoporosis, Postmenopausal",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,10,15/08/2012,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Envarsus,EMEA/H/C/002655,tacrolimus,tacrolimus,Graft Rejection,L04AD02,,Chiesi Farmaceutici S.p.A.,5,17/07/2014,"Via Palermo 26/A
43122 Parma
Italy",,,,,,,,,Italy
Vitekta,EMEA/H/C/002577,elvitegravir,elvitegravir,HIV Infections,J05AX11,,Gilead Sciences International Ltd,4,12/11/2013,"Flowers Building
Granta Park
Abington
Cambridge
CB21 6GT
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Cialis,EMEA/H/C/000436,tadalafil,tadalafil,Erectile Dysfunction,G04BE08,,Eli Lilly Nederland B.V.,26,11/11/2002,"Eli Lilly Nederland BV
Papendorpseweg 83
3528 BJ Utrecht
The Netherlands",,,,,,,,,The Netherlands
Adcirca (previously Tadalafil Lilly),EMEA/H/C/001021,tadalafil,tadalafil,"Hypertension, Pulmonary",G04BE08,,Eli Lilly Nederland B.V.,11,30/09/2008,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Pioglitazone Accord,EMEA/H/C/002277,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,4,21/03/2012,"5th Floor Charles House
108/110 Finchley Road
London NW3 5JJ
United Kingdom",,,,,,,,,United Kingdom
Cholestagel,EMEA/H/C/000512,colesevelam,colesevelam,Hypercholesterolemia,C10AC04,,Genzyme Europe B.V.,18,09/03/2004,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Defitelio,EMEA/H/C/002393,defibrotide,defibrotide,Hepatic Veno-Occlusive Disease,B01AX01,,Gentium S.r.l.,6,17/10/2013,"Piazza XX Settembre 2
22079 Villa Guardia (Como)
Italy","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Italy
Xenical,EMEA/H/C/000154,orlistat,orlistat,Obesity,A08AB01,,CHEPLAPHARM Arzneimittel GmbH,22,28/07/1998,"Ziegelhof 24
17489 Greifswald
Germany",,,,,,,,,Germany
Vepacel,EMEA/H/C/002089,"Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1)","Prepandemic influenza vaccine (H5N1) (whole virion, inactivated,prepared in cell culture)","Influenza, Human
Immunization
Disease Outbreaks",J07BB01,,Nanotherapeutics UK LTD,8,16/02/2012,"10 Chiswell Street
London EC1Y 4UQ
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Imprida,EMEA/H/C/000775,"amlodipine (as besylate)
valsartan",amlodipine / valsartan,Hypertension,C09DB01,,Novartis Europharm Ltd,20,16/01/2007,"Frimley Business Park
Camberley GU16 7SR
United Kingdom",,,,,,,,,United Kingdom
Vaniqa,EMEA/H/C/000325,Eflornithine,eflornithine,Hirsutism,D11AX,,"Almirall, S.A.",21,19/03/2001,"Ronda General Mitre, 151
ES-08022 Barcelona
Spain",,,,,,,,,Spain
Integrilin,EMEA/H/C/000230,eptifibatide,eptifibatide,"Angina, Unstable
Myocardial Infarction",B01AC16,,Glaxo Group Ltd,21,30/06/1999,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel/Acetylsalicylic acid Teva,EMEA/H/C/002272,"clopidogrel
acetylsalicylic acid",clopidogrel / acetylsalicylic acid,"Acute Coronary Syndrome
Myocardial Infarction",B01AC30,,Teva Pharma B.V.,1,31/08/2014,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Pandemic Influenza Vaccine H5N1 Baxter AG,EMEA/H/C/001200,"influenza vaccine (whole virion, inactivated) containing antigen of: A/Vietnam/1203/2004 (H5N1)","pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture)","Influenza, Human
Immunization
Disease Outbreaks",J07BB01,,"Nanotherapeutics Bohumil, s.r.o.",5,15/10/2009,"Nanotherapeutics UK Limited
10 Chiswell Street
London
EC1Y 4UQ
United Kingdom",,,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,United Kingdom
Unituxin,EMEA/H/C/002800,Dinutuximab,dinutuximab,Neuroblastoma,L01XC,,United Therapeutics Europe Ltd,3,13/08/2015,"Uniter House
Curfew Bell Road
Chertsey
Surrey KT16 9FG
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Xydalba,EMEA/H/C/002840,dalbavancin hcl,dalbavancin,"Soft Tissue Infections
Skin Diseases, Bacterial",J01XA04,,Allergan Pharmaceuticals International Ltd,6,18/02/2015,"Clonshaugh Business Technology Park
Coolock
Dublin 17
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Dutrebis,EMEA/H/C/003823,"lamivudine
raltegravir potassium",lamivudine / raltegravir potassium,HIV Infections,J05AR16,,Merck Sharp Dohme Limited,0,25/03/2015,"Hertford Road
EN11 9BU Hoddesdon
United Kingdom",,,,,,,,,United Kingdom
Olazax Disperzi,EMEA/H/C/001088,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Glenmark Pharmaceuticals s.r.o. ,8,09/12/2009,"Glenmark Pharmaceuticals s.r.o.
Hvezdova 1716/2b
CZ-140 78 Praha 4
Czech Republic",,,,,,,,,Czech Republic
Olanzapine Glenmark,EMEA/H/C/001085,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Glenmark Pharmaceuticals Europe Limited,11,03/12/2009,"Laxmi House
2 B Draycott Avenue
Kenton
Middlesex
HA3 0BU
United Kingdom",,,,,,,,,United Kingdom
Olazax,EMEA/H/C/001087,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Glenmark Pharmaceuticals s.r.o. ,9,10/12/2009,"Glenmark Pharmaceuticals s.r.o.
Hvezdova 1716/2b
CZ-140 78 Praha 4
Czech Republic",,,,,,,,,Czech Republic
Vihuma,EMEA/H/C/004459,simoctocog alfa,simoctocog alfa,Hemophilia A,B02BD02,,Octapharma AB,0,13/02/2017,"Lars Forssells gata
23 112 75 Stockholm
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Efient,EMEA/H/C/000984,prasugrel,prasugrel,"Acute Coronary Syndrome
Angina, Unstable
Myocardial Infarction",B01AC22,,Daiichi Sankyo Europe GmbH,14,24/02/2009,"Zielstattstrasse 48
81379 Munich
Germany",,,,,,,,,Germany
Pylobactell,EMEA/H/C/000151,13C-urea,13C-urea,"Breath Tests
Helicobacter Infections",V04CX,,Torbet Laboratories Limited,9,07/05/1998,"14D Wendover Road
Rackheath Industrial Estate
Norwich
Norfolk
NR13 6LH
United Kingdom",,,,,,,,,United Kingdom
Pedea,EMEA/H/C/000549,Ibuprofen,ibuprofen,"Ductus Arteriosus, Patent",C01EB16,,Orphan Europe S.A.R.L.,12,28/07/2004,"Orphan Europe SARL
Immeuble “Le Wilson”
70, avenue du Général de Gaulle
F-92800 Puteaux
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Rebetol,EMEA/H/C/000246,Ribavirin,ribavirin,"Hepatitis C, Chronic",J05AB04,,Merck Sharp Dohme Limited,31,06/05/1999,"Hertford Road
Hoddesdon EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Rasilamlo,EMEA/H/C/002073,"aliskiren
amlodipine",aliskiren / amlodipine,Hypertension,C09XA53,,Novartis Europharm Ltd,7,13/04/2011,"Wimblehurst Road
Horsham
West Sussex
RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Zyprexa,EMEA/H/C/000115,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,,Eli Lilly Nederland B.V.,38,27/09/1996,"Eli Lilly Nederland BV
Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Zyprexa Velotab,EMEA/H/C/000287,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,,Eli Lilly Nederland B.V.,27,02/02/2000,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands",,,,,,,,,The Netherlands
Velcade,EMEA/H/C/000539,bortezomib,bortezomib,Multiple Myeloma,L01XX32,,Janssen-Cilag International NV,39,26/04/2004,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Zypadhera,EMEA/H/C/000890,olanzapine pamoate,olanzapine,Schizophrenia,N05AH03,,Eli Lilly Nederland B.V.,17,18/11/2008,"Eli Lilly Nederland BV
Papendorpseweg 83
3528 BJ Utrecht
The Netherlands",,,,,,,,,The Netherlands
Cancidas (previously Caspofungin MSD),EMEA/H/C/000379,caspofungin,caspofungin,"Candidiasis
Aspergillosis",J02AX04,,Merck Sharp Dohme Ltd,22,23/10/2001,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Ketek,EMEA/H/C/000354,telithromycin,telithromycin,"Sinusitis
Tonsillitis
Bronchitis, Chronic
Pharyngitis
Community-Acquired Infections
Pneumonia, Bacterial",J01FA15,,Aventis Pharma S.A.,25,08/07/2001,"20 avenue Raymond Aron
92165 Antony Cedex
France",,,,,,,,,France
Olanzapine Apotex,EMEA/H/C/001178,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Apotex Europe B.V. ,7,09/06/2010,"Apotex Europe B.V.
Darwinweg 20
NL-2333 CR Leiden
The Netherlands",,,,,,,,,The Netherlands
Duloxetine Lilly,EMEA/H/C/004000,duloxetine,duloxetine,"Neuralgia
Diabetic Neuropathies",N06AX21,,Eli Lilly Nederland B.V.,3,07/12/2014,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Cymbalta,EMEA/H/C/000572,duloxetine,duloxetine,"Anxiety Disorders
Diabetic Neuropathies
Depressive Disorder, Major",N06AX21,,Eli Lilly Nederland B.V.,25,16/12/2004,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands",,,,,,,,,The Netherlands
Xeristar,EMEA/H/C/000573,duloxetine,duloxetine,"Anxiety Disorders
Depressive Disorder, Major
Diabetic Neuropathies",N06AX21,,Eli Lilly Nederland B.V.,26,16/12/2004,"Grootslag 1-5
NL-3991 RA Houten
The Netherlands",,,,,,,,,The Netherlands
Caspofungin Accord,EMEA/H/C/004134,caspofungin acetate,caspofungin,"Candidiasis
Aspergillosis",J02AX04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,3,10/02/2016,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Beromun,EMEA/H/C/000206,tasonermin,tasonermin,Sarcoma,L03AX11,,Boehringer Ingelheim International GmbH,11,12/04/1999,"Binger Strasse 173 55216
Ingelheim am Rhein
Germany",,,,,,,,,Germany
Ivabradine JensonR,EMEA/H/C/004217,ivabradine hydrochloride,ivabradine,"Angina Pectoris
Heart Failure",C01EB17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",JensonR+ Limited,0,10/11/2016,"Fishleigh Court
Fishleigh Road
Barnstaple EX31 3UD
United Kingdom",,,,,,,,,United Kingdom
Granpidam,EMEA/H/C/004289,sildenafil citrate,sildenafil,"Hypertension, Pulmonary",G04BE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,1,14/11/2016,"Sage House
319 Pinner Road
North Harrow
Middlesex HA1 4HF
United Kingdrom",,,,,,,,,United Kingdom
Yentreve,EMEA/H/C/000545,duloxetine hydrochloride,duloxetine,"Urinary Incontinence, Stress",N06AX21,,Eli Lilly Nederland B.V.,23,11/08/2004,"Papendorpseweg 83
3528 BJ Utrecht
The Netherlands",,,,,,,,,The Netherlands
Relistor,EMEA/H/C/000870,methylnaltrexone bromide,methylnaltrexone bromide,"Opioid-Related Disorders
Constipation",A06AH01,,PharmaSwiss Ceska Republika s.r.o,14,01/07/2008,"Jankovcova 1569/2c
Lighthouse
17000 Prague 7
Czech Republic",,,,,,,,,Czech Republic
Ikervis,EMEA/H/C/002066,ciclosporin,ciclosporin,Corneal Diseases,S01XA18,,Santen Oy,4,18/03/2015,"Niittyhaankatu
20 FI-33720
Tampere
Finland",,,,,,,,,Finland
Ongentys,EMEA/H/C/002790,opicapone,opicapone,Parkinson Disease,N04,,"Bial - Portela Cª, S.A.",1,23/06/2016,"Av. da Siderurgia Nacional S.
Mamede do Coronado 4745-457
Portugal","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Portugal
Entacapone Orion,EMEA/H/C/002440,entacapone,entacapone,Parkinson Disease,N04BX02,,Orion Corporation,7,17/08/2011,"Orionintie 1
FI-02200 Espoo
Finland",,,,,,,,,Finland
Comtess,EMEA/H/C/000170,entacapone,entacapone,Parkinson Disease,N04BX02,,Orion Corporation,25,16/09/1998,"Orionintie 1
FI-02200 Espoo
Finland",,,,,,,,,Finland
Orfadin,EMEA/H/C/000555,nitisinone,nitisinone,Tyrosinemias,A16AX04,,Swedish Orphan Biovitrum International AB,13,20/02/2005,"SE-112 76 Stockholm
Sweden",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Sweden
Ambirix,EMEA/H/C/000426,"hepatitis-A virus (inactivated)
hepatitis-B surface antigen",hepatitis-A (inactivated) and hepatitis-B (rDNA) (HAB) vaccine (adsorbed),"Hepatitis B
Hepatitis A
Immunization",J07BC20,,GlaxoSmithKline Biologicals S.A.,14,29/08/2002,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Budesonide/Formoterol Teva,EMEA/H/C/003951,"budesonide
formoterol fumarate dihydrate",budesonide / formoterol,"Pulmonary Disease, Chronic Obstructive
Asthma",R03AK07,,Teva Pharma B.V.,2,18/11/2014,"Computerweg 10
3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Budesonide/Formoterol Teva Pharma B.V.,EMEA/H/C/003953,"budesonide
formoterol",budesonide / formoterol fumarate dihydrate,Asthma,R03AK07,,Teva Pharma B.V.,1,18/11/2014,"Computerweg 10
3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Vylaer Spiromax,EMEA/H/C/003952,"budesonide
formoterol fumarate dihydrate",budesonide / formoterol,"Pulmonary Disease, Chronic Obstructive
Asthma",R03AK07,,Teva Pharma B.V.,3,18/11/2014,"Computerweg 10
3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Ovitrelle,EMEA/H/C/000320,choriogonadotropin alfa,choriogonadotropin alfa,"Anovulation
Reproductive Techniques, Assisted
Infertility, Female",G03GA08,,Merck Serono Europe Limited,17,01/02/2001,"56 Marsh Wall
London
E14 9TP
United Kingdom",,,,,,,,,United Kingdom
Biograstim,EMEA/H/C/000826,filgrastim,filgrastim,"Neutropenia
Hematopoietic Stem Cell Transplantation
Cancer",L03AA02,,AbZ-Pharma GmbH,8,14/09/2008,"Graf -Arco-Strase 3
99079 Ulm
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Competact,EMEA/H/C/000655,"pioglitazone
metformin hydrochloride",pioglitazone / metformin,"Diabetes Mellitus, Type 2",A10BD05,,Takeda Pharma A/S,16,27/07/2006,"Dybendal Alle 10
2630 Taastrup
Denmark",,,,,,,,,Denmark
NovoSeven,EMEA/H/C/000074,eptacog alfa (activated),eptacog alfa (activated),"Hemophilia B
Thrombasthenia
Factor VII Deficiency
Hemophilia A",B02BD08,,Novo Nordisk A/S,31,23/02/1996,"Novo Allé
DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
ChondroCelect,EMEA/H/C/000878,characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins,characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins,Cartilage Diseases,M09AX02,,TiGenix N.V.,6,04/10/2009,"Romeinse straat 12/2
B-3001 Leuven
Belgium",,,,,,,,,Belgium
Tandemact,EMEA/H/C/000680,"pioglitazone
glimepiride",pioglitazone / glimepiride,"Diabetes Mellitus, Type 2",A10BD06,,Takeda Pharma A/S,15,07/01/2007,"Dybendal Alle 10
2630 Taastrup
Denmark",,,,,,,,,Denmark
Nonafact,EMEA/H/C/000348,human coagulation factor IX,human coagulation factor IX,Hemophilia B,B02BD04,,Sanquin Plasma Products B.V.,9,02/07/2001,"Plesmanlaan 125
NL-1066 CX Amsterdam
The Netherlands",,,,,,,,,The Netherlands
Mepact,EMEA/H/C/000802,mifamurtide,mifamurtide,Osteosarcoma,L03AX15,,Takeda France SAS,13,06/03/2009,"Immeuble Pacific
11-13 cours Valmy
92800 Puteaux
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Kolbam,EMEA/H/C/002081,cholic acid,cholic acid,"Metabolism, Inborn Errors",A05AA03,,Retrophin Europe Ltd,12,19/11/2015,"Palmerston House
Fenian Street
Dublin 2
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Ireland
Capecitabine SUN,EMEA/H/C/002050,capecitabine,capecitabine,"Stomach Neoplasms
Breast Neoplasms
Colonic Neoplasms
Colorectal Neoplasms",L01BC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sun Pharmaceutical Industries Europe B.V.,3,20/06/2013,"Polarisavenue 87
NL-2132 JH Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
Celvapan,EMEA/H/C/000982,"whole virion, inactivated containing antigen: A/California/07/2009 (H1N1)v","influenza vaccine (H1N1)v (whole virion, inactivated, prepared in cell culture)","Disease Outbreaks
Influenza, Human
Immunization",J07BB01,,"Nanotherapeutics Bohumil, s.r.o.",11,03/03/2009,"Bohumill38
28163 Jevany
Czech Republic",,,,,,,,,Czech Republic
Foclivia,EMEA/H/C/001208,"influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1)","pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,Seqirus S.r.l. ,5,18/10/2009,"Seqirus S.r.l.
Via Fiorentina 1
I-53100
Siena
Italy",,,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Italy
Ebixa,EMEA/H/C/000463,memantine hydrochloride,memantine,Alzheimer Disease,N06DX01,,H. Lundbeck A/S,24,14/05/2002,"Ottiliavej 9
DK-2500 Valby
Denmark",,,,,,,,,Denmark
Mysildecard,EMEA/H/C/004186,sildenafil citrate,sildenafil,"Hypertension, Pulmonary",G04BE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,0,14/09/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Portrazza,EMEA/H/C/003886,necitumumab,necitumumab,"Carcinoma, Non-Small-Cell Lung",L01,,Eli Lilly Nederland B.V.,2,14/02/2016,"Papendorpseweg 83
3528 BJ Utrecht
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Ribavirin Teva,EMEA/H/C/001018,Ribavirin,ribavirin,"Hepatitis C, Chronic",J05AB04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,13,30/03/2009,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Ibandronic Acid Teva,EMEA/H/C/001195,ibandronic acid,ibandronic acid,"Breast Neoplasms
Neoplasm Metastasis
Fractures, Bone
Osteoporosis, Postmenopausal",M05BA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,8,16/09/2010,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Iasibon,EMEA/H/C/002025,ibandronic acid,ibandronic acid,"Hypercalcemia
Fractures, Bone
Neoplasm Metastasis
Breast Neoplasms",M05BA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Pharmathen S.A.,7,20/01/2011,"6, Dervenakion
EL-15351 Pallini Attiki
Greece",,,,,,,,,Greece
Fexeric,EMEA/H/C/003776,ferric citrate coordination complex,ferric citrate coordination complex,"Hyperphosphatemia
Renal Dialysis",V03AE,,Keryx Biopharma UK Ltd,1,22/09/2015,"Riverbank House
2 Swan Lane
London EC4R 3TT
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Pantecta Control,EMEA/H/C/001099,pantoprazole,pantoprazole,Gastroesophageal Reflux,A02BC02,,Takeda GmbH,7,11/06/2009,"Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany",,,,,,,,,Germany
Zerit,EMEA/H/C/000110,stavudine,stavudine,HIV Infections,J05AF04,,Bristol-Myers Squibb Pharma EEIG,30,07/05/1996,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Scintimun,EMEA/H/C/001045,besilesomab,besilesomab,"Osteomyelitis
Radionuclide Imaging",V09HA03,,CIS bio international ,5,10/01/2010,"CIS bio international
Route Nationale 306, BP 32
F-91192 Gif-sur-Yvette
Cedex
France",,,,,,,,,France
Ifirmasta (previously Irbesartan Krka),EMEA/H/C/000962,irbesartan hydrochloride,irbesartan,Hypertension,C09CA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",8,30/11/2008,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Ibandronic Acid Sandoz,EMEA/H/C/002367,ibandronic acid,ibandronic acid,"Breast Neoplasms
Neoplasm Metastasis
Fractures, Bone",M05BA06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sandoz GmbH,7,25/07/2011,"Biochemiestrasse 10
6250 Kundl
Austria",,,,,,,,,Austria
Irbesartan Teva,EMEA/H/C/001093,irbesartan,irbesartan,Hypertension,C09CA04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,9,29/10/2009,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Protelos,EMEA/H/C/000560,strontium ranelate,strontium ranelate,"Osteoporosis, Postmenopausal",M05BX03,,Les Laboratoires Servier,18,21/09/2004,"Les laboratoires Servier
50, rue Carnot
F-92284 Suresnes Cedex
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Osseor,EMEA/H/C/000561,strontium ranelate,strontium ranelate,"Osteoporosis, Postmenopausal",M05BX03,,Les Laboratoires Servier,18,21/09/2004,"Les laboratoires Servier
50, rue Carnot
F-92284 Suresnes Cedex
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Incivo,EMEA/H/C/002313,telaprevir,telaprevir,"Hepatitis C, Chronic",J05AE,,Janssen-Cilag International N.V.,19,19/09/2011,"Turnhoutseweg 30
BE-2340 Beerse
Belgium","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Belgium
Repaglinide Teva,EMEA/H/C/001067,repaglinide,repaglinide,"Diabetes Mellitus, Type 2",A10BX02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,7,28/06/2009,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Raloxifene Teva,EMEA/H/C/001075,raloxifene hydrochloride,raloxifene,"Osteoporosis, Postmenopausal",G03XC01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,7,28/04/2010,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Efavirenz Teva,EMEA/H/C/002352,efavirenz,efavirenz,HIV Infections,J05AG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,7,08/01/2012,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Rivastigmine Sandoz,EMEA/H/C/001183,rivastigmine,rivastigmine,"Dementia
Alzheimer Disease
Parkinson Disease",N06DA03,,Sandoz GmbH,10,10/12/2009,"Biochemiestrasse 10
6250 Kundl
Austria",,,,,,,,,Austria
Nevirapine Teva,EMEA/H/C/001119,nevirapine,nevirapine,HIV Infections,J05AG01,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,8,29/11/2009,"Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Rivastigmine Hexal,EMEA/H/C/001182,rivastigmine,rivastigmine,"Dementia
Alzheimer Disease
Parkinson Disease",N06DA03,,Hexal AG ,9,10/12/2009,"Hexal AG
Industriestrasse 25
D-83607 Holzkirchen
Germany",,,,,,,,,Germany
Macugen,EMEA/H/C/000620,pegaptanib,pegaptanib,Wet Macular Degeneration,S01LA03,,PharmaSwiss Ceska Republika s.r.o,15,30/01/2006,"Jankovcova 1569/2c
Lighthouse
17000 Prague 7
Czech Republic",,,,,,,,,Czech Republic
Enyglid,EMEA/H/C/001065,repaglinide,repaglinide,"Diabetes Mellitus, Type 2",A10BX02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",6,13/10/2009,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Ribavirin Mylan (previously Ribavirin Three Rivers),EMEA/H/C/001185,Ribavirin,ribavirin,"Hepatitis C, Chronic",J05AB04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Generics [UK] Ltd,9,09/06/2010,"Station Close
Potters Bar
Hertfordshire
EN6 1TL
United Kingdom",,,,,,,,,United Kingdom
Telmisartan Teva Pharma,EMEA/H/C/002511,telmisartan,telmisartan,Hypertension,C09CA07,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,7,02/10/2011,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Zoledronic acid Teva Generics,EMEA/H/C/002805,zoledronic acid monohydrate,zoledronic acid,"Osteoporosis
Osteitis Deformans",M05BA08,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Generics B.V,2,26/03/2014,"Computerweg 10
Postbus 43028
3540AA Utrecht
The Netherlands",,,,,,,,,The Netherlands
Osigraft,EMEA/H/C/000293,eptotermin alfa,eptotermin alfa,Tibial Fractures,M05BC02,,Olympus Biotech International Limited,13,16/05/2001,"Raheen Business Park
Limerick
Ireland",,,,,,,,,Ireland
Dropcys,,mercaptamine,mercaptamine,"Corneal Diseases
Cystinosis",S01XA21,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Lucane Pharma,31/03/2016,,23/06/2016,
Krystexxa,EMEA/H/C/002208,pegloticase,pegloticase,Gout,M04AX02,,Crealta Pharmaceuticals Ireland Limited,3,07/01/2013,"Commercial House
Millbank Business Park
Lower Lucan Road
Lucan, Co.
Dublin
Ireland",,,,,,,,,Ireland
Enzepi,EMEA/H/C/002070,pancreas powder,pancreas powder,Exocrine Pancreatic Insufficiency,A09AA02,,Allergan Pharmaceuticals International Ltd,1,28/06/2016,"Clonshaugh Business Technology Park
Coolock
Dublin
D17 E400
Ireland","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Ireland
Opgenra,EMEA/H/C/000819,eptotermin alfa,eptotermin alfa,Spondylolisthesis,M05BC02,,Olympus Biotech International Limited,9,18/02/2009,"Block 2
International Science Centre
National Technology Park
Castletroy
Limerick
Ireland",,,,,,,,,Ireland
Tractocile,EMEA/H/C/000253,atosiban acetate,atosiban,Premature Birth,G02CX01,,Ferring Pharmaceuticals A/S,21,19/01/2000,"Kay Fiskers Plads 11
2300 København S
Denmark",,,,,,,,,Denmark
Viagra,EMEA/H/C/000202,sildenafil,sildenafil,Erectile Dysfunction,G04BE03,,Pfizer Limited,30,13/09/1998,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Trobalt,EMEA/H/C/001245,retigabine,retigabine,Epilepsy,N03AX21,,Glaxo Group Limited ,11,27/03/2011,"Glaxo Group Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Rasagiline Mylan,EMEA/H/C/004064,rasagiline tartrate,rasagiline,Parkinson Disease,N04BD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,1,03/04/2016,"117 Allée des Parcs
69800 Saint Priest
France",,,,,,,,,France
Glustin,EMEA/H/C/000286,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,,Takeda Pharma A/S,24,11/10/2000,"Dybendal Alle 10
2630 Taastrup
Denmark",,,,,,,,,Denmark
Pandemrix,EMEA/H/C/000832,"split influenza virus inactivated, containing antigen equivalent to A/California/07/2009 (H1N1)-derived strain used NYMC X-179A","influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (x-179a)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,GlaxoSmithKline Biologicals S.A.,23,20/05/2008,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Avandamet,EMEA/H/C/000522,"rosiglitazone
metformin hydrochloride,",rosiglitazone / metformin,"Diabetes Mellitus, Type 2",A10BD03,,SmithKline Beecham Plc,16,20/10/2003,"SmithKline Beecham plc
980 Great West Road,
Brentford, Middlesex, TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Palonosetron Accord,EMEA/H/C/004129,palonosetron,palonosetron,"Vomiting
Nausea
Cancer",A04AA05,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Ltd,0,25/05/2016,"Sage House
319 Pinner Road
North Harrow
Middlesex
HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Avandia,EMEA/H/C/000268,rosiglitazone,rosiglitazone,"Diabetes Mellitus, Type 2",A10BG02,,SmithKline Beecham Plc,23,10/07/2000,"SmithKline Beecham plc
980 Great West Road,
Brentford, Middlesex, TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Actos,EMEA/H/C/000285,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,,Takeda Pharma A/S,24,12/10/2000,"Dybendal Alle 10
2630 Taastrup
Denmark",,,,,,,,,Denmark
Lysodren,EMEA/H/C/000521,Mitotane,mitotane,Adrenal Cortex Neoplasms,L01XX23,,Laboratoire HRA Pharma,12,27/04/2004,"15 rue Béranger
75003 Paris
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Sildenafil Teva,EMEA/H/C/001073,sildenafil,sildenafil,Erectile Dysfunction,G04BE03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V. ,13,29/11/2009,"Teva B.V.
Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Entacapone Teva,EMEA/H/C/002075,entacapone,entacapone,Parkinson Disease,N04BX02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,7,17/02/2011,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Repso,EMEA/H/C/001222,leflunomide,leflunomide,"Arthritis, Rheumatoid
Arthritis, Psoriatic",L04AA13,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva B.V.,11,13/03/2011,"Swensweg 5
2031GA Haarlem
The Netherlands",,,,,,,,,The Netherlands
Foscan,EMEA/H/C/000318,temoporfin,temoporfin,"Head and Neck Neoplasms
Carcinoma, Squamous Cell",L01XD05,,Biolitec Pharma Ltd,18,23/10/2001,"Otto-Schott-Str. 15
07745 Jena
Germany",,,,,,,,,Germany
Kepivance,EMEA/H/C/000609,palifermin,palifermin,Mucositis,V03AF08,,Swedish Orphan Biovitrum AB (publ),19,24/10/2005,"SE-112 76 Stockholm
Sweden",,,,,,,,,Sweden
Heparesc,,Human heterologous liver cells,human heterologous liver cells,"Urea Cycle Disorders, Inborn",A16,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Cytonet GmbH KG,21/10/2015,,20/12/2015,
Nuedexta,EMEA/H/C/002560,"dextromethorphan
quinidine",dextromethorphan hydrobromide / quinidine sulfate,Neurobehavioral Manifestations,N07XX59,,Jenson Pharmaceutical Services Limited,2,23/06/2013,"Carradine House
237 Regents Park Road
London
N3 3LF
United Kingdom",,,,,,,,,United Kingdom
Paglitaz,EMEA/H/C/002309,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",1,20/03/2012,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
"Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics",EMEA/H/C/002269,influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1),"prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,Novartis Vaccines and Diagnostics S.r.l.,2,28/11/2010,"Via Fiorentina, 1
IT-53100 Siena
Italy",,,,,,,,,Italy
Pravafenix,EMEA/H/C/001243,"fenofibrate
Pravastatin",fenofibrate / pravastatin,Dyslipidemias,C10BA03,,Laboratoires SMB S.A.,4,13/04/2011,"Rue de la Pastorale 26-28
B-1080 Brussels
Belgium",,,,,,,,,Belgium
Solumarv,,insulin human,insulin human,Diabetes Mellitus,A10AB01,,,,,,,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",Marvel Lifesciences Ltd,18/11/2015,,18/11/2015,
Focetria,EMEA/H/C/000710,Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose,"influenza vaccine (H1N1) (surface antigen, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,Novartis Vaccines and Diagnostics S.r.l.,9,01/05/2007,"Via Fiorentina, 1
IT-53100 Siena
Italy",,,,,,,,,Italy
Scenesse,EMEA/H/C/002548,afamelanotide,afamelanotide,"Protoporphyria, Erythropoietic",D02BB02,,Clinuvel UK Limited,2,21/12/2014,"Devonshire House
60 Goswell Road
London EC1M 7AD
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,United Kingdom
Eptifibatide Accord,EMEA/H/C/004104,eptifibatide,eptifibatide,Myocardial Infarction,B01AC16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Accord Healthcare Limited,0,10/01/2016,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom",,,,,,,,,United Kingdom
Nivolumab BMS,EMEA/H/C/003840,nivolumab,nivolumab,"Carcinoma, Non-Small-Cell Lung",L01XC17,,Bristol-Myers Squibb Pharma EEIG,0,19/07/2015,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Altargo,EMEA/H/C/000757,retapamulin,retapamulin,"Impetigo
Staphylococcal Skin Infections",D06AX13,,Glaxo Group Ltd,15,23/05/2007,"980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Sonata,EMEA/H/C/000227,zaleplon,zaleplon,Sleep Initiation and Maintenance Disorders,N05CF03,,Meda AB,19,11/03/1999,"Pipers väg 2A
170 09 Solna
Sweden",,,,,,,,,Sweden
Lympreva,,dasiprotimut-t,dasiprotimut-t,"Lymphoma, Non-Hodgkin",L03AX,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Biovest Europe Ltd,22/04/2015,,02/07/2015,
Rienso,EMEA/H/C/002215,Ferumoxytol,ferumoxytol,"Anemia
Kidney Failure, Chronic",B03,,Takeda Pharma A/S,7,14/06/2012,"P.O. Box 260
Dybendal Alle 10
2630 Taastrup
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Clopidogrel DURA,EMEA/H/C/001132,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan dura GmbH,6,20/07/2009,"Wittichstraße 6
D-64295 Darmstadt
Germany",,,,,,,,,Germany
Ytracis,EMEA/H/C/000460,yttrium [90Y] chloride,yttrium [90Y] chloride,Radionuclide Imaging,V09,,CIS bio international,7,23/03/2003,"Route Nationale 306, Saclay
B.P. 32
F-91192 Gif sur Yvette Cedex
France",,,,,,,,,France
Quadramet,EMEA/H/C/000150,samarium [153Sm] lexidronam pentasodium,samarium [153Sm] lexidronam pentasodium,"Pain
Cancer",V10BX02,,CIS bio international,15,04/02/1998,"Route Nationale 306, Saclay
B.P. 32
F-91192 Gif sur Yvette Cedex
France",,,,,,,,,France
Provenge,EMEA/H/C/002513,autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor,autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-T),Prostatic Neoplasms,L03AX17,,Dendreon UK Ltd,1,05/09/2013,"41 Chalton Street
London NW1 1JD
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
BindRen,EMEA/H/C/002377,colestilan,colestilan,Hyperphosphatemia,V03AE,,Mitsubishi Pharma Europe Ltd,2,20/01/2013,"Dashwood House
69 Old Broad Street
London EC2M 1QS
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Pumarix,EMEA/H/C/001212,"pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) ","pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,GlaxoSmithKline Biologicals S.A. ,4,03/03/2011,"GlaxoSmithKline Biologicals S.A.
89, rue de l'Institut
B-1330 Rixensart
Belgium",,,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Belgium
Docetaxel Mylan,EMEA/H/C/002317,"docetaxel, anhydrous",docetaxel,"Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Adenocarcinoma
Prostatic Neoplasms
Breast Neoplasms",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,6,30/01/2012,"117 allée des Parcs
F-69 800 Saint Priest
France",,,,,,,,,France
Topotecan Actavis,EMEA/H/C/001031,topotecan,topotecan,"Uterine Cervical Neoplasms
Small Cell Lung Carcinoma",L01XX17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Actavis Group PTC ehf,6,24/07/2009,"Reykjavikurvegur 76-78
220 Hafnarfjordur
Iceland",,,,,,,,,Iceland
Vipidia,EMEA/H/C/002182,alogliptin,alogliptin benzoate,"Diabetes Mellitus, Type 2",A10BH04,,Takeda Pharma A/S,3,18/09/2013,"Langebjerg 1
DK-4000 Roskilde
Denmark","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Denmark
Clopidogrel Teva Pharma B.V.,EMEA/H/C/001226,clopidogrel hydrobromide,clopidogrel,"Peripheral Vascular Diseases
Acute Coronary Syndrome
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V. ,4,15/06/2011,"Teva Pharma B.V.
Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Vistide,EMEA/H/C/000121,cidofovir,cidofovir,Cytomegalovirus Retinitis,J05AB12,,Gilead Sciences International Limited,21,22/04/1997,"Cambridge
CB21 6GT
United Kingdom",,,,,,,,,United Kingdom
Masiviera,,masitinib,masitinib,Pancreatic Neoplasms,L01XE,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,AB Science,22/01/2014,,21/05/2014,
Ipreziv,EMEA/H/C/002517,Azilsartan medoxomil,azilsartan medoxomil,Hypertension,C09CA09,,Takeda Pharma A/S,4,06/12/2011,"Dybendal Alle 10
2630 Taastruup
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,United Kingdom
Fluenz,EMEA/H/C/001101,"Reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain","influenza vaccine (intranasal, live attenuated)","Influenza, Human
Immunization",J07BB03,,MedImmune LLC,4,26/01/2011,"Lagelandseweg 78
NL-6545 CG Nijmegen
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Topotecan Eagle,EMEA/H/C/002261,topotecan hydrochloride,topotecan,"Carcinoma
Small Cell Lung Carcinoma",L01XX17,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Eagle Laboratories Ltd.   ,2,21/12/2011,"Eagle Laboratories Ltd.
c/o Pink Accounting Resources Ltd
The Clockhouse, Station Approach
Marlow, Bucks SL7 1NT
United Kingdom",,,,,,,,,United Kingdom
Doribax,EMEA/H/C/000891,doripenem,doripenem,"Pneumonia, Ventilator-Associated
Pneumonia, Bacterial
Urinary Tract Infections
Bacterial Infections
Cross Infection",J01DH04,,Janssen-Cilag International NV,10,24/07/2008,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Pioglitazone Krka,EMEA/H/C/002453,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.","Krka, d.d., Novo mesto",2,20/03/2012,"Šmarješka cesta 6
8501 Novo mesto
Slovenia",,,,,,,,,Slovenia
Rivastigmine 3M Health Care Ltd,EMEA/H/C/003824,rivastigmine,rivastigmine,Alzheimer Disease,N06DA03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",3M Health Care Limited,1,03/04/2014,"1 Morley Street
Loughborough
Leicestershire
LE11 1EP
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel Qualimed,EMEA/H/C/001135,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC06,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Qualimed,4,22/09/2009,"117 allée des Parcs
F-69 800 Saint Priest
France",,,,,,,,,France
Reasanz,,Serelaxin,serelaxin,Heart Failure,C01,,,,,,,,,,Novartis Europharm Ltd,21/05/2014,,04/08/2014,
Nerventra,,laquinimod,laquinimod,Multiple Sclerosis,N07,,,,,,,,,,Teva Pharma GmbH,21/05/2014,,18/08/2014,
Ioa,EMEA/H/C/002068,"Nomegestrol acetate
estradiol",nomegestrol acetate / estradiol,Contraception,G03AA14,,N.V. Organon,4,15/11/2011,"Kloosterstraat 6
NL-5349 AB Oss
The Netherlands",,,,,,,,,The Netherlands
Yttriga,EMEA/H/C/000596,yttrium [90Y] chloride,yttrium [90Y] chloride,Radionuclide Imaging,V09,,Eckert Ziegler Radiopharma GmbH,9,19/01/2006,"Robert-Rossle-Str. 10
D-13125 Berlin
Germany",,,,,,,,,Germany
Diacomit,EMEA/H/C/000664,stiripentol,stiripentol,"Myoclonic Epilepsy, Juvenile",N03AX17,,Biocodex,14,03/01/2007,"7 avenue Galliéni
F-94250 Gentilly
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Revasc,EMEA/H/C/000104,desirudin,desirudin,Venous Thrombosis,B01AE01,,Canyon Pharmaceuticals Ltd.,12,08/07/1997,"Canyon Pharmaceuticals Limited
7th Floor
52-54 Gracechurch Street
London
EC3V 0EH
United Kingdom",,,,,,,,,United Kingdom
Olanzapine Cipla (previously Olanzapine Neopharma),EMEA/H/C/000793,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Cipla (EU) Limited,12,13/11/2007,"Cipla (EU) Limited
Hillbrow House
Hillbrow Road
Esher
Surrey
KT10 9NW
United Kingdom",,,,,,,,,United Kingdom
Preotact,EMEA/H/C/000659,parathyroid hormone (rDNA),parathyroid hormone (rDNA),"Osteoporosis, Postmenopausal",H05AA03,,NPS Pharma Holdings Limited,4,23/04/2006,"Grand Canal House
1 Grand Canal Street Upper
Dublin
Dublin 4
IRELAND",,,,,,,,,Ireland
Optison,EMEA/H/C/000166,perflutren,perflutren,Echocardiography,V08DA01,,GE Healthcare AS,17,17/05/1998,"Nycoveien 1-2
P.O.BOX 4220 Nydalen
NO-0401 Oslo
Norway",,,,,,,,,Norway
Viracept,EMEA/H/C/000164,nelfinavir,nelfinavir,HIV Infections,J05AE04,,Roche Registration Ltd.,25,21/01/1998,"Roche Registration Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel Teva Generics B.V.,EMEA/H/C/002254,clopidogrel hydrochloride,clopidogrel,"Peripheral Vascular Diseases
Acute Coronary Syndrome
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,3,27/10/2010,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Onduarp,EMEA/H/C/002118,telmisartan / amlodipine besilate,telmisartan / amlodipine,Hypertension,C09DB04,,Boehringer Ingelheim International GmbH,2,23/11/2011,"Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Leflunomide Teva,EMEA/H/C/002356,leflunomide,leflunomide,"Arthritis, Rheumatoid",L04AA13,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,6,09/03/2011,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Docetaxel Teva Pharma,EMEA/H/C/002032,docetaxel,docetaxel,"Carcinoma, Non-Small-Cell Lung
Breast Neoplasms
Prostatic Neoplasms",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,6,21/01/2011,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Tritanrix HepB,EMEA/H/C/000093,diphtheria toxoid / hepatitis B recombinant surface antigen / Bordetella pertussis (inactivated) / tetanus toxoid,"diphtheria, tetanus, pertussis (whole cell) and hepatitis-B (rDNA) vaccine (adsorbed)","Hepatitis B
Tetanus
Immunization
Whooping Cough
Diphtheria",J07CA05,,GlaxoSmithKline Biologicals S.A.,15,18/07/1996,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Clopidogrel ratiopharm,EMEA/H/C/001173,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Archie Samuel s.r.o.,5,22/09/2009,"Slunná 16
61700 Brno
Czech Republic",,,,,,,,,Czech Republic
Masican,,masitinib,masitinib,Gastrointestinal Stromal Tumors,L01XE,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,07/05/2014,,03/07/2014,
Infanrix Penta,EMEA/H/C/000295,"Diphtheria toxoid
tetanus toxoid
Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin)
hepatitis-B surface antigen
poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain))","diphtheria, tetanus, pertussis (acellular, component), hepatitis-B (rDNA) and poliomyelitis (inactivated) vaccine (adsorbed)","Hepatitis B
Tetanus
Immunization
Whooping Cough
Poliomyelitis
Diphtheria",J07CA12,,GlaxoSmithKline Biologicals S.A.,13,22/10/2000,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Sepioglin,EMEA/H/C/002021,pioglitazone hydrochloride,pioglitazone,"Diabetes Mellitus, Type 2",A10BG03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Vaia S.A.,1,08/03/2012,"1, 28 Octovriou Str.
Ag. Varvara
EL-12351 Athens
Greece",,,,,,,,,Greece
Daronrix,EMEA/H/C/000706,"Whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs","Pandemic influenza vaccine (H5N1) (whole virion, inactivated, adsorbed)","Influenza, Human
Immunization
Disease Outbreaks",J07BB01,,GlaxoSmithKline Biologicals S.A.,0,20/03/2007,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,Belgium
Kynamro,,mipomersen sodium,mipomersen sodium,Hypercholesterolemia,C10AX11,,,,,,,,,,Genzyme Europe BV,20/03/2013,,28/05/2013,
Qsiva,,"phentermine
topiramate",phentermine / topiramate,Obesity,,,,,,,,,,,Vivus BV,20/02/2013,,13/05/2013,
Trevaclyn,EMEA/H/C/000897,"laropiprant
nicotinic acid",laropiprant / nicotinic acid,Dyslipidemias,C10AD52,,Merck Sharp Dohme Ltd,11,03/07/2008,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Pelzont,EMEA/H/C/000903,"laropiprant
nicotinic acid",laropiprant / nicotinic acid,Dyslipidemias,C10AD52,,Merck Sharp Dohme Ltd,11,02/07/2008,"Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Tredaptive,EMEA/H/C/000889,laropiprant / nicotinic acid,laropiprant / nicotinic acid,Dyslipidemias,C10AD52,,Merck Sharp Dohme Ltd.,11,02/07/2008,"Merck Sharp Dohme Ltd
Hertford Road
Hoddesdon
Hertfordshire
EN11 9BU
United Kingdom",,,,,,,,,United Kingdom
Bondenza (previously Ibandronic Acid Roche),EMEA/H/C/000502,ibandronic acid,ibandronic acid,"Osteoporosis, Postmenopausal",M05BA06,,Roche Registration Ltd.,16,22/02/2004,"Roche Registration Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom",,,,,,,,,United Kingdom
Ribavirin BioPartners,EMEA/H/C/001184,Ribavirin,ribavirin,"Hepatitis C, Chronic",J05AB04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",BioPartners GmbH,2,05/04/2010,"Kaiserpassage 11
D-72764 Reutlingen
Germany",,,,,,,,,Germany
Possia,EMEA/H/C/002303,ticagrelor,ticagrelor,"Peripheral Vascular Diseases
Acute Coronary Syndrome",B01AC24,,AstraZeneca AB,2,02/12/2010,"Gärtunavägen
151 85 Södertälje
Sweden",,,,,,,,,Sweden
Labazenit,,"budesonide
salmeterol",budesonide / salmeterol,Asthma,R03AK06,,,,,,,,,,Laboratoires SMB S.A.  ,26/06/2013,,05/09/2013,
Istodax,,romidepsin,romidepsin,"Lymphoma, Non-Hodgkin",L01XX39,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Celgene Europe Ltd.,14/11/2012,,11/02/2013,
Balaxur,,"memantine hydrochloride
donepezil hydrochloride",memantine hydrochloride / donepezil hydrochloride,Alzheimer Disease,N06DA52,,,,,,,,,,Merz Pharmaceuticals GmbH,17/10/2012,,19/02/2013,
Acrescent,,"memantine hydrochloride
donepezil hydrochloride",memantine hydrochloride / donepezil hydrochloride,Alzheimer Disease,N06D,,,,,,,,,,H. Lundbeck A/S,17/10/2012,,19/02/2013,
Riprazo,EMEA/H/C/000853,aliskiren,aliskiren,Hypertension,C09XA02,,Novartis Europharm Ltd.,8,21/08/2007,"Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Duloxetine Boehringer Ingelheim,EMEA/H/C/001007,duloxetine,duloxetine,Diabetic Neuropathies,N06AX21,,Boehringer Ingelheim International GmbH,2,08/10/2008,"Binger Str 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
Elelyso,,Taliglucerase alfa,taliglucerase alfa,Gaucher Disease,A16AB11,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Pfizer Ltd.   ,02/07/2012,,24/10/2012,
Rilonacept Regeneron (previously Arcalyst),EMEA/H/C/001047,Rilonacept,rilonacept,Cryopyrin-Associated Periodic Syndromes,L04AC08,,Regeneron UK Limited,5,22/10/2009,"40 Bank Street
London
E14 5DS
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,United Kingdom
Imprida HCT,EMEA/H/C/001161,"amlodipine
valsartan
hydrochlorothiazide",amlodipine / valsartan / hydrochlorothiazide,Hypertension,C09DX01,,Novartis Europharm Ltd.,3,14/10/2009,"Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Zerene,EMEA/H/C/000228,zaleplon,zaleplon,Sleep Initiation and Maintenance Disorders,N05CF03,,Meda AB,13,11/03/1999,"Pipers väg 2A
SE-Solna 170 09
Sweden",,,,,,,,,Sweden
Rivastigmine Teva,EMEA/H/C/001044,rivastigmine,rivastigmine,"Dementia
Alzheimer Disease
Parkinson Disease",N06DA03,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Teva Pharma B.V.,4,17/04/2009,"Computerweg 10
NL-3542 DR Utrecht
The Netherlands",,,,,,,,,The Netherlands
Rasitrio,EMEA/H/C/002017,"aliskiren
amlodipine
hydrochlorothiazide",aliskiren / amlodipine / hydrochlorothiazide,Hypertension,C09XA54,,Novartis Europharm Ltd.,1,22/11/2011,"Wimblehurst Road
Horsham
West Sussex
RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Riprazo HCT,EMEA/H/C/002420,"aliskiren
hydrochlorothiazide",aliskiren / hydrochlorothiazide,Hypertension,C09XA52,,Novartis Europharm Ltd.,0,12/04/2011,"Wimblehurst Road
Horsham
West Sussex
RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Sprimeo HCT,EMEA/H/C/002421,"aliskiren
hydrochlorothiazide",aliskiren / hydrochlorothiazide,Hypertension,C09XA52,,Novartis Europharm Ltd.,0,22/06/2011,"Wimblehurst Road
Horsham
West Sussex
RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Hexavac,EMEA/H/C/000298,"purified diphtheria toxoid
Purified Tetanus Toxoid
purified pertussis toxoid
purified pertussis filamentous haemagglutinin
hepatitis B surface antigen
Inactivated Type 1 Poliovirus (Mahoney)
inactivated type 2 poliovirus (MEF 1)
Inactivated Type 3 Poliovirus (Saukett)
Haemophilus influenzae type b polysaccharide","diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted","Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Poliomyelitis
Diphtheria",J07CA,,"Sanofi Pasteur MSD, SNC",0,22/10/2000,"Sanofi Pasteur MSD SNC
8 rue Jonas Salk
F-69007 Lyon
FRANCE",,,,,,,,,France
Exalief,EMEA/H/C/000987,eslicarbazepine acetate,eslicarbazepine acetate,Epilepsy,N03AF04,,"BIAL - Portela Ca, S.A.",5,20/04/2009,"A Avenida da Siderurgia Nacional
PT-4745-457 S. Mamede do Coronado
Portugal",,,,,,,,,Portugal
Regranex,EMEA/H/C/000212,becaplermin,becaplermin,"Wound Healing
Skin Ulcer",D03AX06,,Janssen-Cilag International NV,18,28/03/1999,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
MabCampath,EMEA/H/C/000353,alemtuzumab,alemtuzumab,"Leukemia, Lymphocytic, Chronic, B-Cell",L01XC04,,Genzyme Europe B.V.,14,06/07/2001,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,,,,,,,,The Netherlands
Valtropin,EMEA/H/C/000602,somatropin,somatropin,"Turner Syndrome
Dwarfism, Pituitary",H01AC01,,BioPartners GmbH,5,23/04/2006,"Kaiserpassage 11
D-72764 Reutlingen
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Teslascan,EMEA/H/C/000137,mangafodipir trisodium,mangafodipir,Magnetic Resonance Imaging,V08CA05,,GE Healthcare AS,9,21/05/1997,"Nycoveien 1-2
P.O.BOX 4220 Nydalen
NO-0401 Oslo
Norway",,,,,,,,,Norway
Refludan,EMEA/H/C/000122,lepirudin,lepirudin,"Thromboembolism
Thrombocytopenia",B01AE02,,Celgene Europe Ltd.,15,12/03/1997,"Riverside House
Riverside Walk
Windsor
Berkshire
SL4 1NA
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel Acino Pharma GmbH,EMEA/H/C/001175,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Acino Pharma GmbH,1,20/09/2009,"Am Windfeld 35
83714 Miesbach
Germany",,,,,,,,,Germany
Clopidogrel Acino Pharma,EMEA/H/C/001172,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Acino Pharma GmbH,1,20/09/2009,"Am Windfeld 35
83714 Miesbach
Germany",,,,,,,,,Germany
Clopidogrel Hexal,EMEA/H/C/001139,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Acute Coronary Syndrome
Myocardial Infarction
Stroke",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Acino Pharma GmbH,2,27/07/2009,"Am Windfeld 35
DE-83714 Miesbach
Germany",,,,,,,,,Germany
Sprimeo,EMEA/H/C/000851,aliskiren,aliskiren,Hypertension,C09XA02,,Novartis Europharm Ltd.,5,21/08/2007,"Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Folotyn,,Pralatrexate,pralatrexate,"Lymphoma, T-Cell",L01BA05,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Allos Therapeutics Ltd,18/04/2012,,20/06/2012,
Fablyn,EMEA/H/C/000977,Lasofoxifene tartrate,lasofoxifene,"Osteoporosis, Postmenopausal",G03,,Dr. Friedrich Eberth Arzneimittel GmbH,2,23/02/2009,"Am Bahnhof 2
D-92289 Ursensollen
Germany",,,,,,,,,Germany
Intrinsa,EMEA/H/C/000634,Testosterone,testosterone,"Sexual Dysfunctions, Psychological",G03BA03,,Warner Chilcott UK Ltd.,6,27/07/2006,"Old Belfast Road
Milbrook
Larne
County Antrim
BT40 2SH
United Kingdom",,,,,,,,,United Kingdom
Docefrez,EMEA/H/C/001074,docetaxel,docetaxel,"Stomach Neoplasms
Adenoma
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Prostatic Neoplasms",L01CD02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Sun Pharmaceutical Industries Europe B.V.,1,09/05/2010,"SUN Pharmaceutical Industries Europe B.V.
Polaris Avenue 87
2132 JH Hoofddorp
The Netherlands",,,,,,,,,The Netherlands
PhotoBarr,EMEA/H/C/000493,porfimer sodium,porfimer sodium,Barrett Esophagus,L01XD01,,Pinnacle Biologics B.V. ,9,24/03/2004,"Pinnacle Biologics B.V.
p/a Trust Company Amsterdam B.V.
Crystal Tower 21st Floor
Orlyplein 10
1043 DP Amsterdam
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Livensa,EMEA/H/C/000630,Testosterone,testosterone,"Sexual Dysfunctions, Psychological",G03BA03,,Warner Chilcott  Deutschland GmbH,6,27/07/2006,"Warner Chilcott Deutschland GmbH
Dr.-Otto-Röhm-Strasse 2-4
D-64331 Weiterstadt
Germany",,,,,,,,,Germany
"Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals",EMEA/H/C/001015,"split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)","prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,GlaxoSmithKline Biologicals S.A.,3,25/09/2008,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Xigris,EMEA/H/C/000396,drotrecogin alfa (activated),drotrecogin alfa (activated),"Sepsis
Multiple Organ Failure",B01AD10,,Eli Lilly Nederland B.V.,13,22/08/2002,"Eli Lilly Nederland BV
Grootslag 1-5,
NL-3991 RA Houten
The Netherlands",,,,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,The Netherlands
Sumatriptan Galpharm,,sumatriptan succinate,sumatriptan,Migraine Disorders,,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",,,,,,,,,Galpharm Healthcare Ltd.,16/11/2011,,08/02/2012,
Ablavar (previously Vasovist),EMEA/H/C/000601,gadofosveset trisodium,gadofosveset trisodium,Magnetic Resonance Angiography,V08CA,,TMC Pharma Services Ltd.,10,03/10/2005,"Finchampstead
Berkshire RG40 4LJ
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel Sandoz,EMEA/H/C/001174,clopidogrel,clopidogrel,"Peripheral Vascular Diseases
Stroke
Myocardial Infarction",B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Acino Pharma GmbH,2,20/09/2009,"Am Windfeld 35
83714 Miesbach
Germany",,,,,,,,,Germany
Arepanrix,EMEA/H/C/001201,"split influenza virus, inactivated, containing antigen* : A/California/7/2009 (H1N1)v like strain (X-179A)* produced in eggs","pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,GlaxoSmithKline Biologicals S.A.,1,22/03/2010,"89, rue de l'Institut
BE-1330 Rixensart
Belgium",,,"This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,Belgium
Alisade,EMEA/H/C/001019,fluticasone furoate,fluticasone furoate,"Rhinitis, Allergic, Perennial
Rhinitis, Allergic, Seasonal",R01AD12,,Glaxo Group Ltd.,4,05/10/2008,"Glaxo Group Limited
Greenford Road
Greenford, Middx UB6 0NN
United Kingdom",,,,,,,,,United Kingdom
Avaglim,EMEA/H/C/000675,"rosiglitazone
glimepiride",rosiglitazone / glimepiride,"Diabetes Mellitus, Type 2",A10BD04,,SmithKline Beecham Ltd,11,26/06/2006,"980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Filgrastim ratiopharm,EMEA/H/C/000824,filgrastim,filgrastim,"Neutropenia
Hematopoietic Stem Cell Transplantation
Cancer",L03AA02,,Ratiopharm GmbH,1,15/09/2008,"atiopharm GmbH
Graf-Arco-Str. 3
D-89079 Ulm
Germany",,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Humenza,EMEA/H/C/001202,"split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.","pandemic influenza vaccine (H1N1, split virion, inactivated, adjuvanted)","Influenza, Human
Immunization
Disease Outbreaks",J07BB02,,Sanofi Pasteur S.A.,0,07/06/2010,"2, avenue Pont Pasteur
FR-69007 Lyon
France",,,"This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see Conditional marketing authorisation.",,,,,,France
Agenerase,EMEA/H/C/000264,amprenavir,amprenavir,HIV Infections,J05AE05,,Glaxo Group Ltd.,18,19/10/2000,"Glaxo Group Limited
Greenford Road
Greenford, Middx UB6 0NN
United Kingdom",,,,,,,,,United Kingdom
Enviage,EMEA/H/C/000850,aliskiren,aliskiren,Hypertension,C09XA02,,Novartis Europharm Ltd.,4,21/08/2007,"Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Onsenal,EMEA/H/C/000466,Celecoxib,celecoxib,Adenomatous Polyposis Coli,L01XX33,,Pfizer Limited,13,16/10/2003,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,"This medicine was authorised under exceptional circumstances, because the applicant was unable to provide comprehensive data on the efficacy and safety of the medicine under normal conditions of use. This can happen because the condition to be treated is rare or because collection of full information is not possible or is unethical. For more information, see Pre-authorisation guidance.",,United Kingdom
Thelin,EMEA/H/C/000679,sitaxentan sodium,sitaxentan sodium,"Hypertension, Pulmonary",C02KX03,,Pfizer Ltd.,13,09/08/2006,"Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Clopidogrel 1A Pharma,EMEA/H/C/001054,clopidogrel,clopidogrel,Peripheral Vascular Diseases,B01AC04,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Acino Pharma GmbH ,1,27/07/2009,"Acino Pharma GmbH
Am Windfeld 35
D-83714 Miesbach
Germany",,,,,,,,,Germany
Ionsys,EMEA/H/C/000612,fentanyl hydrochloride,fentanyl,"Pain, Postoperative",N02AB03,,Janssen-Cilag International NV,3,23/01/2006,"Turnhoutseweg, 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
ImmunoGam,EMEA/H/C/001055,human hepatitis B immunoglobulin,human hepatitis B immunoglobulin,"Immunization, Passive
Hepatitis B",J06BB04,,Cangene Europe Limited,0,15/03/2010,"Cangene Europe Ltd.
Parkshot House
5 Kew Road
Richmond, Surrey TW9 2PR
United Kingdom",,,,,,,,,United Kingdom
NeoSpect,EMEA/H/C/000263,depreotide trifluoroacetate,depreotide,Radionuclide Imaging,V09IA05,,CIS bio international,10,28/11/2000,"Route Nationale 306, Saclay
B.P. 32
F-91192 Gif sur Yvette Cedex
France",,,,,,,,,France
Zeftera (previously Zevtera),,ceftobiprole medocaril,ceftobiprole,"Skin Diseases, Infectious
Soft Tissue Infections",J01DI01,,,,,,,,,,Janssen-Cilag International NV,23/06/2010,,15/09/2010,
Milnacipran Pierre Fabre Medicament,,milnacipran,milnacipran,Fibromyalgia,,,,,,,,,,,Pierre Fabre Medicament,18/11/2009,,07/04/2010,
Impulsor,,milnacipran,milnacipran,Fibromyalgia,,,,,,,,,,,Pierre Fabre Medicament,18/11/2009,,07/04/2010,
Paxene,EMEA/H/C/000216,paclitaxel,paclitaxel,"Sarcoma, Kaposi
Carcinoma, Non-Small-Cell Lung
Ovarian Neoplasms
Breast Neoplasms",L01CD01,,Norton Healthcare Ltd.,14,18/07/1999,"Norton Healthcare Limited
Albert Basin
Royal Docks
London E16 2QJ
United Kingdom",,,,,,,,,United Kingdom
Bextra,EMEA/H/C/000431,valdecoxib,valdecoxib,"Arthritis, Rheumatoid
Osteoarthritis
Dysmenorrhea",M01AH03,,Pharmacia - Pfizer EEIG,2,26/03/2003,"Pharmacia-Pfizer EEIG
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Clopidogrel BMS,EMEA/H/C/000974,clopidogrel hydrogen sulphate,clopidogrel,"Stroke
Peripheral Vascular Diseases
Myocardial Infarction
Acute Coronary Syndrome",B01AC04,,Bristol-Myers Squibb Pharma EEIG,3,15/07/2008,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Turvel,EMEA/H/C/000158,trovafloxacin,trovafloxacin,Bacterial Infections,J01MA13,,Pfizer Limited,0,07/07/1998,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Turvel IV,EMEA/H/C/000159,alatrofloxacin mesylate,trovafloxacin,Bacterial Infections,J01MA13,,Pfizer Limited,0,02/07/1998,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Trovan IV,EMEA/H/C/000161,alatrofloxacin mesylate,trovafloxacin,Bacterial Infections,J01MA13,,Pfizer Limited,0,03/07/1998,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Allex,EMEA/H/C/000312,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Urticaria
Rhinitis, Allergic, Seasonal",R06AX27,,Schering-Plough Europe,0,15/01/2001,"SP Europe
Rue de Stalle, 73
B-1180 Bruxelles
Belgium",,,,,,,,,Belgium
Sovrima,,idebenone,idebenone,Friedreich Ataxia,N06BX13,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Centocor B.V.,19/11/2008,,26/04/2009,
Indimacis 125,EMEA/H/C/000065,igovomab,igovomab,"Radionuclide Imaging
Ovarian Neoplasms",V09IB03,,CIS bio international,0,03/10/1996,"B.P. 32
91192 Gif-sur-Yvette Cedex
France",,,,,,,,,France
Destara,EMEA/H/C/000103,ibandronic acid,ibandronic acid,"Hypercalcemia
Cancer",M05BA06,,Roche Registration Ltd.,0,24/06/1996,"Roche Registration Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom",,,,,,,,,United Kingdom
Tikosyn,EMEA/H/C/000238,dofetilide,dofetilide,"Atrial Fibrillation
Atrial Flutter",C01BD04,,Pfizer Limited,0,28/11/1999,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Rhucin,,recombinant human C1 inhibitor,recombinant human C1 inhibitor,Angioedema,B06C,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Pharming Group N.V.,18/03/2008,,21/05/2008,
Zelnorm,,tegaserod,tegaserod,Irritable Bowel Syndrome,A03AE02,,,,,,,,,,Novartis Europharm Limited,14/12/2005,,18/05/2006,
Genasense,,oblimersen,oblimersen,Melanoma,,,,,,,,,,,Genta Development Ltd. c/o Ross Craig,18/07/2007,,14/10/2007,
Tecnemab K1,EMEA/H/C/000068,anti-melanoma mab fragments,anti-melanoma mab fragments,Radioimmunodetection,V09IA02,,Amersham Sorin.S.r.l.,0,04/09/1996,",
Via dei Giardini 7
20121 Milan Italy",,,,,,,,,Italy
Evotopin,EMEA/H/C/000124,topotecan,topotecan,Ovarian Neoplasms,L01XX17,,Beecham Group plc,0,14/04/1997,",
Great West Road
Brentford, Middlesex, TW8 9BD
United Kingdom",,,,,,,,,United Kingdom
Trovan,EMEA/H/C/000160,trovafloxacin,trovafloxacin,Bacterial Infections,J01MA13,,Pfizer Limited,0,02/07/1998,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Rotashield,EMEA/H/C/000192,"rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant","rotavirus vaccine, attenuated","Immunization
Rotavirus Infections",J07BH,,Wyeth Lederle Vaccines S.A.,0,06/05/1999,"Rue du Bosquet, 15
B-1348 Louvain-la-Neuve
Belgium",,,,,,,,,Belgium
Irbesartan BMS,EMEA/H/C/000786,irbesartan,irbesartan,Hypertension,C09CA04,,Bristol-Myers Squibb Pharma EEIG,7,19/01/2007,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Irbesartan Hydrochlorothiazide BMS,EMEA/H/C/000784,"irbesartan
hydrochlorothiazide",irbesartan / hydrochlorothiazide,Hypertension,C09DA04,,Bristol-Myers Squibb Pharma EEIG,8,18/01/2007,"Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom",,,,,,,,,United Kingdom
Gemesis,,becaplermin,becaplermin,"Guided Tissue Regeneration, Periodontal",,,,,,,,,,,BioMimetic Therapeutics Ltd,18/11/2009,,28/01/2010,
Tekturna,EMEA/H/C/000852,aliskiren,aliskiren,Hypertension,C09XA02,,Novartis Europharm Ltd.,4,22/08/2007,"Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Trazec,EMEA/H/C/000383,nateglinide,nateglinide,"Diabetes Mellitus, Type 2",A10BX03,,Novartis Europharm Ltd.,5,02/04/2001,"Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom",,,,,,,,,United Kingdom
Posaconazole SP,EMEA/H/C/000611,posaconazole,posaconazole,"Candidiasis
Mycoses
Coccidioidomycosis
Aspergillosis",J02AC04,,Schering-Plough Europe,5,25/10/2005,"SP Europe
Rue de Stalle, 73
B-1180 Bruxelles
Belgium",,,,,,,,,Belgium
Raptiva,EMEA/H/C/000542,efalizumab,efalizumab,Psoriasis,L04AA21,,Serono Europe Limited,8,19/09/2004,"Serono Europe Ltd.
56 Marsh Wall
London E14 9TP
United Kingdom",,,,,,,,,United Kingdom
Procomvax,EMEA/H/C/000231,"polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC
outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B)
adsorbed hepatitis B surface antigen produced in recombinant yeast cells (Saccharomyces cerevisiae)",haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine,"Hepatitis B
Meningitis, Haemophilus
Immunization",J07CA,,"Sanofi Pasteur MSD, SNC",9,06/05/1999,"Sanofi Pasteur MSD SNC
8 rue Jonas Salk
F-69007 Lyon
FRANCE",,,,,,,,,France
Parareg,EMEA/H/C/000575,cinacalcet,cinacalcet,"Hypercalcemia
Parathyroid Neoplasms
Hyperparathyroidism",H05BX01,,Dompé Biotec S.p.A.,6,21/10/2004,"Via San Martino 12
I-20122 Milan
Italy",,,,,,,,,Italy
Dynepo,EMEA/H/C/000372,epoetin delta,epoetin delta,"Kidney Failure, Chronic
Anemia",B03XA,,Shire Pharmaceutical Contracts Limited,9,17/03/2002,"Shire Pharmaceutical Contracts Ltd.
Hampshire International Business Park
Basingstoke, Hampshire RG24 8EP
United Kingdom",,,,,,,,,United Kingdom
Velosulin,EMEA/H/C/000423,insulin human,insulin human (rDNA),Diabetes Mellitus,A10AB01,,Novo Nordisk A/S,5,06/10/2002,"Novo Allé
DK-2880 Bagsvaerd
Denmark",,,,,,,,,Denmark
Zenapax,EMEA/H/C/000198,daclizumab,daclizumab,"Graft Rejection
Kidney Transplantation",L04AA08,,Roche Registration Ltd.,8,25/02/1999,"Roche Registration Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom",,,,,,,,,United Kingdom
Zimulti,EMEA/H/C/000691,rimonabant,rimonabant,Obesity,A08AX01,,sanofi-aventis,8,18/06/2006,"174, avenue de France
F - 75013 Paris
France",,,,,,,,,France
Acomplia,EMEA/H/C/000666,rimonabant,rimonabant,Obesity,A08AX01,,sanofi-aventis,8,18/06/2006,"74, avenue de France
F - 75013 Paris
France",,,,,,,,,France
Nespo,EMEA/H/C/000333,darbepoetin alfa,darbepoetin alfa,"Kidney Failure, Chronic
Anemia
Cancer",B03XA02,,Dompé Biotec S.p.A.,19,08/06/2001,"Via San Martino 12
I-20122 Milan
Italy",,,,,,,,,Italy
Neupopeg,EMEA/H/C/000422,pegfilgrastim,pegfilgrastim,"Neutropenia
Cancer",L03AA13,,Dompé Biotec S.p.A.,9,22/08/2002,"Via San Martino 12
I-20122 Milan
Italy",,,,,,,,,Italy
Forcaltonin,EMEA/H/C/000197,recombinant salmon calcitonin (rsct),recombinant salmon calcitonin,"Hypercalcemia
Osteitis Deformans
Bone Resorption",H05BA01,,Unigene UK Ltd.,0,11/01/1999,"Unigene UK Limited
191 Sparrows Herne
Bushey Heath
Hertfordshire WD23 1AJ
United Kingdom",,,,,,,,,United Kingdom
Viraferon,EMEA/H/C/000282,interferon alfa-2b,interferon alfa-2b,"Hepatitis C, Chronic
Hepatitis B, Chronic",L03AB05,,Schering-Plough Europe,11,08/03/2000,"SP Europe
Rue de Stalle, 73
B-1180 Bruxelles
Belgium",,,,,,,,,Belgium
Exubera,EMEA/H/C/000588,insulin human,insulin human,Diabetes Mellitus,A10AF01,,Pfizer Limited,6,24/01/2006,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Protopy,EMEA/H/C/000375,tacrolimus,tacrolimus,"Dermatitis, Atopic",D11AX14,,Astellas Pharma GmbH,10,27/02/2002,"Astellas Pharma Europe B.V.
Elisabethhof 19
NL-2353 EW Leiderdorp
The Netherlands",,,,,,,,,The Netherlands
Quintanrix,EMEA/H/C/000556,"Diphtheria toxoid
tetanus toxoid
inactivated Bordetella pertussis
hepatitis B surface antigen (rDNA)
Haemophilus influenzae type b polysaccharide","diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus influenzae type B conjugate vaccine (absorbed)","Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Diphtheria",J07CA10,,GlaxoSmithKline Biologicals S.A.,2,17/02/2005,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Quixidar,EMEA/H/C/000404,fondaparinux sodium,fondaparinux sodium,"Venous Thrombosis
Pulmonary Embolism
Myocardial Infarction
Angina, Unstable",B01AX05,,Glaxo Group Ltd.,10,20/03/2002,"Glaxo Group Limited
Greenford Road
Greenford, Middx UB6 0NN
United Kingdom",,,,,,,,,United Kingdom
Cimzia,,Certolizumab pegol,certolizumab pegol,Crohn Disease,L04AB05,,,,,,,,,,UCB Pharma SA,18/03/2008,,20/05/2008,
Levviax,EMEA/H/C/000355,telithromycin,telithromycin,"Community-Acquired Infections
Pharyngitis
Bronchitis, Chronic
Pneumonia
Tonsillitis
Sinusitis",J01FA15,,Aventis Pharma S.A.,10,09/07/2001,"20 avenue Raymond Aron
92165 Antony Cedex
France",,,,,,,,,France
Trudexa,EMEA/H/C/000482,adalimumab,adalimumab,"Spondylitis, Ankylosing
Arthritis, Rheumatoid
Arthritis, Psoriatic
Crohn Disease",L04AA17,,Abbott Laboratories Ltd.,8,31/08/2003,"Queenborough
Kent ME11 5EL
United Kingdom",,,,,,,,,United Kingdom
Monotard,EMEA/H/C/000440,insulin human,insulin human (rDNA),Diabetes Mellitus,A10AC01,,Novo Nordisk A/S,0,06/10/2002,"DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Ultratard,EMEA/H/C/000439,insulin human,insulin human (rDNA),Diabetes Mellitus,A10AE01,,Novo Nordisk A/S,0,06/10/2002,"DK-2880 Bagsværd
Denmark",,,,,,,,,Denmark
Natalizumab Elan Pharma,,natalizumab,natalizumab,Crohn Disease,L03AD,,,,,,,,,,Elan Pharma International Ltd.,14/11/2007,,10/01/2008,
Mylotarg,,gemtuzumab ozogamicin,gemtuzumab ozogamicin,"Leukemia, Myeloid, Acute",L01XC05,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,Wyeth Europa Ltd,23/01/2008,,13/04/2008,
Mycograb,,recombinant human monoclonal antibody to hsp,efungumab,Candidiasis,J02,,,,,,,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,NeuTec Pharma plc,19/03/2007,,21/05/2007,
Fortovase,EMEA/H/C/000178,saquinavir,saquinavir,HIV Infections,J05AE01,,Roche Registration Ltd.,11,19/08/1998,"Roche Registration Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom",,,,,,,,,United Kingdom
Thymanax,,Agomelatine,Agomelatine,"Depressive Disorder, Major",,,,,,,,,,,Les Laboratoires Servier,26/07/2006,,15/01/2007,
Valdoxan,,Agomelatine,Agomelatine,"Depressive Disorder, Major",,,,,,,,,,,Les Laboratoires Servier,26/07/2006,,15/01/2007,
Alpheon,,recombinant human interferon alfa-2a,interferon alfa-2a,"Hepatitis C, Chronic",L03AB04,,,,,,,,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",BioPartners GmbH,27/06/2006,,04/09/2006,
Infergen,EMEA/H/C/000186,interferon alfacon-1,interferon alfacon-1,"Hepatitis C, Chronic",L03AB09,,Astellas Pharma Europe B.V.,8,31/01/1999,"Elisabethhof 19
NL-2350 AC Leiderdorp
The Netherlands",,,,,,,,,The Netherlands
Uprima,EMEA/H/C/000327,apomorphine hydrochloride,apomorphine,Erectile Dysfunction,G04BE,,Abbott Laboratories Ltd.,4,27/05/2001,"Queenborough
Kent ME11 5EL
United Kingdom",,,,,,,,,United Kingdom
Daquiran,EMEA/H/C/000135,pramipexole dihydrochloride monohydrate,pramipexole,Parkinson Disease,N04BC05,,Dr. Karl Thomae GmbH,5,26/10/1997,"Birkendorfferstr. 65
D-88397 Biberach/Riss
Germany",,,,,,,,,Germany
Theryttrex,EMEA/H/C/000445,yttrium [90Y] chloride,yttrium [90Y] chloride,Radionuclide Imaging,V09,,MDS Nordion S.A.,1,06/01/2003,"Zoning Industriel
B-6220 Fleurus
Belgium",,,,,,,,,Belgium
Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KG,EMEA/H/C/000307,tenecteplase,tenecteplase,Myocardial Infarction,B01AD,,Boehringer Ingelheim International GmbH,2,22/02/2001,"Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany",,,,,,,,,Germany
CEA-Scan,EMEA/H/C/000041,arcitumomab,arcitumomab,"Radionuclide Imaging
Colorectal Neoplasms",V09IA01,,Immunomedics GmbH,6,03/10/1996,"Immunomedics Europe
Otto-Rà¶hm-Strasse 69
D-64293 Darmstadt
Germany",,,,,,,,,Germany
Rayzon,EMEA/H/C/000382,parecoxib,parecoxib,"Pain, Postoperative",M01AH04,,Pharmacia Europe EEIG,4,21/03/2002,"Hillbottom Road
High Wycombe
Buckinghamshire
HP12 4PX
United Kingdom",,,,,,,,,United Kingdom
Patrex,EMEA/H/C/000204,sildenafil,sildenafil,Erectile Dysfunction,G04BE03,,Pfizer Limited,4,14/09/1998,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Valdyn (previously Kudeq),EMEA/H/C/000437,valdecoxib,valdecoxib,"Arthritis, Rheumatoid
Osteoarthritis
Dysmenorrhea",M01AH03,,Pfizer Limited,0,27/03/2003,"Ramsgate Road
Sandwich
Kent
CT13 9NJ
United Kingdom",,,,,,,,,United Kingdom
Infanrix HepB,EMEA/H/C/000126,"Diphtheria toxoid
tetanus toxoid
pertussis toxoid
pertussis haemagglutin filamentous
pertactin
hepatitis B recombinant surface antigen","diphtheria, tetanus, acellular pertussis and hepatitis B recombinant, adsorbed vaccine","Hepatitis B
Tetanus
Immunization
Whooping Cough
Diphtheria",J07CA,,GlaxoSmithKline Biologicals S.A.,3,29/07/1997,"Rue de l'Institut, 89
B-1330 Rixensart
Belgium",,,,,,,,,Belgium
Nyracta,EMEA/H/C/000269,rosiglitazone,rosiglitazone,"Diabetes Mellitus, Type 2",A10BG02,,SmithKline Beecham Plc,6,10/07/2000,"SmithKline Beecham plc
980 Great West Road,
Brentford, Middlesex, TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Venvia,EMEA/H/C/000270,rosiglitazone,rosiglitazone,"Diabetes Mellitus, Type 2",A10BG02,,SmithKline Beecham Plc,6,10/07/2000,"SmithKline Beecham plc
980 Great West Road,
Brentford, Middlesex, TW8 9GS
United Kingdom",,,,,,,,,United Kingdom
Taluvian,EMEA/H/C/000386,apomorphine hydrochloride,apomorphine,Erectile Dysfunction,G04BE,,Abbott S.r.l.,0,27/05/2001,"Abbott S.p.A.
I-04010 Campoverde di Aprilia
(Latina)
Italy",,,,,,,,,Italy
Ixense,EMEA/H/C/000328,apomorphine hydrochloride,apomorphine,Erectile Dysfunction,G04BE,,Takeda Europe R Centre Ltd.,0,27/05/2001,"Takeda Global Research and Development Centre (Europe) Ltd.
Arundel Great Court
2 Arundel Street
London WC2R 3DA
United Kingdom",,,,,,,,,United Kingdom
Xapit,EMEA/H/C/000380,parecoxib,parecoxib,"Pain, Postoperative",M01AH04,,Pharmacia Europe EEIG,0,21/03/2002,"Hillbottom Road
High Wycombe
Buckinghamshire
HP12 4PX
United Kingdom",,,,,,,,,United Kingdom
Valdyn,EMEA/H/C/000432,valdecoxib,valdecoxib,"Osteoarthritis
Arthritis, Rheumatoid
Dysmenorrhea",M01AH03,,Pharmacia Europe EEIG,0,26/03/2003,"Hillbottom Road
High Wycombe
Buckinghamshire
HP12 4PX
United Kingdom",,,,,,,,,United Kingdom
Opulis,EMEA/H/C/000311,desloratadine,desloratadine,"Rhinitis, Allergic, Perennial
Urticaria
Rhinitis, Allergic, Seasonal",R06AX27,,Schering-Plough Europe,0,15/01/2001,"SP Europe
Rue de Stalle, 73
B-1180 Bruxelles
Belgium",,,,,,,,,Belgium
Cotronak,EMEA/H/C/000247,Ribavirin,ribavirin,"Hepatitis C, Chronic",J05AB04,,Schering-Plough Europe,4,06/05/1999,"SP Europe
Rue de Stalle, 73
B-1180 Bruxelles
Belgium",,,,,,,,,Belgium
HumaSPECT,EMEA/H/C/000145,votumumab,votumumab,"Ultrasonography
Colorectal Neoplasms
Tomography, X-Ray Computed",V09IX,,KS Biomedix Limited,0,24/09/1998,"KS Biomedix
Unit 7, Romans Business Park
East Street
Farnham, Surrey GU9 7SX
United Kingdom",,,,,,,,,United Kingdom
Yondelis,,trabectedin,trabectedin,Sarcoma,L01CX01,,,,,,,,,,Pharma Mar S.A.,19/11/2003,,06/09/2004,
Olansek,EMEA/H/C/000114,olanzapine,olanzapine,"Schizophrenia
Bipolar Disorder",N05AH03,,Eli Lilly Co. Ltd.,0,06/10/1996,"Eli Lilly and Company Limited
Erl Wood Manor
Sunningham Road
Windlesham, Surrey GU20 6PH
United Kingdom",,,,,,,,,United Kingdom
Hepacare,EMEA/H/C/000261,"hepatitis B, recombinant surface antigen",triple antigen hepatitis B vaccine (recombinant),"Hepatitis B
Immunization",J07BC,,Evans Vaccines Ltd.,0,03/08/2000,"Evans Vaccines Limited
Gaskill Road
Speke
Liverpool
L24 9GR
United Kingdom",,,,,,,,,United Kingdom
Vitravene,EMEA/H/C/000244,fomivirsen,fomivirsen,"Cytomegalovirus Retinitis
HIV Infections",S01AD08,,Novartis Ophthalmics Europe Ltd.,0,28/07/1999,"Delta House, Southwood Crescent
Southwood, Farnborough
Hants, GU14 0NL
United Kingdom",,,,,,,,,United Kingdom
Zartra,EMEA/H/C/000180,imiquimod,imiquimod,Condylomata Acuminata,L03AX,,Laboratoires 3M Santé,0,17/09/1998,"Laboratories 3M Sante
Boulevard de l'Oise
F-95029 Cergy Pontoise Cedex
France",,,,,,,,,France
Triacelluvax,EMEA/H/C/000181,"diphtheria toxoid, haemagglutinin filamentous, adsorbed, pertactin, pertussis toxin, tetanus toxoid","combined diphtheria, tetanus and acellular pertussis vaccine","Immunization
Tetanus
Whooping Cough
Diphtheria",J07AJ,,Chiron S.p.A.,0,10/01/1999,"CHIRON S.p.A.,
Via Fiorentina 1,
53100, Siena
Italy",,,,,,,,,Italy
Orlaam,EMEA/H/C/000077,levacetylmethadol,levacetylmethadol,Opioid-Related Disorders,N02AC,,Sipaco Internacional Lda.,0,30/06/1997,"Sipaco Internacional, Lda.
Avenida 5 de Outubro, 267 - 6a dto
1600 Lisboa
Portugal",,,,,,,,,Portugal
Vitrasert Implant,EMEA/H/C/000120,ganciclovir,ganciclovir,"Cytomegalovirus Retinitis
HIV Infections",J05AB06,,"Dr. Gerhard Mann, Chem.-Pharm. Fabrik GmbH..",0,18/03/1997,"Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH
Brunsbuetteler Damm 165-173
D-13581Berlin (Spandau)
Germany",,,,,,,,,Germany
Liprolog,EMEA/H/C/000143,insulin lispro,insulin lispro,Diabetes Mellitus,A10AB04,,Eli Lilly and Company Limited,0,06/05/1997,"Kingsclere Road
Basingstoke
Hants RG21 6XA
United Kingdom",,,,,,,,,United Kingdom
EchoGen,EMEA/H/C/000149,dodecafluoropentane,dodecafluoropentane,Echocardiography,V08DA,,Sonus Pharmaceuticals Ltd.,0,16/07/1998,"Knyvett House
The Causeway
Staines, Middlesex TW18 3BA
United Kingdom",,,,,,,,,United Kingdom
Ecokinase,EMEA/H/C/000106,reteplase,reteplase,Myocardial Infarction,B01AD07,,Roche Registration Ltd.,0,28/08/1996,"Roche Registration Limited
6 Falcon Way
Shire Park
Welwyn Garden City
AL7 1TW
United Kingdom",,,,,,,,,United Kingdom
Primavax,EMEA/H/C/000156,"diphtheria toxoid purified / hepatitis B, recombinant surface antigen / tetanus toxoid purified","diphtheria, tetanus and hepatitis B vaccine, adsorbed","Hepatitis B
Tetanus
Immunization
Diphtheria",J07CA,,Pasteur Mà¨rieux MSD,0,04/02/1998,"PASTEUR MERIEUX - MSD
8, rue Jonas SALK
69367 LYON Cà©dex 07
France",,,,,,,,,France
Pylori-Chek,EMEA/H/C/000182,13C-urea,13C-urea,"Breath Tests
Helicobacter Infections",V04CX,,Alimenterics B.V.,0,15/06/1998,"Paul-Ehrlich-Strasse 32 H8
D-63322 Roedermark
Germany",,,,,,,,,Germany
Slenyto,EMEA/H/C/004425,melatonin,melatonin,"Sleep Initiation and Maintenance Disorders
Autistic Disorder",N05CH01,,RAD Neurim Pharmaceuticals EEC Ltd.,0,19/09/2018,"5th Floor Thames Tower
Station Road
Reading
RG1 1LX
United Kingdom",,,,,,,,,United Kingdom
Pelgraz,EMEA/H/C/003961,pegfilgrastim,pegfilgrastim,Neutropenia,L03AA13,,Accord Healthcare Limited,0,20/09/2018,"Sage House
319 Pinner Road
North Harrow
Middlesex HA1 4HF
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,United Kingdom
Udenyca,EMEA/H/C/004413,pegfilgrastim,pegfilgrastim,Neutropenia,L03AA13,,ERA Consulting GmbH,0,20/09/2018,"Lange Strasse 70
29664 Walsrode
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Germany
Gefitinib Mylan,EMEA/H/C/004826,gefitinib,gefitinib,"Carcinoma, Non-Small-Cell Lung",L01XE02,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S.,0,26/09/2018,"117 Allée des Parcs
69800 Saint Priest
France","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,France
Imfinzi,EMEA/H/C/004771,durvalumab,durvalumab,"Carcinoma, Non-Small-Cell Lung",L01XC28,,AstraZeneca AB,0,20/09/2018,"SE-151-85 Sodertalje
Sweden","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,Sweden
Galafold,EMEA/H/C/004059,migalastat hydrochloride,migalastat,Fabry Disease,A16AX,,Amicus Therapeutics UK Ltd,7,25/05/2016,"Phoenix House
Oxford Road
Tatling End
Gerrards Cross SL9 7AP
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.","This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,United Kingdom
Champix,EMEA/H/C/000699,varenicline,varenicline,Tobacco Use Cessation,N07BA03,,Pfizer Europe MA EEIG,33,25/09/2006,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Wilzin,EMEA/H/C/000535,zinc,zinc,Hepatolenticular Degeneration,A16AX05,,Orphan Europe S.A.R.L.,9,12/10/2004,"Immeuble ""Le Wilson""
70, avenue du Général de Gaulle
FR-92800 Puteaux
France",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,France
Cyltezo,EMEA/H/C/004319,adalimumab,adalimumab,"Hidradenitis Suppurativa
Arthritis, Psoriatic
Psoriasis
Crohn Disease
Arthritis, Juvenile Rheumatoid
Uveitis
Arthritis, Rheumatoid
Colitis, Ulcerative
Spondylitis, Ankylosing",L04AB04,,Boehringer Ingelheim International GmbH,2,10/11/2017,"Binger Strasse 173 55216
Ingelheim am Rhein
Germany","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Germany
Zessly,EMEA/H/C/004647,infliximab,infliximab,"Arthritis, Psoriatic
Psoriasis
Crohn Disease
Arthritis, Rheumatoid
Colitis, Ulcerative
Spondylitis, Ankylosing",L04AB02,,Sandoz GmbH,1,18/05/2018,"Biochemiestrasse 10
6250 Kundl
Austria","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,Austria
Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover),EMEA/H/C/001144,"clopidogrel
acetylsalicylic acid",clopidogrel / acetylsalicylic acid,"Acute Coronary Syndrome
Myocardial Infarction",B01AC30,,Sanofi-Aventis Groupe,21,14/03/2010,"54 rue La Boétie
F-75008 Paris
France",,,,,,,,,France
Volibris,EMEA/H/C/000839,Ambrisentan,ambrisentan,"Hypertension, Pulmonary",C02KX02,,GlaxoSmithKline (Ireland) Limited,18,20/04/2008,"12 Riverwalk
Citywest Business Campus
Dublin 24
Ireland",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,Ireland
Mozobil,EMEA/H/C/001030,Plerixafor,plerixafor,"Multiple Myeloma
Hematopoietic Stem Cell Transplantation
Lymphoma",L03AX16,,Genzyme Europe B.V.,15,30/07/2009,"Gooimer 10
NL-1411 DD Naarden
The Netherlands",,"This medicine was designated an orphan medicine. This means that it was developed for use against a rare, life-threatening or chronically debilitating condition or, for economic reasons, it would be unlikely to have been developed without incentives. For more information, see Orphan designation. ",,,,,,,The Netherlands
Galvus,EMEA/H/C/000771,vildagliptin,vildagliptin,"Diabetes Mellitus, Type 2",A10BH02,,Novartis Europharm Limited,16,25/09/2007,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Jalra,EMEA/H/C/001048,vildagliptin,vildagliptin,"Diabetes Mellitus, Type 2",A10BH02,,Novartis Europharm Limited,16,18/11/2008,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Xiliarx,EMEA/H/C/001051,vildagliptin,vildagliptin,"Diabetes Mellitus, Type 2",A10BH02,,Novartis Europharm Limited,16,19/11/2008,"Elm Park
Merrion Road
Dublin 4
Ireland",,,,,,,,,Ireland
Grastofil,EMEA/H/C/002150,filgrastim,filgrastim,Neutropenia,L03AA02,,Apotex Europe BV,10,17/10/2013,"Archimedesweg 2
2333 CN Leiden
Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,The Netherlands
Caelyx,EMEA/H/C/000089,doxorubicin hydrochloride,doxorubicin,"Sarcoma, Kaposi
Multiple Myeloma
Ovarian Neoplasms
Breast Neoplasms",L01DB,,Janssen-Cilag International N.V.,29,20/06/1996,"Turnhoutseweg 30
B-2340 Beerse
Belgium",,,,,,,,,Belgium
Moventig,EMEA/H/C/002810,naloxegol oxalate,naloxegol,"Constipation
Opioid-Related Disorders",A06AH03,,Kyowa Kirin Holdings B.V.,7,07/12/2014,"Bloemlaan 2
21 32NP Hoofddorp
E-mail: medinfo@kyowakirin.com
The Netherlands","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,,,,,,The Netherlands
Samsca,EMEA/H/C/000980,Tolvaptan,tolvaptan,Inappropriate ADH Syndrome,C03XA01,,Otsuka Pharmaceutical Netherlands B.V.,11,02/08/2009,"Herikerbergweg 292
1101 CT Amsterdam
Netherlands",,,,,,,,,The Netherlands
Accofil,EMEA/H/C/003956,filgrastim,filgrastim,Neutropenia,L03AA02,,Accord Healthcare Ltd,8,17/09/2014,"Sage House
319 Pinner Road
North Harrow HA1 4HF
United Kingdom","This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.",,,"This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.",,,,,United Kingdom
Vfend,EMEA/H/C/000387,voriconazole,voriconazole,"Candidiasis
Mycoses
Aspergillosis",J02AC03,,Pfizer Europe MA EEIG,43,19/03/2002,"Boulevard de la Plaine 17
1050 Bruxelles
Belgium",,,,,,,,,Belgium
Pregabalin Mylan,EMEA/H/C/004078,pregabalin,pregabalin,"Anxiety Disorders
Epilepsy",N03AX16,"This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.",Mylan S.A.S,6,24/06/2015,"117 Allee des Parcs
69800
Saint-Priest
France",,,,,,,,,France
